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Abbreviations and nomenclature 
 
 
MDR   methylation determining region 
TF    Transcription factor 
Pol II    RNA polymerase II 
KAT    Histone acetyltransferase 
HDAC   Histone deacetylase 
KMT    Histone lysine methyltransferase 
PRMT    Protein arginine methyltransferase 
me    any methylation state of an arginine or lysine 
me1    mono-methylation 
me2    di-methylation 
me3   tri-methylation 
PcG    Polycomb group protein 
TxG   Trithorax-group protein 
ES cell   Embryonic stem cell 
PRC    Polycomb repressive complex 
E1   embryonic day 1   
DNMT    DNA methyltransferase 
ICR   imprinting control region 
MBP   Methyl-CpG-binding protein 
PGC   primordial germ cell 
IAP    Intracisternal A particle (low copy retroviral-like element) 
DMR   differentially methylated region 
 
 
Protein names in capitals irrespective of mouse or human origin 
Gene names italic 
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The identity and function of different cellular subtypes critically depend on their 
unique set of expressed genes. Gene expression programs and their changes during 
development are mainly controlled by sequence-specific DNA binding factors. It has recently 
become clear that chromatin modifications are important regulators of these processes. 
While there are several chromatin-based pathways that correlate with gene repression, their 
exact role in silencing remains elusive. Moreover, for many repressive chromatin 
modifications a complete picture of the genomic distribution and its dynamics during 
development is lacking. Finally, it is still unclear how these genomic patterns of repressive 
chromatin marks are established. We here set out to address these questions by studying 
the targeting of H3K9me2 and DNA methylation during cellular differentiation. 
Our analysis revealed that H3K9me2 is highly abundant in embryonic stem cells and 
occurs in large domains that occupy more than half of the genome. H3K9me2 marks 
chromatin outside of transcribed, active or polycomb regulated sites, possibly keeping it in a 
repressed state. Importantly, abundance of H3K9me2 increases only slightly during neuronal 
differentiation, with a localized gain occurring at gene bodies of transcribed genes. By gene 
expression profiling we further show that the transcriptome complexity is very similar in stem 
cells and derived post-mitotic neurons. These data are in contrast to a previously suggested 
model which states that the pluripotent state of stem cells is accompanied by a global 
reduction in heterochromatin and a concomitant higher proportion of transcription. Together 
with results from other groups our data rather indicate that repressive chromatin is abundant 
in stem cells and upon differentiation gets redistributed only locally and not globally. It has 
been suggested that such a localized increase of repression at gene regulatory regions 
helps stabilizing lineage choices and differentiation processes. 
In order to investigate how chromatin-based repression pathways are targeted to 
gene regulatory sites, we focused on DNA methylation, a modification whose catalysis and 
epigenetic propagation are well understood. By site-specific sequence integration 
experiments we show that 1 kb promoter elements are sufficient to recapitulate endogenous 
DNA methylation patterns in stem cells and their dynamic changes upon differentiation, in a 
process that is independent of transcription. In stem cells, promoters are protected from 
DNA methylation by small sequence elements that we termed methylation determining 
regions (MDRs). Protection from DNA methylation by MDRs depends on a combination of 
DNA binding motifs, which get recognized by transcription factors such as RFX2. It has been 
speculated before that establishment of an unmethylated promoter state is facilitated by 
proteins that recognize unmethylated CpGs. While not excluding a role in maintenance, our 
data suggest that CpG-richness alone is not sufficient for initiation of this chromatin state. 
Summary 
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Remarkably, no additional sequence besides an MDR is needed to recapitulate 
differentiation-induced de novo methylation. Moreover, MDRs are able to protect neighboring 
sequences from DNA methylation in stem cells and from de novo methylation during 
differentiation. These results imply that one possible way of differentiation-induced de novo 
methylation could involve reduced binding of factors that protect from DNA methylation. 
In summary, H3K9me2 and DNA methylation occupy per default most the genome, 
even in cells with a high developmental potential. Accordingly, cellular differentiation is 
accompanied by focal, rather than global changes in repressive chromatin modifications. In 
the case of DNA methylation, such local changes at gene regulatory sites are determined by 
the underlying sequence and likely involve binding of transcription factors that protect from 
DNA methylation. 
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During mammalian development a single fertilized egg gives rise to hundreds of 
specialized cell types. During this process, cells go through a series of sequential lineage 
choices and gradually decrease their developmental potential. While the genetic information 
content of differentiating cells stays constant throughout development, their set of expressed 
genes is subject to major changes. Switches in transcriptional programs that govern 
embryogenesis are mainly determined by sequence specific DNA binding proteins. These 
transcription factors form gene regulatory networks that are reused during different steps 
throughout development (Davidson 2010). While DNA sequence recognition lies at the core 
of transcription networks, the packaging of DNA into chromatin allows for a second layer of 
regulation. Changes in the occupancy, structure and modifications of chromatin alter its 
accessibility and thereby influence binding of sequence specific factors. Furthermore, some 
chromatin modifications were demonstrated or proposed to be epigenetically inherited during 
cellular division (Margueron and Reinberg 2010). Given these properties of chromatin 
modifications, it has been speculated that they are major players in determining the plasticity 
and stability of lineage choices during development (Reik 2007). 
The following paragraphs will summarize current knowledge on the structure and 
remodeling of chromatin, on chromatin modifications and the role of these processes in 
transcriptional regulation in relation to my PhD thesis project. 
Introduction: Gene regulation 
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2.1. Gene regulation in bacteria and mammals 
 
The genome of E. coli, the most studied bacterial organism, contains around 4’300 
genes embedded in a circular genome of 4.6 x 106 basepairs (Blattner et al. 1997). In 
bacteria, regulation of gene expression is mostly needed to adjust the growth rate and 
metabolism in response to environmental changes. Jacob and Monod, who pioneered the 
study of bacterial gene regulation, suggested that promoters of structure genes are 
controlled by operator sites. Their operon model further stated that regulator genes act on 
the operator through action of a repressor, which itself can be modulated by small molecules 
(Jacob and Monod 1961). While this early model proposed that the repressor would be an 
RNA molecule and inhibit activity by base-pairing to the operator, it was later shown that 
transcriptional repressors represent proteins which bind to DNA in a sequence specific 
manner (Ptashne 1967). In bacteria, transcriptional repressors act by directly preventing 
access of the RNA polymerase to promoter regions. Transcriptional activators, on the other 
hand, facilitate binding of RNA polymerase and its associated factors and thereby induce 
transcription. While most transcription factors (TFs) show the same mode of activity (either 
repressive or active) on all their target genes, there are also examples where a TF acts as a 
repressor at some genes and as an activator at other target genes (Taniguchi and de 
Crombrugghe 1983). The activating and repressing transcription factors of E. coli form a 
highly interconnected network. More precisely, one TF regulates on average three genes, 
and one E.coli gene is directly controlled by two TFs (Thieffry et al. 1998). However, the 
connectivity of the TF network follows a power-law distribution and of the ~300 TFs that the 
E. coli genome codes for, only nine proteins control over half of all genes (Martinez-Antonio 
and Collado-Vides 2003). The TF network of E. coli is composed of smaller, repeatedly 
occurring network motifs, of which each has a specific function in determining gene 
expression (Shen-Orr et al. 2002). These functions include generation of temporal 
expression programs, control of responses to fluctuating external signals, adjustment of 
response time and generation of bi-stable gene expression (Alon 2007). 
Most of the basic transcriptional mechanisms are conserved between bacteria and 
eukaryotes. However, it has been argued that the logic of gene regulation is fundamentally 
different in eukaryotes (Struhl 1999). Prokaryotic transcription is mainly determined by the 
quality of the promoter sequence, and the in vivo transcription rate of an isolated promoter is 
similar to that achieved in vitro. The ground state for prokaryotic transcription therefore 
seems to be non-restrictive. In eukaryotes, RNA polymerase II (Pol II) needs help of several 
general transcription factors to be able to initiate transcription in vitro. Furthermore, in 
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contrast to the situation in bacteria, a eukaryotic core promoter is not sufficient to induce 
transcription in vivo. The ground state for eukaryotic transcription is therefore thought to be 
restrictive (Struhl 1999). This is mainly a consequence of the fact that eukaryotic DNA is 
packaged into a dense chromatin structure. Notably, emergence of histones, the basic unit 
of this chromatin structure, accompanied the evolutionary transition from prokaryotes to 
eukaryotes. It has therefore been speculated that evolution of a restrictive chromatin 
structure has been instrumental in allowing to acquire more genes in the eukaryotic genome 
by reducing noisy transcription initiation (Bird 1995).  
To overcome the restrictive state of chromatin, eukaryotic Pol II needs the action of 
transcriptional co-activators, which either directly interact with the Pol II complex or facilitate 
transcription by modifying the chromatin structure. Interaction of activators and the Pol II 
machinery further depends on a large protein complex known as the mediator complex 
[reviewed in (Malik and Roeder 2010)]. In addition, transcription initiation in higher 
eukaryotes is often regulated by enhancers; distal binding sites of transcriptional activators 
[reviewed in (Ong and Corces 2011)]. Together, these diverse transcriptional regulatory 
mechanisms enable eukaryotes to generate and fine-tune very complex temporal and spatial 
patterns of gene expression. 
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2.2. Chromatin 
2.2.1. The nucleosome as the basic unit of chromatin 
 
The term chromatin was first used by Walther Flemming to describe a structure in 
cell nuclei that strongly absorbed basophilic dyes (Flemming 1882). During the same time 
period, Miescher and Kossel investigated the chemical composition of the nucleus and 
identified nucleic acid and a protein portion that Kossel named ‘histon’ (Miescher 1871; 
Kossel 1884). Later, advances in fractionation methods revealed that the ‘histon’ protein part 
is composed of four different histones (Johns 1964). Experiments using endonuclease 
digestion further indicated that chromatin is composed of a sub-structure of around 200 bp in 
length (Hewish and Burgoyne 1973). Based on these results and cross-linking studies of 
histones it was proposed that the basic repeating unit of chromatin is formed by ~200 bp of 
DNA in complex with 4 histone pairs (Kornberg 1974; Kornberg and Thomas 1974). Electron 
microscopy revealed that this basic unit, which was later termed nucleosome, can be 
observed on isolated chromatin and that in vitro reconstituted nucleosomes can self-
assemble (Oudet et al. 1975). Finally, by obtaining crystal structures it was shown that 
histones contain two different domains: a globular histone-fold domain, consisting of one 
long and two short hydrophobic alpha-helices and a long unstructured, hydrophilic N-
terminal tail. Two histone H2A-H2B dimers and a histone H3-H4 tetramer build up the 
nucleosome core (Fig. 1). DNA is wrapped around this octamer of histones 1.65 times, 
corresponding to 147 bp of DNA (Luger et al. 1997). Repeats of nucleosome cores further 
assemble into higher-order chromatin structures which are stabilized by the linker histone 
H1, which is not part of the nucleosome core particle, but binds the nucleosome at the entry 
and exit sites of the DNA (Luger 2003).  
The in vivo architecture of higher-order assemblies of nucleosomal arrays and its 
potential influence on transcription regulation are still unclear. Transcriptional regulation at 
the level of nucleosomes, on the other hand, has been intensely investigated. Initial in vitro 
studies revealed that nucleosomes bound to promoters inhibit initiation of transcription 
(Knezetic and Luse 1986; Lorch et al. 1987). Besides generally hindering access of the 
transcription machinery, nucleosome occupancy directly influences binding of transcription 
factors. Notably, the inherent ability to bind nucleosomal templates seems to vary among 
different TFs (Taylor et al. 1991). Nucleosomes are generally depleted from active regulatory 
sites in the yeast genome, partly trough action of polyA tract sequences that repel 
nucleosomes (Iyer and Struhl 1995; Lee et al. 2004; Kaplan et al. 2009; Zhang et al. 2009). 
At yeast promoters, an interplay of nucleosome-free regions and TF binding sites of varying 
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affinity is used to fine tune transcriptional responses (Lam et al. 2008). There is recent 
evidence that also in mammalian cells transcription factor binding sites might be 
predetermined by reduced nucleosomal occupancy (John et al. 2011). 
 
2.2.2. Chromatin remodeling 
 
Eukaryotes possess specific protein complexes which change nucleosome 
positioning and thereby potentially influence the accessibility of DNA. Genes that influence 
transcription by altering the chromatin structure were initially identified by screens for mutant 
yeast strains that affect mating-type switching and growth on sucrose (Neigeborn and 
Carlson 1984; Hirschhorn et al. 1992; Peterson and Herskowitz 1992). These so called 
chromatin remodeling complexes use ATP hydrolysis to disrupt DNA-nucleosome contacts, 
remove or exchange nucleosomes or to move nucleosomes along DNA.  Chromatin 
remodelers can be grouped in to four different protein families: The SWI/SNF family, the 
INO80/SWR1 family, the ISWI family and the CHD family [reviewed in (Hargreaves and 
Crabtree 2011)]. To function in vivo, most chromatin remodeler ATPases form large 
complexes with additional factors. Reports on a neuron-specific SWI/SNF complex 
suggested that switches in the subunit composition of remodeler complexes are critically 
involved in cellular differentiation processes (Lessard et al. 2007). Since most functional in 
vitro studies on ATP dependent remodelers where performed without including all subunits 
of the complex, it is unclear how much such experiments reflect the in vivo function 
(Hargreaves and Crabtree 2011) . Despite this caveat, in vitro studies led to models, how 
remodeling complexes utilize ATP hydrolysis to move DNA around nucleosomes. In case of 
ACF, a member of the ISWI family, it has been proposed that the remodeler introduces a 
DNA loop at the nucleosome entry site that propagates and leads to repositioning of the 
nucleosome (Strohner et al. 2005). A way how such repositioning of nucleosomes can affect 
the expression of genes has been shown for the Isw2 complex in yeast. Here, the Isw2 
complex is needed for positioning of nucleosomes over sequences at promoters that are 
thermodynamically unfavorable for nucleosomes, which leads to reduced accessibility and 
transcription factor binding (Whitehouse and Tsukiyama 2006). Moreover, this repositioning 
enforces the directionality of transcription initiation and prevents transcription from cryptic 
sites (Whitehouse et al. 2007). Conversely, remodelers also play a role in increasing 
accessibility of chromatin and can thereby enhance gene expression. The time point of the 
transcriptional cycle, during which the action of a particular remodeler is needed, varies from 
gene to gene (Clapier and Cairns 2009). The timing itself is likely regulated by specific 
transcription factors that recruit chromatin modelers. For instance, recruitment of SWI/SNF 
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by the transcription factor SWI5 represents the first step of transcription initiation at the yeast 
HO promoter (Cosma et al. 1999). 
 
2.2.3. Histone variants 
 
The first indications that histone proteins occur as different variants came from 
biochemical studies on calf thymus nuclei (Marzluff et al. 1972). It was later shown that these 
non-canonical histone-variants are found as single copies in the genome and are expressed 
throughout the cell cycle. This stands in contrast to canonical histones (H2A, H2B, H3 and 
H4), which occur as clustered arrays in the genome and are transcriptionally linked to DNA 
replication [for a recent review on histone variants see (Talbert and Henikoff 2010)]. Certain 
histone variants, including CENP-A, H3.3, H2A.Z and H2A.X, evolutionary date back to the 
earliest known diversifications of eukaryotic lineages, while others, such as Macro H2A, are 
only found in animals (Malik and Henikoff 2003; Talbert and Henikoff 2010). In general, 
these universal variants are thought to directly alter the nucleosome structure and thereby its 
stability. 
CENP-A is an H3 like histone variant that is specifically found at centromeres and 
plays an essential role in assembly of the kinetochore (Palmer et al. 1991; Santaguida and 
Musacchio 2009). The histone variant H2AX, on the other hand, is involved in DNA repair 
processes. Phosphorylation of H2AX upon induction of double-strand breaks leads to 
recruitment of DNA repair proteins, histone modifying enzymes and chromatin remodeling 
complexes (van Attikum and Gasser 2009). Macro H2A occurs on the inactive X 
chromosome and was recently reported to bind to proteins modified by poly-ADP-
ribosylation (Chadwick and Willard 2002; Timinszky et al. 2009). Further, it has been shown 
that in vitro assembled nucleosome containing macro H2A show an altered structure which 
prevents binding of a particular transcription factor (NK-kB) and impedes remodeling by the 
SWI/SNF complex  (Angelov et al. 2003). In yeast, the histone variant H2A.Z occurs 
preferentially around nucleosome-free regions at promoters irrespective of their 
transcriptional status (Raisner et al. 2005). H2A.Z has seemingly contradictory influence on 
activation and repression of transcription, heterochromatin and DNA repair (Zlatanova and 
Thakar 2008). It has however been proposed that a common feature of these diverse roles 
might be the tendency of H2A.Z to form stably positioned nucleosomes (Talbert and Henikoff 
2010). The histone variant H3.3 replaces nucleosomes that get evicted during the process of 
transcription (Wirbelauer et al. 2005). H3.3 is also enriched at DNA hypersensitive sites, at 
sites regulated by the trithorax and polycomb group proteins and at origins of replication 
(Mito et al. 2007). It has recently been reported that these different sites of H3.3 deposition 
Introduction: Chromatin 
 
15 
 
show differential turnover of nucleosomes, which might directly influence local accessibility 
and gene expression (Deal et al. 2010). However, transcriptional regulation does not seem 
to critically depend on the histone variant H3.3, since Drosophila mutants lacking both 
copies of H3.3 are viable (Hodl and Basler 2009). 
 
 
Figure 1. Model of chromatin structure. 
The box shows the nucleosome core structure with the 146-bp DNA backbones (brown and turquoise) 
and the main chains of the core histones (blue: H3; green: H4; yellow: H2A; red: H2B. Adapted from 
(Probst et al. 2009) and (Luger et al. 1997). 
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2.3. Chromatin modifications 
2.3.1. Histone modifications 
 
The first indications that histones are posttranslationally modified came from an in 
vitro experiment using isolated calf thymus nuclei and labeled acetyl and methyl donors. This 
study further provided evidence that acetylated histones keep a high affinity for 
nucleosomes, yet lose some of their capacity to inhibit RNA synthesis (Allfrey et al. 1964). 
Nowadays, it is known that histones can be posttranslationally modified in many different 
ways (Fig. 2). These various histone modifications either influence chromatin structure over 
short or long distances and regulate binding of effector molecules [reviewed in (Bannister 
and Kouzarides 2011)]. Below I will discuss different histone modifications, concentrating on 
the ones that relate to my PhD thesis work. 
2.3.1.1. Histone acetylation 
In their pioneering study on histone modifications, Allfrey et al. suggested that 
facilitation of transcription by histone acetylation depends on the neutralization of positively 
charged lysines, which disrupts stable electrostatic interactions of DNA with histones (Allfrey 
et al. 1964). 30 years later, this notion was supported by the observation that sites of histone 
acetylation overlap with DNAse hypersensitive regions, which are thought to reflect regions 
of nucleosome displacement (Hebbes et al. 1994). A further link between histone acetylation 
and gene activation was provided by identification of a histone acetyltransferase with high 
homology to the yeast transcriptional activator GCN5 (Brownell et al. 1996). At the same 
time, a screen for histone deacetylases identified a homolog of the yeast transcriptional 
regulator RPD3, suggesting that also removal of histone acetylation might play a regulatory 
role in transcription (Taunton et al. 1996). Since then, a multitude of histone 
acetyltranserases (KAT) and histone decetylases (HDAC) have been identified, many of 
which with a role in transcription. Most members of the KAT and HDAC protein families 
occur as stable multiprotein complexes and show relatively relaxed substrate specificity; a 
single enzyme is often able to modify multiple lysine sites of histone proteins (Yang and Seto 
2007). Genome-wide mapping of acetylation at all four core histones revealed that these 
marks often overlap and are highly correlative with transcription (Schubeler et al. 2004; 
Pokholok et al. 2005; Wang et al. 2008). Histone acetylation marks might therefore have an 
additive effect on chromatin accessibility and transcription. In support of this notion, 
combinatorial substitutions of lysine 5,8,12 of histone H4 in yeast lead to transcriptional 
changes that scale with the number of affected residues in a non-specific manner (Dion et al. 
2005). However, this model does not exclude that some acetylated lysine residues have a 
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specific role. In fact, the study by Dion et al. further reported a unique expression pattern 
associated with the deletion of lysine K16 on histone H4 (H4K16) (Dion et al. 2005). A 
specific effect of this particular acetylated lysine was later supported by the finding that 
H4K16 acetylation alone can inhibit formation of a 30 nm higher-order chromatin structure in 
vitro (Shogren-Knaak et al. 2006). Besides disrupting nucleosome-DNA interaction and 
chromatin fiber formation, histone acetylation also influences DNA templated events through 
binding of mediator proteins. Recognition of acetylated lysines occurs almost exclusively 
through highly conserved bromodomains, which occur in most KAT proteins, in the general 
transcription factor TAF1 and in many chromatin remodeling complexes (Zeng and Zhou 
2002; Taverna et al. 2007). 
 
2.3.1.2. Histone methylation 
Histone methylation occurs at lysines and arginines and, in contrast to acetylation, 
does not alter the amino acid charge. Histone lysine methyltransferases (KMTs) and protein 
arginine methyltransferases (PRMTs) catalyze addition of up to three methyl marks (me1, 
me2, me3). These enzymes show a high specificity for the residues they modify and for the 
number of added methyl groups (Bannister and Kouzarides 2011). 
 
2.3.1.2.1. Arginine methylation 
Shortly after the first report of a gene encoding a PRMT (Gary et al. 1996), Chen et 
al. identified CARM1 (now called PRMT4) that methylates histones and enhances 
transcription as a coactivator (Chen et al. 1999). Of the 11 PRMTs found in human, PRMT1 
and 4 possess a role as transcriptional coactivators and methylate either TFs, other 
coactivators or histones [reviewed in (Bedford and Clarke 2009)]. In case of the transcription 
factor RUNX1, arginine methylation by PRMT1 leads to its dissociation from the corepressor 
SIN3A, thereby promoting transcriptional activation (Zhao et al. 2008b). The mechanism of 
transcriptional activation by arginine methylation of histones is less clear, since up to date no 
specific mediator which binds arginine methylation has been identified. PRMT5 and 6 are the 
only two PRMTs with a role in transcriptional repression, with both acting through 
methylation of histones (Bedford and Clarke 2009). Again, no proteins that recognize single 
methylated arginines and possess repressive function are known. However, it has been 
shown that PRMT6 mediated histone H3 arginine 2 (H3R2) methylation precludes binding of 
proteins that bind to methylated lysine 4 on the same histone (H3K4me), such as the H3K4 
methyltransferase MLL1 (Hyllus et al. 2007; Iberg et al. 2008). This suggests that histone 
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arginine methylation might influence transcriptional activation through inhibition of H3K4 
methylation, which is generally correlated with accessible chromatin. 
 
2.3.1.2.2. H3K9 methylation 
Only recently, the Jenuwein group identified the first histone lysine 
methyltransferase, SUV39H1, and showed that its SET domain catalyses H3K9 methylation 
(Rea et al. 2000). The same group later identified SUV39H2 and showed that deletion of 
both of these KMTs impairs pericentric hetereochromatin formation and genome stability 
(O'Carroll et al. 2000; Peters et al. 2001). This work led to a model how constitutive 
heterochromatin, which is mainly found at the repeat-rich centromeric and telomeric regions, 
is assembled and maintained. In this model, H3K9me3 recruits HP1, which itself recruits two 
different SUV420H enzymes that mediate H4K20me3 (Lachner et al. 2001; Schotta et al. 
2004). The H4K20me3 mark might be directly involved in setting up a compact higher-order 
structure at heterochromatin, since in vitro reconstituted nucleosomal arrays carrying 
H4K20me3 show enhanced condensation (Lu et al. 2008). Intact constitutive heterchromatin 
further depends on the association of HP1 with the de novo DNA methyltransferase 
DNMT3B. In line with a connection to DNA methylation, SUV39H double-knockout cells 
show reduced DNA methylation and slight transcriptional up-regulation of major satellite 
repeats (Lehnertz et al. 2003). Recent evidence indicates that transcripts originating from 
major satellite repeats are the initial trigger for recruitment of HP1 at pericentric 
heterochromatin (Maison et al. 2011). Whether HP1 subsequently recruits SUV39H and 
thereby starts a self-reinforcing loop of heterochromatin formation remains to be determined.  
SETDB1, G9a and GLP represent three additional KMTs with specificity towards 
H3K9. In contrast to the SUV39H homologs, these enzymes do not localize to constitutive 
heterochromatin and are rather involved in silencing repetitive DNA and retroviral repeats in 
euchromatic regions (Kouzarides 2007). It was recently reported that SETDB1, which 
catalyzes H3K9me3, acts together with the corepressor KAP1 in silencing of endogenous 
retroviruses during the period of early embryogenesis (Matsui et al. 2010). G9a and GLP 
form a heterodimeric complex and catalyze di-methylation of the H3K9 residue (Tachibana 
et al. 2005). G9a plays a role in targeting as well as in maintaining DNA methylation, which 
however occurs independently of its catalytic activity (Feldman et al. 2006; Dong et al. 
2008). Similarly, while G9a seems to be involved in promoter silencing at several genes, 
such as MAGE-2, IF-β and P21, it is yet unclear whether the H3K9me2 mark itself is 
required for transcriptional regulation (Tachibana et al. 2002; Gyory et al. 2004; Nishio and 
Walsh 2004). 
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2.3.1.2.3. H3K27 methylation 
Besides H3K9 methylation, H3K27me3 represents a second histone methyl mark 
that correlates with transcriptional repression. H3K27me3 is known as a mechanistic 
intermediate during transcriptional repression by Polycomb-group (PcG) proteins. PcG 
proteins and the antagonistically acting Trithorax-group (TrxG) proteins have initially been 
identified as regulators of HOX gene expression throughout drosophila embryonic 
development (Maeda and Karch 2006). While keeping a role in HOX gene regulation, PcG 
genes underwent a major expansion and diversification during vertebrate evolution 
(Whitcomb et al. 2007). 
In mammals, H3K27me3 seems to be essential for embryonic development, as 
deletion of PcG proteins that set this mark is early embryonic lethal (Faust et al. 1995; 
O'Carroll et al. 2001; Pasini et al. 2004). In embryonic stem (ES) cells, H3K27me3 and PcG 
proteins occupy many inactive promoters of key developmental regulators and are therefore 
thought to maintain pluripotency and cellular identity in these cells (Bernstein et al. 2006; 
Boyer et al. 2006; Lee et al. 2006). Gene repression by PcG proteins has also been 
implicated in regulation of cellular differentiation during later steps of development (Mohn et 
al. 2008; Ezhkova et al. 2009). 
Biochemical studies of PcG proteins revealed that they form at least two classes of 
complexes designated as polycomb repressive complexes 1 and 2 (PRC1 and PRC2), with 
each class including several complexes with distinct compositions (Kerppola 2009). PRC2 
directly mediates H3K27me3, which in turn leads to recruitment of PRC1 through binding by 
chromodomains (Cao et al. 2002; Fischle et al. 2003). However, the dependency of PRC1 
on PRC2 does not seem to be strict, as at certain polycomb targets recruitment of PRC1 
seems to occur independently of H3K27me3 (Schoeftner et al. 2006). The PRC1 proteins 
RING1A and RING1B mediate monoubiquitination of histone H2A, a modification which was 
proposed to be directly responsible for PcG mediated gene repression (de Napoles et al. 
2004; Wang et al. 2004). However, as a recent study revealed that PRC1 mediated 
chromatin compaction does not depend on the ubiquitin mark (Eskeland et al. 2010), the 
mechanism of gene repression by PcG proteins remains elusive. 
It is also still not fully understood how PcG proteins are guided to their genomic 
targets. In drosophila, PRC2 gets recruited to defined sequences, termed polycomb 
response elements (PRE) [reviewed in (Muller and Kassis 2006)]. Binding of PREs is 
mediated by a complex pattern of different motifs recognized by various sequence-specific 
DNA-binding proteins, such as GAF, Zeste, DSP1, Pipsqueak, Grainyhead and SP1. 
However, as all of these factors also participate in processes other than PcG silencing, it 
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remains unclear which part of their range of activities is involved in targeting PREs (Beisel 
and Paro 2011). In mammals, the mechanism of polycomb recruitment is even less well 
understood. Recently reported mammalian PREs were of rather large size (2-3 kb) and their 
mode of specifying polycomb recruitment remained undefined (Sing et al. 2009; Woo et al. 
2010). Moreover, based on integration of ectopic DNA in murine ES cells, Mendenhall et al. 
proposed that PRC2 might be recruited by default to any CpG-rich sequence that is depleted 
of activating motifs (Mendenhall et al. 2010). On the other hand, it has been suggested that 
long noncoding RNAs, such as XIST, HOTAIR and ANRIL, directly recruit PcG proteins 
(Rinn et al. 2007; Zhao et al. 2008a; Yap et al. 2010). 
 
 2.3.1.2.4. H3K4 methylation 
The yeast protein SET1 was the first H3K4 methyltransferase to be identified (Briggs 
et al. 2001; Roguev et al. 2001). While these initial studies suspected H3K4 methylation to 
be involved in gene silencing, mapping of H3K4me in the yeast genome revealed that this 
mark is highly correlated with transcription. Remarkably, different methylation states of K4 
show a distinct profile over expressed genes: K4me3 peaks at start sites, K4me1 towards 
the 3' end of genes and K4me2 in between (Pokholok et al. 2005). As H3K4 methylation can 
be bound by chromatin remodelling complexes and different histone acetyltransferases, it 
might be directly involved in facilitating transcription initiation (Santos-Rosa et al. 2003; 
Taverna et al. 2006). In yeast, SET1 gets recruited by the Ser5 phosphorylated C-terminal of 
PollI through a link of H2BK123 monoubiquitination by a yet elusive mechanism (Dehe and 
Geli 2006). In mammals, the recruitment mechanism of SET1 to transcribed genes seems to 
be largely conserved (Zhu et al. 2005). However, mammals have at least ten known or 
predicted H3K4 methyltransferases indicating a high degree of specialization and/or 
redundancy (Ruthenburg et al. 2007). The H3K4 KMT MLL1, for example, binds to only a 
subset of transcribed genes and mice with an inactive Mll1 show a defined homeotic 
developmental phenotype (Milne et al. 2005; Terranova et al. 2006). Furthermore, although 
H3K4me3 can be directly bound by the general transcription factor TFIID and thereby might 
facilitate transcription (Vermeulen et al. 2007), H3K4me is not exclusively located at 
transcribed regions in mammals. Genome-wide maps rather showed that H3K4 methylation 
marks all promoters with a high CpG density irrespective of their activity (Roh et al. 2006; 
Guenther et al. 2007; Mikkelsen et al. 2007; Weber et al. 2007). The location of H3K4 
methylation at these regions might be linked to their general higher accessibility (Roh et al. 
2005). As an additional layer of complexity different methylation states of H3K4 seem to 
mark regions with distinct functions. H3K4me2 and me3 were suggested to play unique roles 
during developmental switches in progenitor cells and H3K4me1 is part of a group of histone 
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modifications that uniquely marks enhancer regions (Heintzman et al. 2007; Orford et al. 
2008). There is evidence that, similar to the situation at promoters, K4 methylation at 
enhancers may be involved in recruitment of chromatin modelers (Schnetz et al. 2009). It is 
not clear yet, how H3K4 HMTs are targeted to these regions, but it is likely that various 
mechanisms play a role, such as recruitment through TFs, RNAs or other histone 
modifications (Ruthenburg et al, 2007). 
 
2.3.1.2.5. H3K36 and H3K79 methylation 
In yeast, a second HMT, named SET2, is recruited by the elongating Pol II (Krogan 
et al. 2003). SET2 mediates H3K36 methylation, which in turn gets recognized by the 
histone deacetylase complex Rpd3 (Keogh et al. 2005). It has been suggested that H3K36 
mediated deacetylation within transcribed genes is involved in preventing spurious 
transcription (Carrozza et al. 2005). While higher eukaryotes posses at least three additional 
H3K36 HMTs (Kouzarides 2007), the preferential location of H3K36 methylation at gene 
bodies of active genes is conserved (Barski et al. 2007; Bell et al. 2007). Experiments in 
drosophila revealed that two different HMTs mediate H3K36me2 and me3, with the latter 
mark showing preferred enrichment towards the 3’ end of transcribed genes. Interestingly, 
while H3K36me3 in analogy to the situation in yeast signals reduction of H4K16ac, the 
dimethyl mark seems to have the opposing effect (Bell et al. 2007). 
H3K79 methylation represents an additional mark that was shown to be enriched at 
transcribed genes (Schubeler et al. 2004). H3K79 methylation is catalyzed by DOT1, which 
is the only lysine HMT that does not contain a SET domain (Feng et al. 2002; van Leeuwen 
et al. 2002). DOT1 catalyses all three methylation variants of H3K79, which seem to 
colocalize in the genome (Frederiks et al. 2008). To date, no protein that specifically binds to 
H3K79me has been identified and the role of this modification in regulation of gene 
expression remains unclear. 
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Figure 2. Histone modifications. 
Overview of some of the known post-translational modifications on the N-terminal and C-
terminal tails of canonical histones. Modifications groups are indicated as follows: ac, acetyl; 
Cit, citrullyl; me, methyl; ph, phosphoryl; pr, propionyl; rib, ADP-ribosyl; and Ub, ubiquityl. 
Adapted from (Chatterjee and Muir 2010). 
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2.3.2. DNA methylation 
 
In prokaryotes, DNA methylation at cytosines and adenines is part of the so called 
restriction-modification system, a defense mechanism against invading foreign DNA 
[reviewed in (Kobayashi 2001)]. In addition, bacterial DNA methylation plays a role in cell 
cycle regulation, DNA repair and transcriptional regulation  [reviewed in (Marinus and 
Casadesus 2009)]. 
In eukaryotes, DNA methylation occurs only at cytosines and is involved in 
maintaining a repressed chromatin state and stably silencing promoters (Bird and Wolffe 
1999; Colot and Rossignol 1999). While in plants and fungi cytosines can be methylated in 
the context of CpG, CpNpG or even in cytosines followed by any other bases, DNA 
methylation in animals occurs almost exclusively in the context of CpG dinucleotides. Not 
only the sequence context but also the extent and global patterns of DNA methylation vary 
extensively among different eukaryote species. 
2.3.2.1. DNA methylation in fungi and plants 
  
While the yeast species Saccharomyces cerevisiae and Saccharomyces pombe are 
both entirely devoid of DNA methylation, Neurospora crassa shows moderate levels of DNA 
methylation. In this fungal species, DNA methylation exclusively localizes to relics of 
transposons that were subject to repeat-induced point mutation, a genome defense system 
that mutates duplicated sequences (Selker et al. 2003). It was proposed that recruitment of 
DNA methylation to these loci involves recognition of A:T rich repeated sequences, followed 
by H3K9 methylation which subsequently triggers binding of HP1 and the DNA 
methyltransferase DIM-2 (Lewis et al. 2010). A recent genome-wide survey of DNA 
methylation at base-pair resolution revealed that the DNA methylation pattern observed in 
Neurospora crassa seems to be conserved in many fungal species (Zemach et al. 2010). 
  The model plant Arabidopsis thaliana displays moderate levels of DNA methylation 
and a mosaic genomic pattern with the mark exclusively occurring at gene bodies, 
transposons and repetitive elements (Zhang et al. 2006). In contrast to fungi, de novo 
methylation of transposons and repeat elements in plants depends on a RNA-directed 
mechanism (Wassenegger et al. 1994). This process involves two plant-specific RNA 
polymerases and several proteins of the RNA interference machinery [reviewed in (Matzke 
et al. 2009)]. Notably, non-CpG methylation is abundant in plant transposons, with short 
elements particularly enriched for asymmetric methylation (Zemach et al. 2010). Methylation 
in gene bodies, on the other hand, occurs almost exclusively at CpG dinucleotides (Lister et 
al. 2008). Remarkably, the highest enrichment of gene body methylation is found in genes 
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with moderate expression levels and it has been speculated that this might prevent spurious 
initiation during transcription elongation (Zilberman et al. 2007). The validity of this model 
remains however unclear, as in mutants with low levels of DNA methylation the observed 
increase of anti-sense transcripts is relatively moderate and not correlated to gene-body 
methylation (Zhang et al. 2006). 
From a comparative study of genome-wide methylomes of a variety of different 
species, it has been suggested that the common ancestor of plants, fungi and animals 
possessed a mosaic methylation pattern, with methylation at gene bodies and transposons, 
similarly to what is observed in Arabidopsis thaliana (Zemach et al. 2010). Loss of either or 
both targets of DNA methylation has occurred in many eukaryotic lineages, suggesting that 
methylation might come with a price in terms of evolutionary fitness. 
 
2.3.2.2. DNA methylation in animals 
 
While it has been reported that Drosophila melanogaster shows low levels of DNA 
methylation specifically during early embryonic development, subsequent studies could not 
reproduce these results and indicated that this insect species is entirely lacking DNA 
methylation (Phalke et al. 2009; Schaefer and Lyko 2010; Zemach et al. 2010). Moderate 
levels of DNA methylation have however been found in the following invertebrates; the 
honey bee Apis melifera, the silk moth Bombyx mori, the tunicate Ciona intestinalis and the 
anemone Nematostella vectensis (Wang et al. 2006; Zemach et al. 2010). These species 
show high CpG methylation in gene bodies of expressed genes, but no correlation between 
promoter methylation and transcription and no evidence of transposon methylation (Zemach 
et al. 2010). 
In contrast to invertebrates, which posses a mosaic methylation pattern, the vast 
majority of the vertebrate genome is methylated. Methylation occurs in a bimodal 
distribution; most of the genome is highly methylated (80-100%) and a few regions are 
unmethyated (0-20%) (Eckhardt et al. 2006). While DNA methylation generally localizes 
exclusively to CpG dinucleotides, a recent whole genome bisulfite sequencing study showed 
that non-CpG methylation occurs in pluripotent stem cells and localizes mainly to gene 
bodies of transcribed genes (Lister et al. 2009). It remains to be determined whether these 
low levels of non-CpG methylation have any functional role.  
How the evolutionary transition from mosaic to global DNA methylation in vertebrates 
was accomplished is unclear, yet is has been speculated that this change might have 
benefited the innate immune system (Suzuki and Bird 2008). Additionally, global DNA 
methylation might have been needed to more efficiently suppress noisy transcription in the 
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larger genomes of vertebrates (Bird 1995). Given the global methylation of vertebrate 
genomes, it is difficult to determine whether specific targeting of gene body methylation 
remained conserved from invertebrates to vertebrates. Evidence for a conservation of this 
relationship has been provided by studies on X chromosome inactivation. This phenomenon 
occurs in female mammals and is used to compensate the differing dosage of the X 
chromosome between females and males [reviewed in (Chow and Heard 2009)]. While on 
the inactivated X chromosome many promoter regions get hypermethylated, their associated 
gene bodies generally show less methylation, arguing that transcription in gene bodies and 
methylation might be linked (Hellman and Chess 2007). Interestingly, the connection 
between transcription elongation and DNA methylation might depend on direct recognition of 
H3K36 methylation by one of the mammalian DNA methyltransferases (Dhayalan et al. 
2010). 
 
2.3.2.3. The DNA methylation machinery 
 
As described above, fungi, plants and animals show substantial differences in 
patterns and functional roles of DNA methylation. This variation is also reflected in the 
proteins involved in writing and reading DNA methylation. Below, I will concentrate on 
describing the mammalian version of the DNA methylation machinery. Comprehensive 
descriptions of these processes in plants and fungi can be found elsewhere (Law and 
Jacobsen 2010; Rountree and Selker 2010). 
The first eukaryotic enzyme able to catalyze DNA methylation was purified and 
cloned by Bestor et al. and was later named DNA methyltransferase 1 (DNMT1) (Bestor et 
al. 1988). Subsequently, it was shown that purified DNMT1 preferentially acts on a 
hemimethylated DNA substrate (Yoder et al. 1997). While this in vitro study also reported 
reduced but significant activity on unmethylated DNA, recent structural work showed that 
DNMT1 contains a loop that prevents de novo methylation, confirming that DNMT1 solely 
acts on hemi-methylated DNA (Song et al. 2011b). Remarkably, the existence of a 
eukaryotic enzyme that methylates symmetric sites on a hemi-methylated substrate has 
been postulated more than ten years before the identification of DNMT1 (Holliday and Pugh 
1975; Riggs 1975). Recognition and methylation of CpGs in hemi-methylated DNA by 
DNMT1 provides a simple model how DNA methylation is propagated and stably maintained 
during mitosis. In accordance with this model, DNMT1 interacts with PCNA, which localizes 
to sites of DNA replication during S-phase (Chuang et al. 1997). Recognition of hemi-
methylated CpGs at replication forks is further aided by UHRF1 (also known as NP95) 
(Bostick et al. 2007; Sharif et al. 2007; Arita et al. 2008; Avvakumov et al. 2008). The 
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importance of an interaction between UHRF1 and DNMT1 is demonstrated by the high 
phenotypic resemblance of UHRF1-/- and DNMT1-/- mice, with both showing a 
developmental arrest shortly after gastrulation (Li et al. 1992; Sharif et al. 2007). The first 
indications that DNA methylation might have an effect on cellular differentiation resulted from 
studying the effect of a 5-azacytidine, an inhibitor of DNA methylation, on in vitro 
differentiation of myotubes (Jones and Taylor 1980). Remarkably, murine ES cells with a 
homozygous deletion of DNTM1 are viable and can be maintained in culture over a long 
period of time even though their total DNA methylation is dramatically reduced (Li et al. 
1992; Lei et al. 1996). However, consistent with the observed early lethality in vivo, in vitro 
differentiation of DNMT1-/- ES cells is not efficient (Li et al. 1992; Lei et al. 1996; Jackson et 
al. 2004). Furthermore, it has been reported that induced deletion of DNMT1 in cultured 
fibroblasts results in cell death (Jackson-Grusby et al. 2001). The different sensitivity of ES 
cells and differentiated cell to loss of DNA methylation could be related to transposon control 
mechanisms. In ES cells and presumably in the early embryo, repression of transposable 
elements mostly relies on H3K9 methylation, through a mechanism that is independent of 
DNA methylation (Matsui et al. 2010). In contrast, loss of DNA methylation in somatic cells 
leads to highly elevated levels of transposable elements, which might have a deleterious 
effect (Walsh et al. 1998; Jackson-Grusby et al. 2001). Alternatively, the lethal phenotype of 
DNMT1-/- embryos might be attributed to the loss of imprinting or the misregulated 
inactivation of one of the X chromosomes (Li et al. 1993; Panning and Jaenisch 1996). 
First evidence that early embryonic cells also encode an enzyme with de novo DNA 
methyltransferase activity was provided by experiments involving infection of DNMT1-/- ES 
cells with provirus DNA (Lei et al. 1996). This subsequently led to the identification of 
DNMT3A and DNMT3B, two highly homologous proteins which in vitro are able to de novo 
methylate fully unmethylated as well as hemi-methylated substrates (Okano et al. 1998). 
Only a combined deletion of both DNTM3 genes leads to impaired de novo methylation of 
inserted proviral DNA, suggesting that DNMT3A and DNMT3B might have overlapping 
functions in ES cells and early embryos (Okano et al. 1999). However, their expression 
patterns and functional role seems to be partially distinct. During embryogenesis, DNMT3B 
is specifically expressed in preimplantation stages, while DNMT3A expression is detected in 
an ubiquitous manner from embryonic day 10.5 (E10.5) on (Watanabe et al. 2002).  Mice 
deleted for both DNMT3 homologues show largely reduced methylation and stop 
development shortly after gastrulation, similarly to the DNMT1 mutant. Single deletions of 
DNMT3A and DNMT3B lead to less severe phenotypes, suggesting partially overlapping 
function during embryonic development. However, in accordance with their differential 
expression, single mutants of DNMT3A or DNMT3B show distinct phenotypes.  Mice with a 
homozygous deletion of DNMT3A develop to term, but die 4 weeks after birth. In contrast, 
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embryos lacking DNMT3B die shortly after E9.5, showing multiple developmental effects, 
including growth impairment and neural tube defects  (Okano et al. 1999). In line with these 
distinct deletion phenotypes, DNMT3A and DNMT3B vary in their target specificity. Promoter 
de novo methylation during early embryonic development mostly depends on DNMT3B 
(Borgel et al. 2010). During germ cell development, DNMT3A is required for methylation of 
most imprinting control regions (ICRs) and of SINEB1 elements, while only DNMT3B is 
involved in methylation of satellite repeats (Kato et al. 2007). 
The DNMT3 protein family includes a third member, DNMT3L, which however does 
not possess a catalytic domain. DNMT3L is expressed in germ cells and in the early embryo 
and is needed for methylation of ICRs in both the male and female germ line, as well as for 
methylation of several repetitive elements in the male germ line (Bourc'his et al. 2001; 
Bourc'his and Bestor 2004; Kato et al. 2007). Crystallography and biochemical studies 
revealed that DNMT3L interacts with DNMT3A, with two DNMT3L/3A heterodimers forming 
a tetramer. This interaction was shown to stimulate de novo methylation activity and 
recruitment to chromatin (Jia et al. 2007; Ooi et al. 2007).  
 DNMT2 is a strongly conserved protein that is widely distributed among species, 
even occurring in many species without DNA methylation. Although structure and sequence 
comparison strongly suggest it to be an active DNA methyltransferase, DNMT2 does not 
show any catalytic activity on DNA (Goll and Bestor 2005). DNMT2 was however reported to 
act as a RNA methyltransferase, methylating a cytosine in the anticodon loop of the aspartic 
acid transfer RNA (Goll et al. 2006; Jurkowski et al. 2008). 
 
2.3.2.4. The DNA methylation pattern in mammals 
 
Initial chromatography-based experiments suggested that the majority of CpGs in 
mammalian genomes are methylated (Gruenbaum et al. 1981). Usage of methylation 
sensitive restriction enzymes subsequently led to the identification of a small genomic 
fraction (1-2%) that is unmethylated in all tissues (Bird et al. 1985). Later, sites of  DNA 
methylation were mapped in a genome-wide manner using a variety of different methods 
[reviewed in (Zilberman and Henikoff 2007)]. These studies confirmed that DNA methylation 
levels occur in a bimodal distribution, with most of the genome being highly methylated and 
a minor proportion of genomic regions showing very low methylation (Weber et al. 2005; 
Weber et al. 2007; Meissner et al. 2008; Lister et al. 2009). Already the pioneering study by 
Bird et al. revealed that these unmethylated regions show an elevated CpG density (Bird et 
al. 1985). Due to this property, these regions were later termed CpG islands (Bird 1986). The 
occurrence of CpG islands is specific to genomes of vertebrates and a consequence of the 
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DNA methylation pattern found in these species. As C-to-T transitions occur in a higher 
frequency when a cytosine is methylated, the global DNA methylation in vertebrates led to 
an increased loss of CpGs during evolution (Illingworth and Bird 2009). Genomic regions 
that are unmethylated in the germ line, on the other hand, kept the expected CpG density 
and therefore appear as CpG islands (Weber et al. 2007). Different methods have been 
employed to predict CpG islands based on a limited set of sequence criteria such as GC 
content, ratio of the number of observed CpGs over expected, CpG clustering and region 
length (Gardiner-Garden and Frommer 1987; Takai and Jones 2002; Hackenberg et al. 
2006). Depending on the combination and thresholds of these somewhat arbitrary definition 
criteria, it was estimated that mammalian genomes contain 30’000 to 200’000 CpG islands, 
which cover around 1 % of the genome. CpG islands represent a large fraction of gene-
regulatory elements as around 70 % of all promoters contain CpG islands (Bajic et al. 2006). 
Additionally, there is evidence that CpG islands outside of promoters are involved in distal 
gene regulatory function (Tanay et al. 2007). While initiation at CpG poor promoters mostly 
relies on the TATA-box-binding protein and starts at a defined nucleotide position, initiation 
start sites in CpG islands are less strictly defined and fall in a broader sequence region of 
around 100 bp (Bajic et al. 2006; Carninci et al. 2006; Sandelin et al. 2007). Notably, CpG 
islands promoters are also more likely to initiate transcription in the antisense direction (Core 
et al. 2008; Seila et al. 2008). Further, it has been shown that activation of immediate early 
genes occurs more rapidly when their promoter contains a CpG island (Ramirez-Carrozzi et 
al. 2009). Together these findings indicate that CpG islands regions are relatively permissive 
for transcription initiation, a property that might be mediated by their unique chromatin state 
(Blackledge and Klose 2011). Histone acetylation, for example, is highly abundant at CpG 
islands irrespective of their association with promoters or transcriptional activity (Roh et al. 
2005). Furthermore, unmethylated CpG islands are generally occupied by H3K4me2/me3, a 
mark that might facilitate binding of proteins that initiate transcription, such as TFIID, the 
nucleosome remodeler NURF or the HBO1 KAT complex (Wysocka et al. 2006; Mikkelsen et 
al. 2007; Vermeulen et al. 2007; Weber et al. 2007; Saksouk et al. 2009). A recent study 
further revealed that CpG islands are enriched for KDM2A, an H3K36me2 specific lysine 
demethylase (Blackledge et al. 2010). Depletion of H3K36me2 at CpG islands might prevent 
binding of HDAC complexes, thereby representing another mechanism to keep these 
regions in open chromatin state (Carrozza et al. 2005). In concordance with their open 
chromatin structure and less stringent transcriptional control, CpG-rich promoters often 
control housekeeping gene. However, this represents not a strict correlation, since also 
around 50% of tissue-specific genes are controlled by CpG-rich promoters. Interestingly, 
CpG-rich, tissue specific gene promoters are enriched among targets of polycomb group 
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proteins, indicating that this repression system might be needed to suppress intrinsic 
transcriptional noise specifically at this promoter class (Mohn and Schubeler 2009). 
 
2.3.2.5. DNA methylation and transcription 
 
The effect of DNA methylation on gene transcription seems to differ between CpG-
poor and CpG-rich promoters. Single gene studies suggested that DNA methylation of CpG-
poor promoters can preclude transcription (Boyes and Bird 1992; Schubeler et al. 2000). 
However, measurements of genome-wide DNA methylation revealed that the majority of 
CpG-poor promoters are methylated in a given cell type even when the associated gene is 
transcribed (Weber et al. 2007; Meissner et al. 2008; Ball et al. 2009). It was therefore 
concluded that methylation at this promoter class does not preclude transcription initiation. 
However, it has recently been shown that transcriptional oscillations at a number of 
oestrogen responsive, CpG-poor promoters are accompanied by a cyclic gain and loss of 
DNA methylation. This indicated that transient hypomethylation might be linked to 
transcription of CpG-poor promoters (Kangaspeska et al. 2008; Metivier et al. 2008). The 
inconsistency of this result with findings from genome-wide studies could be explained by 
the fact that only a minority of alleles are actively transcribed in a group of cells (Larson et al. 
2009). Thus, by measuring DNA methylation of a cell population one could miss a possible, 
transient correlation of hypomethylation and transcription at CpG-poor promoters.  
While the effect of methylation at CpG-poor promoters requires further investigations, 
it is clear that DNA methylation of CpG island promoters is not compatible with transcription 
of the associated gene (Weber et al. 2007). This inhibitory effect of promoter DNA 
methylation happens at the step of transcription initiation and can be explained by two 
different models (Schubeler et al. 2000; Appanah et al. 2007). In the first model, DNA 
methylation precludes binding of methylation-sensitive transcription factors and thereby 
directly interferes with transcription initiation. Such a mode of action has been reported for 
several transcription factors including CREB, C-MYC and E2F (Iguchi-Ariga and Schaffner 
1989; Prendergast and Ziff 1991; Campanero et al. 2000). In the second model, methylated 
promoters get recognized by proteins that specifically bind to methylated CpGs and recruit 
cofactors that in turn repress transcription. A variety of such methyl-CpG-binding proteins 
(MBPs) are known and get generally divided into two classes: those sharing a methyl-CpG-
binding domain (MECP2, MBD1, MBD2 and MBD4) and those which bind via a zinc finger 
domain (KAISO, ZBTB4 and ZBTB38) (Hendrich and Tweedie 2003; Filion et al. 2006; 
Clouaire and Stancheva 2008; Dhasarathy and Wade 2008). For most of these proteins, it 
has been reported that they interact with factors that set up a repressive chromatin 
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environment. Among others, these include the SIN3A histone deacetylation co-repressor 
complex, H3K9 KMTs and the chromatin remodeling factors ATRX and BRM1 [reviewed in 
(Clouaire and Stancheva 2008)]. While such interactions provide a possible mechanism how 
DNA methylation leads to transcriptional repression, the precise function of MBPs at 
methylated promoter is still unclear. First of all, mice lacking one or several MBPs show mild 
and late-onset phenotypes which stands in contrast to the severe developmental phenotypes 
observed in mice lacking DNMT proteins (Li et al. 1992; Okano et al. 1999; Chen et al. 2001; 
Guy et al. 2001; Hendrich et al. 2001; Zhao et al. 2003; Martin Caballero et al. 2009). 
Secondly, the binding specificity of most MBPs has only been studied in vitro and genome-
wide location studies of most MBPs are still lacking. Interestingly, the only study mapping a 
MBP revealed that MECP2 binds to most of the genome, thus questioning its role as a gene-
specific transcriptional repressor (Skene et al. 2010). 
2.3.2.6. Changes of DNA methylation during development 
 
As discussed above, the mammalian genome is globally methylated with only a few 
regions, including CpG islands, being unmethylated. During mammalian development this 
methylation profile gets drastically modulated including gene-specific as well as genome-
wide changes (Fig. 3). One of two major waves of reprogramming of DNA methylation 
occurs during germ cell development [reviewed in (Sasaki and Matsui 2008)]. In mouse 
embryos, primordial germ cells (PGCs) get specified around E7 and then migrate to the 
genital ridge where they settle by E11.5. As shown by immunofluorescence studies, 
migration and maturation of PGCs is accompanied by global changes in various chromatin 
modifications. This reprogramming involves a loss of H3K9me2 and a subsequent decrease 
in DNA methylation, which is followed by an increase in H3K27me3 (Seki et al. 2005; Seki et 
al. 2007). A recent bisulfite sequencing study revealed that this loss of DNA methylation is 
massive, with only around 10% of CpGs remaining methylated (Popp et al. 2010). This study 
also confirmed earlier findings that intracisternal A particle (IAP) transposons are escaping 
the global wave of demethylation in PGCs (Hajkova et al. 2008; Popp et al. 2010). It is likely 
that genome-wide demethylation in PGCs restricts the potential involvement of DNA 
methylation in transgenerational epigenetic inheritance. In line with that notion, the only well-
studied example of transgenerational inheritance in mice involves differential methylation of 
an IAP element (Whitelaw and Whitelaw 2008). Besides a potential role in erasing epigenetic 
modifications from the previous generation, global demethylation in PGCs is needed to reset 
these cells to a more pluripotent state. It has further been shown that demethylation is 
crucial for reactivation of a set of germ-cell specific genes during development from the pre- 
to the postmigratory stage (Maatouk et al. 2006). In addition, methylation reprogramming is 
Introduction: Chromatin modifications 
 
31 
 
crucial for resetting parental imprints, which serve as epigenetic marks that ensure parental-
origin-specific monoallelic expression of around hundred imprinted genes in the next 
generation (Sasaki and Matsui 2008). 
After cell-intrinsic and -extrinsic factor have initiated sex determination at E12.5, 
germ cells progressively reestablish genome-wide DNA methylation (Lin et al. 2008; Kota 
and Feil 2010). While the extent and timing of this global de novo methylation is unclear, it is 
crucial for meiosis, as male germ cells lacking DNMT3L show elevated expression levels of 
retrotransposons and meiotic failure (Bourc'his and Bestor 2004). De novo methylation is 
also crucial in female germ cells, since female mice with a deletion of the chromatin 
remodeler LSH show disrupted meiosis which is likely caused by reduced DNA methylation 
and elevated levels of retrotransposon transcription (De La Fuente et al. 2006). The wave of 
de novo methylation in germ cells is accompanied by reestablishment of parental imprints in 
a gender-specific manner. In the male germ line, imprints at three different well studied loci 
get reestablished between E14.5 and the newborn stage (Li et al. 2004). It was shown that 
methylation at these differentially methylated regions (DMRs) of H19 and DLK1/GTL2 
depends on DNMT3A and DNMT3L, while the DMR at RASGRF1 requires action of all three 
DNMT3 proteins. The fact that the latter DMR contains a sequence derived from an 
endogenous retrovirus might explain the requirement for DNMT3B, since this enzyme is also 
needed for methylation of IAP retrotransposon methylation (Kato et al. 2007; Watanabe et al. 
2011). In the female germ line, various DMRs get methylated after birth during the phase of 
oocyte growth (Lucifero et al. 2004). While DNMT3A and DNMT3L are essential for maternal 
imprinting, DNMT3B seems to be dispensable (Bourc'his et al. 2001; Kaneda et al. 2004). 
The phenotype of LSH mutant mice indicates that besides its role in imprinting, DNA 
methylation is also crucially involved in retrotransposon silencing in oocytes (De La Fuente 
et al. 2006). 
Shortly after fertilization a second wave of genome-wide demethylation occurs. While 
demethylation occurs rapidly and prior to DNA replication in the paternal pronucleus, the 
maternal genome gets demethylated in a more progressive manner (Mayer et al. 2000; 
Oswald et al. 2000; Santos et al. 2002). Since these results are mostly based on 
immunostainings, the extent and targets demethylation are still unclear (Reik 2007). It is 
thought that global demethylation after fertilization facilitates the reprogramming of mature 
gametes, which are highly specialized cells, to a pluripotent state. In line with this, several 
factors that regulate pluripotency in the preimplantation embryo were shown to be 
methylated in sperm cells (Imamura et al. 2006; Farthing et al. 2008). Importantly, there are 
also sequences that resist demethylation after fertilization, including IAPs and parental 
imprints at DMRs (Reik 2007). While, two different proteins, STELLA and ZFP57 were 
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shown to be involved in protection from demethylation, their mode of action still remains to 
be determined (Nakamura et al. 2007; Li et al. 2008). 
Immunostaining experiments indicated that global DNA methylation levels get 
restored in the embryo at the blastocyst stage  (Dean et al. 2001). This was recently 
confirmed by a microarray study that determined DNA methylation levels in 11 kb region 
around promoters during this stage of embryonic development (Borgel et al. 2010). In E3.5 
blastocysts all examined regions were unmethylated, with the exception of genes carrying 
germline DMRs and a small set of gene promoters, which are enriched for genes expressed 
in the male germ line. In E6.5 epiblast, DNA methylation was restored at intergenic, 
intragenic and CpG-poor promoters, showing that the genome gets globally methylated 
during the implantation stage. While most CpG-rich promoters remain unmethylated in E6.5 
epiblast cells and in E9.5 embryonic tissue, a subset of this promoter class was found to get 
de novo methylated in a DNMT3B dependent manner (Borgel et al. 2010). Borget at al. 
showed that these de novo methylated promoters are enriched for germline and 
pluripotency-specific genes, a finding that confirmed earlier studies using ES cells (Farthing 
et al. 2008; Mohn et al. 2008). Although being isolated from the inner cell mass of E3.5 
blastocysts, in vitro cultured ES cells seem to recapitulate some of the de novo DNA 
methylation that happens in vivo. ES cells therefore show a DNA methylation pattern similar 
to that of epiblast cells, however without methylation of pluripotency genes (Borgel et al. 
2010). When comparing ES cell with differentiated cells, it was found that DNA methylation 
seems to control a relatively small set of promoters (Farthing et al. 2008; Meissner et al. 
2008; Mohn et al. 2008). Changes in differentiation-induced promoter DNA methylation are 
mainly unidirectional, with more de novo methylation than demethylation. Furthermore, 
genes of factors that are involved in maintaining the pluripotent state of ES cell are highly 
enriched among de novo methylated promoters. It has therefore been speculated that stable 
promoter repression by DNA methylation during embryonic development helps to restrict 
developmental potential and stabilizes cellular identity (Reik 2007; Guibert et al. 2009). In 
line with this model, DNA methylation of the ELF5 promoter is critically preventing cells of 
the embryonic lineage to enter the trophoblast lineage (Ng et al. 2008). Moreover, DNA 
methylation seems to be a major barrier for reprogramming of differentiated cells to a 
pluripotent state (Mikkelsen et al. 2008). Similarly, it was found that in vitro differentiated ES 
cells that fail in methylating promoters of pluripotency factors can be more easily reverted to 
a pluripotent state (Epsztejn-Litman et al. 2008). DNA methylation of pluripotency factors 
might safeguard these genes from expression in somatic cells, as this could lead to 
dedifferentiation and cause a predisposition to cancer (Hochedlinger et al. 2005). Since the 
kinetics of repression has been studied for only a few promoters that get de novo 
methylated, it is currently unclear whether DNA methylation is directly triggering repression 
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of these genes or rather gets accumulated after silencing (Guibert et al. 2009). In case of the 
OCT4 promoter, de novo methylation is one of the last steps in repression, occurring after 
loss of transcription factor binding, histone deacetylation and gain in H3K9 methylation 
(Feldman et al. 2006). On the other hand, loss of DNMT3B, which is the main enzyme 
responsible for promoter de novo methylation during implantation leads to improper 
activation of several normally methylated testis-specific genes in E9.5 embryos, showing that 
DNA methylation is directly involved in repression of these genes (Borgel et al. 2010). 
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Figure 3. Reprogramming of DNA methylation during mouse development. 
(A) Paternal (blue line) and maternal (red line) genomes are demethylated asynchronously during 
preimplantation development and reach a low point of methylation at the blastocyst stage (E3.5). IAP 
elements (gray line) partially resist this demethylation wave. After implantation, global DNA 
methylation patterns are restored. ICRs (green lines) escape global reprogramming during somatic 
development: the methylated allele resists global demethylation in preimplantation embryos, whereas 
the unmethylated allele resists de novo methylation in post-implantation embryos. (B) PGCs gradually 
loose global DNA methylation until E12.5. Methylation patterns are re-established at different 
developmental time points in male and female germline. In male germ cells (blue line), methylation 
patterns are regained during the maturation to spermatogonia between E14.5 and birth. Methylation 
of paternal ICRs (green line 1) occurs at the same time. In female embryos (red line), germ cells 
arrest in meiotic prophase around E13.0 and initiation of DNA methylation occurs after birth during 
oocyte growth. Methylation of maternal ICRs in the female germline (green line 2) occurs between 10 
and 25 days after birth and is completed in fully grown oocytes.  
 
PN: Pronuclei; FG: Fully grown oocyte; IAP: Intracisternal A-particle; ICR: Imprinting control region; 
MI: Meiosis I; MII: Meiosis II; PGC: Migrating primordial germ cell; SC: Spermatocyte; SG: 
Spermatogonia; SP: Spermatid. 
 
Adapted from (Guibert et al. 2009). 
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2.3.2.7. The establishment of DNA methylation patterns 
2.3.2.7.1. Keeping CpG islands unmethylated 
Soon after the discovery of CpG islands in mammalian genomes, several studies 
addressed how these regions are kept unmethylated. Integration of multi-copy arrays of the 
THY-1 gene in fertilized eggs revealed that the unmethylated state of the THY-1 CpG island 
promoter was recapitulated in all adult tissues, suggesting a cis-acting mechanism (Kolsto et 
al. 1986). Later it was shown that ES cells are able de novo methylate randomly integrated 
foreign DNA, which is in accordance with the wave of de novo methylation observed during 
early embryonic development. Based on genomic integration in ES cells it was found that a 
214 bp fragment in the THY-1 promoter region could protect from DNA methylation (Szyf et 
al. 1990). Subsequently, similar experiments revealed that binding sites of the transcription 
factor SP1 were crucial for the unmethylated state of the CpG island promoter of APRT 
(Brandeis et al. 1994; Macleod et al. 1994). However, it remained unclear whether elevated 
DNA methylation levels were directly linked to a loss of the SP1 binding sites or a 
consequence of reduced transcriptional activity. A direct involvement of SP1 in regulating 
DNA methylation was further questioned by the finding that SP1 knock-out mice do not show 
elevated DNA methylation at CpG islands, including the APRT promoter (Marin et al. 1997). 
These contradictory results were recently resolved by showing that the SP1 binding site in 
the APRT promoter is bound by VEZF1, a zinc finger protein VEZF1 that acts as crucial 
mediator of the unmethylated state at the chicken β-globin enhancer (Dickson et al. 2010). In 
line with a role of transcription factors in defining hypomethylation of CpG islands, an 
algorithm, based on TF binding sites that are enriched in these genomic regions, could 
predict many hypomethylated regions (Straussman et al. 2009). However, a mechanistic 
model how TF binding could lead to protection from de novo DNA methylation is still lacking. 
Based on experiments using the E.coli lac repressor/operator system it has been 
suggested protein binding itself might protect from DNA methylation in mammalian cells 
(Han et al. 2001). On the other hand, the unique chromatin features of CpG islands could 
play a role as regulators of DNA methylation levels (Blackledge and Klose 2011). Particularly 
H3K4 methylation, which strongly correlates with unmethylated CpG islands, has been 
mechanistically linked to DNA methylation. By crystallography it was shown that DNMT3L 
recognizes the histone H3 tail and that this binding is strongly inhibited by H3K4 methylation 
(Ooi et al. 2007). Recent studies indicated that the ADD domains of DNMT3A and 3B show 
the same binding specificity (Otani et al. 2009; Zhang et al. 2010). Furthermore, ectopic 
expression of DNMT3s in S. cerevisiae defined that the N-terminal part of histone H3 tail is 
needed for de novo methylation of chromatin. DNA methylation occurred in regions lacking 
H3K4 methylation and mutants without K4 methylation showed elevated DNA methylation 
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levels (Hu et al. 2009). While these experiments provide evidence that H3K4 methylation 
could mediate protection from DNA methylation, it remains unclear how this histone 
modification is targeted to CpG islands. One potential candidate involved in this process is 
CXXC finger protein 1 (CFP1), which was found to bind unmethylated CpGs in vitro and to 
be part of the SETD1 H3K4 methlytransferase complex (Voo et al. 2000; Lee and Skalnik 
2005). Recent genome-wide mapping revealed that CFP1 exclusively binds to H3K4 
methylated regions in the mouse brain. Moreover, knock-down of CFP1 led to reduced levels 
of H3K4me3 at CFP1 occupied regions (Thomson et al. 2010). Interestingly, the CXXC 
domain also occurs in a number of H3K4 KMTs, suggesting that these enzymes could 
directly bind to unmethylated CpG islands (Voo et al. 2000). 
 
2.3.2.7.2. Targeting of de novo methylation 
While most CpG-rich regions in the mammalian genome remain unmethylated in all 
cell types, a subset of these sequences gets de novo methylated during development (see 
previous chapter). There are different models how targets of de novo methylation are 
defined. Except for a tendency to methylate CpGs with an interval of eight to ten base pairs, 
DNMT3 enzymes themselves do not show specific sequence preferences (Jia et al. 2007). It 
has therefore been suggested that DNMT3 proteins might be directly recruited to their 
targets by binding to sequence specific TFs, such as MYC, PU.1 or GCNF (Brenner et al. 
2005; Sato et al. 2006; Suzuki et al. 2006). However, for these factors, a direct induction of 
de novo methylation has not been shown genetically. Recent experiments, on the other 
hand, provided strong evidence that the transcription factor E2F6 is involved in maintenance 
of DNMT3B-mediated DNA methylation and in silencing of a group of germ-line-specific 
genes (Velasco et al. 2010). Of note, protein array experiments indicated that DNMT3 
enzymes interact with many more TFs, suggesting that direct recruitment of de novo 
methyltransferase activity could be a wide spread mechanism (Hervouet et al. 2009). 
Alternatively, it has been suggested that DNMT3 proteins could be targeted by 
noncoding RNAs. For instance, it was recently reported that a small RNA in the promoter of 
rRNAs can form a DNA:RNA triplex which is specifically recognized by DNMT3B (Schmitz et 
al. 2010). While binding of DNMT3B to this unusual nucleotide structure awaits further 
investigations, several recent reports demonstrated a role of small RNAs in DNA methylation 
mediated transposon silencing. This mechanism involves MILI and MIWI2, two proteins of 
the PIWI subfamily of Argonaute proteins. MILI and MIWI2 are expressed during 
gametogenesis and interact with PIWI-interacting RNAs, small RNAs that are derived from 
retrotransposons. Deletion of MILI and MIWI2 leads to impaired de novo methylation of IAP 
and LINE-1 elements in male germ cells, causing to derepression of these repeat elements 
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(Carmell et al. 2007; Aravin et al. 2008; Kuramochi-Miyagawa et al. 2008). Remarkably, in 
the male germ line the PIWI system is also needed for de novo methylation of the RASGRF1 
DMR, in a mechanism that seems to be unique to this imprinted locus (Watanabe et al. 
2011). 
A recent study suggested a link to transcription as an alternative mechanism of DNA 
methylation targeting. Chotalia et al. showed that methylation of the GNAS DMR in the 
maternal germ line depends on transcription of a protein-coding transcript through this locus. 
Notably, the authors reported that many more maternally methylated DMRs are positioned 
within transcription units, suggesting that this mechanism might not be limited to the GNAS 
locus (Chotalia et al. 2009). It will be interesting to see how this phenomenon relates to 
observations that DNA methylation is enriched in transcribed gene bodies and that intragenic 
CpG-rich promoters might be regulated by DNA methylation in somatic cells (Maunakea et 
al. 2010). 
Finally, several different histone modifying enzymes, and the respective marks they 
set, might play a role in targeting of DNA methylation (Cedar and Bergman 2009). This 
includes H3K27me3, which in ES cells marks promoters that show an increased frequency 
of de novo DNA methylation during in vitro differentiation (Mohn et al. 2008). In accordance 
with this correlation, the polycomb group protein EZH2, which catalyses H3K27me3, was 
reported to directly interact with DNMT proteins (Vire et al. 2006). G9a (EHMT2), which 
catalyses H3K9me2, represents a second histone modifying enzyme with a role in recruiting 
DNA methylation. Overexpression of a catalytically inactive form of G9a in G9a knock-out 
cells revealed that G9a induces DNA methylation at repeat elements and at several 
promoters during ES cell differentiation independently of its KMT activity (Dong et al. 2008; 
Epsztejn-Litman et al. 2008). It was recently reported that symmetric dimethylation of H4R3 
directly recruits DNMT3A at the γ-globin promoter (Zhao et al. 2009). However, the binding 
of the DNMT3A ADD domain to symmetric H4R3me2 could not be reproduced in an 
unbiased peptide binding screen (Zhang et al. 2010). Finally, H3K4 methylation represents a 
likely histone modification involved in regulating de novo DNA methylation, given its 
inhibitory influence on binding of DNMT3 proteins to chromatin (see above). Indeed, it has 
recently been shown that the H3K4 demethylase AOF1, which is almost exclusively 
expressed during oogenesis, is required for de novo methylation of some imprinted genes in 
oocytes (Ciccone et al. 2009). It is still open whether de novo methylation of promoters 
during somatic development might as well involve action of H3K4 demethylases. 
Furthermore, it remains to be determined how histone modifying enzymes that potentially 
induce de novo DNA methylation are recruited specific targets. 
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2.3.2.7.3. Demethylation 
DNA demethylation can either happen through a passive mechanism, by progressive 
loss owing to an absence of maintenance of CpG methylation during cell replication, or 
through active demethylation. The global wave of demethylation in the female pronucleus is 
thought to occur in a passive manner, involving retention of DNTM1 in the cytosol (Cardoso 
and Leonhardt 1999). As global demethylation in the paternal pronucleus happens more 
rapid and prior to replication, the existence of an active demethylation process of yet 
unknown mechanism has been proposed (Mayer et al. 2000). Similarly, global demethylation 
during germ cell development might involve an active mechanism, given the slow cell cycle 
of PGCs and their rapid loss of DNA methylation (Gehring et al. 2009).  
During somatic development, changes in DNA methylation are biased towards de 
novo DNA methylation and only few cases of demethylation have been reported. 
Interestingly, a group of genes that gets de novo methylated during early embryogenesis is 
active in distinct tissues in the adult mouse, implying that some demethylation must happen 
in a lineage-specific manner (Borgel et al. 2010). In line with this possibility, Klug et al. 
identified several genomic loci that get demethylated during differentiation of human 
monocytes into macrophages and dendritic cells. The fact that these cells are post-mitotic 
implies an active mechanism of demethylation (Klug et al. 2010). 
Active demethylation has been proposed to operate via several different mechanisms 
(Ooi and Bestor 2008). While initial studies reported enzymes that directly remove the 
methyl-group from cytosines, their findings could not be reproduced and such a mechanism 
of demethylation therefore remains unlikely. An alternative model involves removal of entire 
nucleotide stretches by the nucleotide excision repair (NER) machinery. A screen for 
proteins that could reactivate a methylation-silenced reporter identified GADD45A as 
mediator of active demethylation through the NER pathway (Barreto et al. 2007). However, a 
similar study could not reproduce these results and a recent analysis found no DNA 
methylation changes in GADD45A mutant mice (Jin et al. 2008; Engel et al. 2009). A third 
model of active DNA demethylation proposes that proteins of the base excision repair (BER) 
machinery induce deamination of 5mC into thymine, followed by T-G mismatch repair. 
Candidate cytosine deaminases include AID and APOBEC1, which are expressed in PGCs 
and during early embryogenesis and are able to deaminate 5mC in vitro (Morgan et al. 
2004). A recent study indeed revealed that PGCs show elevated DNA methylation levels in 
AID deleted mice (Popp et al. 2010). Furthermore, it was reported that AID is essential for 
cell-fusion induced reprogramming of a somatic genome to a pluripotent state, possibly by 
mediating demethylation of pluripotency genes (Bhutani et al. 2010). A recent study 
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supported a role of AID in active demethylation by showing that overexpression of AID, 
together with the thymine glycosylase MBD4, leads to reduced DNA methylation in zebrafish 
(Rai et al. 2008). Next to MBD4, TDG represents a second G:T mismatch-specific thymine 
glycosylase with a role in BER mediated DNA demethylation. Interestingly, TDG is the only 
DNA glycosylase whose deletion in mice results in embryonic lethality. Further, it was shown 
that lack of TDG has a minor effect on the repair of canonical base damage, but leads to 
increased DNA methylation at a set of promoters in mouse embryonic fibroblasts (Cortazar 
et al. 2011). 
Several recent reports identified 5-hydroxmethylcytosine (5hmC) as a new potential 
factor involved in demethylation processes. 5hmC, albeit at low levels, was found to 
specifically occur in ES cells and cerebellar neurons and to result from hydroxylation of 5mC 
by the family of TET proteins (Kriaucionis and Heintz 2009; Tahiliani et al. 2009). First maps 
of 5hmC in the cerebellum revealed that this mark mainly occurs in gene bodies of active 
genes where its levels correlate with gene expression levels (Song et al. 2011a). 
Interestingly, recent mapping studies in ES cells showed that in this cell type 5hmC 
additionally occurs at a subset of CpG-rich promoters. These are enriched for polycomb 
targets and for promoters that gain 5mC during development, arguing for 5mC/5hmC 
turnover in differentiation (Pastor et al. 2011; Wu et al. 2011). It has been suggested that 
5hmC might be involved in removal of 5mC, either by inhibiting maintenance of 5mC or by 
acting as substrate during BER mediated active demethylation (Guo et al. 2011). ChIPseq 
analysis revealed that TET1 occupies the majority of CpG islands, implicating an 
involvement in regulating the unmethylated state of these genomic regions. However, knock-
down of TET1 resulted in a rather small increase of 5mC at a small set of promoters. 
Furthermore, TET1 seems to influence gene expression independently of its catalytically 
activity (Pastor et al. 2011). The role of TET1 and 5hmC in mediating 5mC methylation 
therefore remains elusive. 
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2.4. Scope of thesis 
 
While sharing the same genetic information, different cell types of an individual 
organism show an enormous variety in shape and function. This variety results from 
transcription of the invariable genetic code into cell-specific gene expression programs, 
specified by a set of transcription factors that are unique to each cell type (Vaquerizas et al. 
2009). Over the last 30 years it became clear that this transcriptional control by sequence 
specific TFs is strongly influenced by chromatin-based regulatory mechanisms.   
When I started my PhD project in 2007, advances in sequencing technology led to 
the first whole genome maps of chromatin modifications in human cells (Barski et al. 2007). 
While such studies confirmed that a set of chromatin modifications correlates with gene 
repression, several aspects of their role in transcriptional silencing remained unclear. Are 
these chromatin modifications directly involved in transcriptional silencing? How dynamic is 
the genomic distribution of repressive marks and how are these patterns established? We 
here set out to address these questions by studying the targeting of H3K9me2 and DNA 
methylation during cellular differentiation. 
While studies on G9a and GLP, which catalyze H3K9me2, suggested that this mark 
is involved in setting up a repressive chromatin state, the genomic pattern of H3K9me2 was 
unknown (Tachibana et al. 2005). We therefore determined the genome-wide distribution of 
H3K9me2 in ES cells by using chromatin-immunoprecipitation in combination with 
microarray technology (ChIP on chip). In order to relate H3K9me2 occupancy to an active 
and an additional repressive chromatin modification, we generated maps of H3K4me2 and 
H3K27me3 by ChIPseq technology. With the aim of studying the dynamics of repressive 
heterochromatin we further expanded our H3K9me2 ChIP on chip experiments to post-
mitotic neurons, which were derived through in vitro differentiation of ES cells by employing 
a protocol that generates highly pure cell populations (Bibel et al. 2007). We then related the 
H3K9me2 occupancy in these two cell types to changes in gene expression as measured by 
RNAseq. Together these experiments allowed us to test a prevalent model in stem cell 
biology which suggests that loss of pluripotency entails a massive increase in 
heterochromatin, which in turn results in reduced transcription in differentiated cells 
(Meshorer and Misteli 2006). 
In order to study how repressive chromatin modifications patterns are established, 
we focused our work on DNA methylation. By then it was known that DNA methylation can 
be epigenetically inherited and has an important role in silencing of repeats, genomic 
imprinting and X-chromosome inactivation (Walsh and Bestor 1999). Ongoing work in the lab 
further showed that promoter DNA methylation is dynamic during cellular differentiation and 
gets acquired de novo at a subset of genes (Mohn et al. 2008). As sequence analysis and 
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correlations to other chromatin modifications were not sufficient to predict the observed DNA 
methylation patterns, we chose to address this question using a different experimental 
approach. In order to determine whether promoter methylation is guided by the underlying 
DNA sequence, we chose a set of promoter regions with different DNA methylation patterns 
and inserted them at an ectopic site in the genome of ES cells. For that we made use of an 
insertion method that allows sequential insertions at the same genomic site without need of 
a transcribed marker gene (Seibler et al. 1998). By following DNA methylation levels at 
inserted promoter sequences during cellular differentiation we further aimed at studying the 
targeting mechanism of this repressive chromatin mark. 
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3.1. Genomic prevalence of heterochromatic H3K9me2  
and transcription do not discriminate pluripotent from 
terminally differentiated cells 
 
Lienert F.*, Mohn F.*, Tiwari V.K., Baubec T., Roloff T.C., Gaidatzis D., Stadler M.B. and 
Schübeler D. 
3.1.1. Summary 
Cell-specific gene expression programs are defined by transcription factors and 
involve processes that depend on chromatin modifications. It has been proposed that 
pluripotent stem cells possess a unique chromatin structure that is characterized by low 
abundance of repressive heterochromatin and coinciding global transcription. In this model, 
loss of pluripotency entails a global increase in heterochromatin and coinciding shutdown of 
lineage unrelated genes (Gaspar-Maia et al. 2011).  
We here tested this model by profiling the distribution of heterochromatic H3K9me2 
in pluripotent ES cells and derived post-mitotic neurons, using a well-defined differentiation 
protocol (Bibel et al. 2004). Our analysis revealed that H3K9me2 is highly abundant in ES 
cells and occurs in large domains that occupy more than half of the genome. H3K9me2 
marks all genomic regions that are devoid of transcription, H3K4me2 and polycomb 
mediated H3K27me3. This suggests that H3K9me2 is set by default and might be involved 
in establishment of a repressive chromatin state outside of regions that are marked by active 
chromatin modifications or regulated by polycomb. Importantly, abundance of H3K9me2 
increases only slightly during differentiation of ES cell into neurons, with a localized gain 
occurring at gene bodies of transcribed genes. Moreover, gene expression profiling by 
RNAseq does not reveal evidence for a reduction of transcriptome complexity as stem cells 
become terminally differentiated neurons.  
Based on these data and on results from many recent studies we suggest that 
pluripotent embryonic stem cells are not per se unique in regards to heterochromatin 
abundance and transcriptional plasticity as compared to somatic cells. Accordingly, 
differentiation entails focal, rather than global, changes in repressive chromatin, which might 
help to stabilize cellular states at any developmental stage (Farthing et al. 2008; Meissner et 
al. 2008; Mohn et al. 2008; Lister et al. 2009; Hawkins et al. 2010; Min et al. 2011). 
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Abstract
Cellular differentiation entails reprogramming of the transcriptome from a pluripotent to a unipotent fate. This process was
suggested to coincide with a global increase of repressive heterochromatin, which results in a reduction of transcriptional
plasticity and potential. Here we report the dynamics of the transcriptome and an abundant heterochromatic histone
modification, dimethylation of histone H3 at lysine 9 (H3K9me2), during neuronal differentiation of embryonic stem cells. In
contrast to the prevailing model, we find H3K9me2 to occupy over 50% of chromosomal regions already in stem cells.
Marked are most genomic regions that are devoid of transcription and a subgroup of histone modifications. Importantly, no
global increase occurs during differentiation, but discrete local changes of H3K9me2 particularly at genic regions can be
detected. Mirroring the cell fate change, many genes show altered expression upon differentiation. Quantitative sequencing
of transcripts demonstrates however that the total number of active genes is equal between stem cells and several tested
differentiated cell types. Together, these findings reveal high prevalence of a heterochromatic mark in stem cells and
challenge the model of low abundance of epigenetic repression and resulting global basal level transcription in stem cells.
This suggests that cellular differentiation entails local rather than global changes in epigenetic repression and
transcriptional activity.
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Introduction
Resetting of the transcriptional program is the key driver for
cell type specification during organismal development [1,2].
While embryonic stem (ES) cells bear the fascinating ability to
acquire very diverse fates, derived somatic stages are usually
irreversible under physiological conditions. This unidirectionality
has been suggested to depend in part on epigenetic repression of
lineage unrelated genes [3,4]. Accordingly, ES cell plasticity was
suggested to rely on a low prevalence of heterochromatin and
coinciding promiscuous low-level expression of many genes in
stem cells [5–11]. In line with this model, distinct changes in
nuclear staining had previously been observed by electron
microscopy during cellular differentiation [12,13]. Further, a
subset of promoters was shown to become DNA methylated [14–
16] and the repressive histone modifications H3K27me3 and
H3K9me3 were reported to locally expand in differentiated cells
[9].
Here, we set out to test the model of widespread heterochro-
matinization via monitoring of the differentiation-coupled
dynamics of H3K9me2, a repressive epigenetic modification,
which appears to be the most abundant heterochromatic
modification and has recently been reported to cover large
domains in differentiated cells [17]. Unexpectedly, we found
that H3K9me2 is not only highly abundant in terminally
differentiated cells, but already occupies large parts of the
genome in pluripotent stem cells. In this cellular state,
H3K9me2 occupies most genomic regions devoid of transcrip-
tion and certain histone modifications. While our analysis
revealed discrete local changes particularly at gene bodies, we
observed little global increase in H3K9me2 during differentia-
tion. This unexpected finding motivated us to revisit the model
of promiscuous low-level gene expression in undifferentiated
cells by quantitative RNA sequencing. Remarkably, we found
the actual number of low-level expressed genes, postulated
hallmarks of stem cells to be equal between both developmental
states. Together, our findings challenge the model of promis-
cuous basal gene expression as a distinct property of pluripo-
tency and a widespread increase of heterochromatin during
cellular differentiation.
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Results
H3K9me2 is nearly invariant and only displays distinct
local changes between developmental stages
To asses differentiation associated dynamics of the repressive
histone modification H3K9me2 we made use of a highly pure and
robust murine in vitro neurogenesis model [18], which we previously
used to profile histone and DNA methylation [14]. Here, we
generated profiles for H3K9me2 in pluripotent embryonic stem
cells and derived terminally differentiated pyramidal neurons. We
made use of custom tiling arrays covering 10% of the mouse
genome including all well-annotated promoters, several large multi-
gene loci and the complete chromosome 19 (see Figure S1 and Text
S1). The chromosomal profiles for H3K9me2 revealed domains of
enrichments that upon visual inspection were highly comparable
between stem cells and the neuronal state (Figure 1A), which is
further supported by a high overall pair-wise correlation (Figure 1B).
Despite this overall similarity we noticed confined regional
differences (Figure 1A), a finding which is consistent with the fact
that biological replicates of H3K9me2 are more similar than the
patterns between cell states (Figure 1B). We also included in our
comparison a recently published dataset for H3K9me2 in a distinct
ES cell line [17], which shows high correlation to our ES cell
datasets despite different experimental conditions (Figure S2). Of
note, analysis of the H3K9me2 dataset from Wen et al. [17]
revealed that chromosome 19 behaves similar to the other
chromosomes (Figure S3), suggesting that our results can be
extrapolated to the entire genome. Together this demonstrates that
our H3K9me2 data are reproducible and of high resolution, yet
overall patterns appear to be highly similar between a pluripotent
and a terminally differentiated state. Visual inspection suggests that
H3K9me2 covers large domains in both ES cells and neurons
(Figure 1A). To quantitatively define the actual location and sizes of
domains we applied a Hidden-Markov-Model (HMM) analysis to
the microarray data. This unsupervised statistical method is a widely
accepted approach for unbiased data segmentation in epigenome
analysis [19,20]. The HMM analysis not only agreed with and
statistically corroborated the visual impression of the raw data, but
also yielded robust results under variable settings (Figure S4). It
revealed that over 50% of chromosome 19 is covered by H3K9me2
in ES cells (Figure 1C). Using the same approach for the H3K9me2
data in the ES cell-derived terminally differentiated neurons, we
detected a modest yet reproducible 5% increase of genomic regions
covered by H3K9me2 (Figure 1C). We conclude that global
coverage and size of H3K9me2 domains is nearly identical between
ES cells and derived post-mitotic pyramidal neurons. In line with
this finding we do not detect a significant change in global
H3K9me2 levels by Western blot detection (Figure 1D). Moreover,
H3K9me2 domain features of ES cells and neurons show similar
size distribution and median length (Figure S4). Further analysis
revealed that changes in H3K9me2 between the two examined
cellular states are rare; 88% of H3K9me2 occupied regions in ES
cells are also occupied in neurons (Figure 1F). Notably, regions that
change in H3K9me2 state tend to be small and are below the
average size of invariant domains (Figure S5). Consistent with the
overall increase of 5% inH3K9me2 coverage during differentiation,
regions which gain H3K9me2 are more frequent and of larger size
than regions showing a loss of the mark (Figure S5 and Figure S6).
Interestingly, most of the larger regions (.10 kb) that gain
H3K9me2 are located within genes, starting downstream of the
promoter region (Figure 2A and Figure S5). These global findings
are fully reproducible in single gene controls (Figure 2B) and
consistent with a focused comparison of only genic regions
(Figure 2C). Importantly, this shows that our experimental and
data analysis approach is indeed highly sensitive to detect
differences if they do occur. Interestingly, many genes that acquire
H3K9me2 show slightly reduced expression in many cases, while
others increase expression upon gain of the modification (Figure 2D
and Figure S5). This suggests that the gain of H3K9me2, while
highly selective for gene bodies, cannot simply be explained by the
silencing of gene activity.
H3K9me2 and H3K27me3 are mutually exclusive
Given the high prevalence of H3K9me2, we next asked how its
presence relates to a distinct repressive chromatin modification,
namely trimethylation of H3K27 (H3K27me3). This mark is set
by the Polycomb pathway and often occurs in domains of several
kilobases [9,21,22]. We find that both heterochromatic histone
modifications occur mutually exclusive even when in direct
neighborhood as illustrated by the sharp boundaries of the
H3K9me2 signal next to H3K27me3 peaks (Figure 3A, 3B and
3C). This is consistent with a previous study in human embryonal
carcinoma cells that was limited to promoters [23].
H3K9me2 is largely exclusive with active chromatin
We further related H3K9me2 occupancy to regions with
transcriptional activity or presence of the active modification
H3K4me2. Active regions are mutually exclusive with H3K9me2
in ES cells but surprisingly to a lesser extent in neurons (Figure 3D).
The compatibility of H3K9me2 and gene expression in neurons is
however limited to gene bodies and does not occur in the
promoters of expressed genes, consistent with the former regions
gaining H3K9me2 during differentiation (Figure 2A and Figure
S7). We find the majority of H3K4me2 regions to be mutually
exclusive with H3K9me2 in stem cells (Figure 3D). In neurons, a
small number of regions become co-occupied, again most of these
being within transcribed genes (Figure 3D). Importantly, an HMM
independent analysis confirms that regions with high H3K9me2
enrichment do not overlap with transcribed genes in stem cells, yet
a subset does in neurons (Figure 3E). We conclude that gain of
H3K9me2 during differentiation has only a minor effect on the
overall chromosomal coverage of the modification, yet it occurs
highly localized and preferentially at genic regions.
Prevalent low-level transcription is not a stem cell–
specific feature
Our finding of surprising conservation of heterochromatin
patterns in a refined model of differentiation let us to revisit the
Author Summary
Epigenetic modifications of DNA and bound histones are
major determinants of cell type–specific gene expression
patterns. A prevalent model in stem cell biology suggests
that the loss of pluripotency entails global increase in
heterochromatin and coinciding shutdown of lineage
unrelated genes. We performed analysis of both H3K9
dimethylation pattern and the global transcriptome in an
advanced murine neuronal differentiation model. In this
paradigm, we do not find evidence for a global increase in
heterochromatic H3K9 dimethylation or reduction of
transcriptome complexity as stem cells become terminally
differentiated post-mitotic neurons. This suggests that
pluripotent embryonic stem cells are not per se unique in
regards to heterochromatin abundance and transcriptional
plasticity as compared to somatic cells. Instead, focal
changes in chromatin might help to stabilize cellular states
at any developmental stage.
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transcriptome in a quantitative manner using high throughput
RNA sequencing (RNAseq). RNAseq in ES cells and derived
neurons revealed the expected down regulation of stem cell
specific genes and induction of neuron specific genes (Figure 4A).
Further, when counting RNA molecules after gene mapping and
normalization, both cell types displayed a characteristic bimodal
distribution. This reflects a group of genes that is in a clear off state
with no detectable RNA molecules and a second peak of expressed
genes (Figure 4B). Separating these two groups of genes by a
stringent cutoff revealed that out of 359606 transcription units,
45% are expressed in ES cells. Interestingly, we identified a slightly
higher number (50%) of expressed genes in terminally differen-
tiated neurons, indicating that differentiation of stem cells is not
coinciding with a reduced number of highly expressed genes. This
agrees with a recent report that suggested that stem cells and
somatic cells do mainly differ in the number of low-level expressed
genes due to a global reduction of basal gene activity in the course
of lineage-commitment and loss of pluripotency [10]. To test this
in our in vitro differentiation system, we grouped the genes that
could not clearly be assigned to the on or off state, into a separate
class of genes expressed at low to background level (Figure 4B).
This analysis reveals that in stem cells 16% of all transcription
units show a basal expression level. Surprisingly however, the
proportion of genes expressed at such low level (14%) is very
similar in neurons. This unexpected finding prompted us to
conduct an additional RNAseq experiment in a second fully
differentiated somatic murine cell type; primary mouse embryonic
fibroblasts (MEFs). Interestingly, also fibroblasts display a similar
Figure 1. H3K9me2 covers large domains in pluripotent stem cells and derived neurons and is largely invariant between both
states. (A) H3K9me2 localization in ES cells and neurons at a representative chromosomal region. Bars above each track indicate H3K9me2 domains
determined by HMM. The red boxes highlight two regions that lose and gain H3K9me2, respectively. (B) Pair-wise correlation of H3K9me2 signal
among different samples and experiments. Biological replicates are indicated as 1 and 2. Pearson correlations of IP/Input ratios were calculated for
500 bp windows on chromosome 19 (white/yellow corresponds to higher correlations). (C) Quantification of genomic coverage of H3K9me2 in ES
cells and neurons applying a two-state HMM (i.e. ‘‘high’’ or ‘‘low’’). Shown is the percentage of chromosome 19 that is in an H3K9me2 ‘‘high’’ state (i.e.
enriched for H3K9me2) in both biological replicates. The value was normalized to the total coverage of the tiled region on the array. (D) Western blot
detection of H3K9me2 levels in ES cells and neurons (TN). (E) Venn diagram showing the overlap of H3K9me2 enriched regions between ES cells and
neurons (TN).
doi:10.1371/journal.pgen.1002090.g001
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transcriptional landscape as stem cells, with 46% of all
transcription units being highly expressed and 13% being
expressed at basal levels. Hence, this qualitative similarity of
expression patterns is not specific to the neuronal subtype we
generated in vitro, but appears to be a more general property of
both undifferentiated and differentiated cells. Thus, while
transcripts expressed at low levels show little overlap between
stem cells and somatic cells (Figure S8), their numbers are
remarkably similar. Stem cells do also not show an increased
number of highly expressed genes. Based on additional analysis we
can exclude that this similarity of the transcriptional landscape is a
consequence of insufficient sampling (Figure S9). Moreover, it is
not limited to genic regions as the abundance of transcripts
generated from diverse classes of endogenous repeat is comparable
between stem cells and neurons (Figure 4C).
Discussion
Embryonic stem cells are characterized by their potential to
differentiate into any cell type of the three germ layers in the
developing embryo, while somatic cells lose this developmental
plasticity upon lineage-commitment. Despite its relevance for our
understanding of development and disease, the molecular
determinants of pluripotency are still not fully understood and
the factors responsible for this uniqueness of stem cells are actively
debated [24]. Our study of gene expression and an abundant
heterochromatin mark reveal surprising conservation of the
transcriptome and epigenome landscape between pluripotent
and unipotent cells. H3K9me2 is already highly prevalent in ES
cells, arguing that the pathways that mediate H3K9me2 are highly
active in stem cells, and serve similar functions as in somatic cells,
Figure 2. Changes in H3K9me2 during differentiation occur localized and at gene bodies. (A) H3K9me2 signal at the Kif20b locus as an
example of a locus, which gains H3K9me2 in neurons. Bars above each track indicate HMM-defined H3K9me2 domains. (B) Validation of microarray
results by single gene PCRs for a set of gene bodies that gain H3K9me2. Enrichments were normalized to Gda. Both Gda and Pcsk5 have equally high
H3K9me2 levels in both cellular states in the array data. Methylation levels of Hprt (negative control) and Oct4 (Pou5f1; positive control [39]) were
measured at the promoter. Shown are averages from 2 independent differentiation experiments. Error bars indicate standard deviation.
(C) Comparison of H3K9me2 enrichments in gene bodies in ES cells and neurons. Genes, which gain and lose H3K9me2 significantly (adjusted P-Value
,0.05) are depicted in green and orange, respectively. (D) RNAseq read counts of 10 genes that show the most significant gain of H3K9me2. Black
and white bars indicate RNA in ES cells (ES) and neurons (TN), respectively.
doi:10.1371/journal.pgen.1002090.g002
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which only show a slight increase of the mark (from 53 to 58%).
Interestingly, the observed gain occurs very localized at gene
bodies and does not necessarily coincide with lower transcription
of the corresponding gene. The analysis of regions that acquire
H3K9me2 during differentiation further revealed a differentiation
specific coexistence of H3K9me2 and transcriptional activity,
which is not detected in the pluripotent state and which could be
involved in modulating expression in the differentiated cell.
Nevertheless, despite the subtle increase we detected, an
involvement of H3K9me2 in globally regulating cell-type specific
gene repression appears unlikely. The limited dynamics as
compared to massive transcriptome reprogramming and the
limited correlation between expression and gain of H3K9me2 at
target genes argue against H3K9me2 as being a major player in
setting up gene expression programs.
These findings disagree with a recent report that suggested
absence of large H3K9me2 domains in ES cells and found a
striking increase in differentiated cells [17]. Notably, our ES cell
profile for H3K9me2 is similar to the one generated previously
(Figure 1B and Figure S2), making data analysis a likely
Figure 3. H3K9me2 occurs mutually exclusive with expression and distinct chromatin marks. (A) Enrichment for H3K27me3 and
H3K9me2 in a representative region. (B) H3K9me2 enrichments relative to peaks of H3K27me3 illustrating the sharp boundaries between both marks.
Plotted are the moving-window averages (median) of H3K9me2 enrichments with window sizes of 500 bp (blue line) around all H3K27me3 domains
on chromosome 19 (shown in grey). (C) and (D) Venn diagram illustrating the actual overlap between H3K9me2 and H3K27me3 occupied regions (C)
and between H3K9me2, H3K4me2 occupied and active regions (D). Numbers indicate base pair coverage on chromosome 19 (in kb). Note that areas
are not drawn to scale. (E) The higher H3K9me2, the less likely a genomic region is active or contains H3K27me3 or H3K4me2. H3K9me2 enrichment
values of 500 bp windows were binned into groups of equal size. Plotted is the frequency for H3K9me2 enrichment bins to overlap with active
regions (orange), H3K27me3 occupied (gray), H3K4me2 occupied (green) and regions in either of these states (black).
doi:10.1371/journal.pgen.1002090.g003
H3K9me2 and Transcription during Differentiation
PLoS Genetics | www.plosgenetics.org 5 June 2011 | Volume 7 | Issue 6 | e1002090
explanation for the discrepancy. We applied an unbiased
approach that is insensitive to variations between arrays and
which we show to lead to similar results under various parameter
settings (Figure 3 and Figure S10). As already discussed by Fillion
and van Steensel [25], the previous study relied on defined
thresholds, which can be prone to false estimation of differences
particular in the absence of biological replicates [25].
Widespread low-level expression in stem cells has previously
been reported and interpreted as a sign of pluripotency [5,6,10].
It has been speculated that this basal promiscuous activity would
poise genes for rapid induction upon receipt of differentiation
cues [5,6,10]. Using mRNA sequencing in our differentiation
paradigm does not confirm this model. We do not find evidence
of elevated transcription throughout the genome or on specific
chromosome (Figure S8; [10]). A likely explanation for these
discrepancies is that microarrays, which were used in the
previous studies, overestimate low level signal due to cross-
hybridization [26]. In the present study we utilized RNAseq,
which permits an actual counting of RNA molecules and thus
enables accurate discrimination between very low and no
expression. Notably, RNA sequencing experiments have recently
put other findings in question that relied on quantifying small
transcriptome differences detected by microarrays. For example,
recent RNAseq data challenged the presence of pervasive
intergenic transcription [26] and the existence of transcriptional
dosage compensation of the single male X chromosome [27]. In
addition to the increased sensitivity of RNAseq that can explain
the differences to previous studies, the presence of a small
fraction of differentiated cells in suboptimal conditions of stem
cell culture could similarly contribute to an overestimation of the
number of genes that are actually expressed in stem cells.
Notably, the ES cell differentiation protocol applied by us is
optimized to reduce the number of differentiated cells in the
culture [18].
Figure 4. Promiscuous low-level expression is not a distinctive feature of the pluripotent state. (A) Representative region illustrating
RNAseq data in ES cells and neurons (TN). Blue boxes indicate genes that either increase (Lrrc3, a neuron specific ion channel) or decrease (Aire,
Dnmt3l, Icosl; three ES cell specific genes) expression during differentiation, while the other genes remain constant. (B) Density distribution of
transcript abundance (measured as read counts) for all RefSeq transcripts in ES cells (green line), derived neurons (dark green line) and mouse
embryonic fibroblasts (red line). Numbers indicate percentage of expressed genes in each cell type based on a threshold of log2(read count) = 5
(black dotted line). The gray area between 2 and 5 indicates the zone of low-level expression. (C) Boxplot representation of expression levels of
prominent repeat classes in ES cells and neurons (TN). Numbers below indicate how many repeat elements are included in each repeat class.
doi:10.1371/journal.pgen.1002090.g004
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In summary, our analysis suggests to revisit the model of massive
heterochromatinization during cellular differentiation via a global
increase in repressive histone marks [5–9,17] and coinciding
repression of basal gene activity [5,6,10].
Our data together with previous reports on dynamics of DNA
methylation, H3K9me3 and the Polycomb pathway between
pluripotent and somatic cells [9,14,15,28–31] support a model
whereby repressive chromatin is already highly active in stem cells
and that epigenome reprogramming entails localized changes of
repressive histone modifications and DNA methylation at
regulatory regions that specify and stabilize lineage specification
and terminal differentiation [32]. It will be interesting to
determine if these local differences account for the observed
changes in nuclear morphology [33]. Notably, epigenetic repres-
sion can be overcome by the local activity of transcription factors
upon strong induction cues during normal differentiation or
artificially during generation of induced pluripotent stem cells (iPS)
[34] and might therefore safeguard rather than actively channel
development via direct transcriptome regulation.
Methods
Cell culture
Wild-type embryonic stem cells (129Sv-C57Bl/6) were cultured
and differentiated as previously described [14,35]. Fibroblasts
were isolated from wild-type embryos (C57Bl/6).
Western blot and peptide dot blot analysis
Peptide sequences can be found in Table S2. Western blot
analysis was performed with acid extracts using 1/1000 dilutions
of either anti-H3K9me2 (Abcam no. 1220) or anti-H4 (Upstate,
no. 07–108) antibodies. Blots were developed with ECL reagent
(GE Healthcare).
Chromatin-IP (ChIP)
ChIP experiments were performed as described before [14],
starting with 70 mg of chromatin and 5 mg of the following
antibodies: anti-dimethyl-H3K9 (LP Bio, no. AR-0108), anti-
dimethyl-H3K9 (Abcam no. 1220), anti-trimethyl-H3K27 (Up-
state, no. 07–449), anti-dimethyl-H3K4 (Upstate, no. 07–030).
H3K9me2 ChIP samples were amplified using the WGA2 kit
(Sigma) and hybridized to a custom tiling microarray (NimbleGen
Systems Inc., see below). H3K27me3 and H3K4me2 ChIP
libraries for Illumina sequencing were prepared with the Illumina
ChIP-Seq DNA Sample Prep Kit (Cat# IP-102-1001) according
to Illumina’s instructions and sequenced on the Genome Analyzer
II following the manufacturer’s protocols. ChIP-real time PCR
was performed using SYBR Green chemistry (ABI) and 1/40 of
ChIP or 20 ng of input chromatin per PCR reaction. Primers are
listed in Table S1.
Microarray design
H3K9me2 ChIP samples were hybridized to custom designed
microarrays representing all well-annotated promoters, several
large multi-gene loci and the complete chromosome 19 with an
average probe spacing of 100 bp and a total of 2.1 million features
(HD2.1, NimbleGen Systems Inc).
Microarray hybridization and analysis
Sample labeling, hybridization and array scanning were performed
by NimbleGen Systems Inc. according to standard procedures. For
analysis, raw fluorescent intensity values were used to calculate log2 of
the bound/input ratios for each individual oligo. Subsequently, for
comparison all arrays were normalized to amedian log2=0 and scale
normalized to have the same median absolute deviation using the
‘‘LIMMA’’ R/Bioconductor package [36,37].
RNAseq data analysis
RNA from ES cells, neurons and fibroblasts of two independent
biological replicates each was used for cDNA preparation using
oligo dT primers followed by sequencing on an Illumina GA II
analyzer. Reads were mapped to the Mus musculus transcriptome
and normalized to transcript length and sequencing library size
(for details see Text S1).
Bioinformatics
Unless otherwise stated, H3K9me2 enriched regions were
identified by HMM and H3K4me2 and H3K27me3 peaks using
MACS peak finder [38]. Active regions were defined as RefSeq
transcription units with a normalized RNAseq log2 read count
above 5 (for details see Text S1). Microarray design, hybridization
and analysis, ChIPseq and RNAseq analysis and additional
references are described in Text S1.
Datasets
Microarray and deep sequencing data were deposited at NCBI’s
Gene Expression Omnibus and are accessible through GEO Series
accession number GSE27866 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE27866).
Supporting Information
Figure S1 Specificity of H3K9me2 antibodies used in this study.
Indicated amounts of either modified or unmodified H3 and H4
peptides (H3 residues 1–20, 19–38 and 25–45, H4 residues 12–31)
were spotted onto polyvinylidene difluoride membranes (GE) and
probed with (A) anti-dimethyl-H3K9 (LP Bio, no. AR-0108) or (B)
anti-dimethyl-H3K9 (Abcam no. 1220) at 1:1000 dilution each.
Both antibodies are highly specific towards H3K9me2.
(TIF)
Figure S2 High similarity of ES cell H3K9me2 datasets.
(A) Comparison of our H3K9me2 enrichment profiles in ES cells
to a previously generated ES cell profile (Wen et al., 2009). (B) Venn
diagram illustrating the overlap of H3K9me2-occupied regions
between the two ES cell datasets from (A) (defined by an HMM
approach). The overlap agrees with the high correlation for this
previously generated ES cell dataset with our two ES cell replicates
(Pearson correlation of 0.73 and 0.74, on 500 bp windows).
(TIF)
Figure S3 H3K9me2 enrichments on chromosome 19 are
representative of the entire genome. (A) H3K9me2 enrichments
in ES cells from a previously generated dataset (Wen et al., 2009).
The boxplots show H3K9me2 enrichment values for all probes
separated by chromosome, with chromosome 19 highlighted in
blue. (B) H3K9me2 enrichments per 900 bp promoter windows
(defined in Mohn et al., 2008) in ES cells. The boxplots represent
average enrichments at promoters separated by chromosome with
chromosome 19 highlighted in blue.
(TIF)
Figure S4 H3K9me2 enriched regions are robustly identified
independent of HMM parameters and H3K9me2 domain size is
highly similar in ES cells and neurons. (A) Shown is the
comparison of H3K9me2 enrichments in ES cells and neurons
using a 3 state HMM to define non-occupied (low), intermediately
and highly occupied domains (top). Importantly, the state specific
HMM distribution parameters (mean and variance of H3K9me2
enrichment) are very similar between ES cells and neurons
H3K9me2 and Transcription during Differentiation
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(bottom). Note that with a 3 state HMM the percentage of
domains in the high state does not change between ES cells and
neurons (TN). However, we detect an overall increase of the
intermediate state of around 10%. (B) H3K9me2 domains were
defined by HMM (see methods). While numbers of domains on
chromosome 19 increase from 1618 to 1914 from ES cells to
neurons, their domain size distribution is very similar. This was
also seen using alternative domain definition methods (data not
shown).
(TIF)
Figure S5 Regions that lose are smaller than regions that gain
H3K9me2 during differentiation and gaining regions often
overlap with gene bodies. (A and B) Histograms displaying the
size distributions of regions that lose (A) and gain (B) H3K9me2
during neuronal differentiation. Adjacent 500 bp windows being
in a low HMM state in both ES cell replicates and in a high HMM
state in the neuron replicates were grouped into H3K9me2 losing
and gaining regions, respectively. (C) Pie chart illustrating the
percentage of large (.10kb) H3K9me2 gaining regions within
(grey) and outside (white) of genes (left). This overlap is
significantly higher than for all regions that have no H3K9me2
in ES cells, i.e. which are in a HMM low state in both replicates
(right). (D) Boxplot showing expression levels of all genes (n = 138,
adjusted P-value ,0.05) that gain H3K9me2 in neurons. Note
that the median expression does not change significantly between
ES cells and neurons (TN), indicating that there is no global trend
towards either up- or down-regulation upon accumulation of
H3K9me2 in the gene bodies of these genes.
(TIF)
Figure S6 Regions losing H3K9me2 during differentiation are
close to background. (A–C) Shown are representative genomic
regions that significantly lose H3K9me2 as defined by HMM
analysis. (D) ChIP-real time PCR validation of the regions shown
in (A–C). Note that H3K9me2 enrichments are already low in ES
and only slightly above background as exemplified by the active
housekeeping gene Hprt, which does not carry H3K9me2. The loss
of enrichment in neurons is small, though reproducible.
(TIF)
Figure S7 H3K9me2 in neurons rarely overlaps with promoter
regions of active genes. (A and B) Pie chart illustrating the
percentage of promoters (1 kb up- and downstream of TSS) (A)
and gene bodies (B) of transcribed genes that overlap H3K9me2-
occupied regions in neurons. Note that promoters are rarely
H3K9 dimethylated when the gene is actively transcribed.
(TIF)
Figure S8 Overlap of low-level expressed genes and expression
of transcripts per chromosome. (A) Venn diagram illustrating the
overlap of transcripts expressed at a low level (log2 RNAseq reads
between 2 and 5) in at least one of the examined cell types. Note
that areas are not drawn to scale. (B) Boxplots showing expression
levels of transcripts per chromosomes.
(TIF)
Figure S9 Absence of difference in transcriptome complexity is
not a function of sample size in next generation sequencing.
Shown is the number of detected Refseq transcripts (at least 32
reads) relative to the number of sampled reads. Number of
detected transcripts is shown as the mean of 100 rounds of
random subsampling with the same total read numbers.
Irrespective of the sample size, a random sampling of RNAseq
reads from ES cells (green line), neurons (dark green line) and
MEFs (red line) revealed a smaller number of detected transcripts
than an artificial sample with pooled reads from all three cell
types (blue line) at any given sample size.
(TIF)
Figure S10 H3K9me2 domain definition by different statistical
methods leads to similar results. (A) HMM-independent quanti-
fication of genomic coverage of H3K9me2 in ES cells and
neurons. Shown is the percentage of chromosome 19 that lies
within H3K9me2 peaks defined by a simple threshold method (t-
peaks, see Text S1). (B) Diagram illustrating the actual overlap
between regions defined to be occupied by H3K9me2 by two
different methods; a simple threshold method (t-peaks; see Text
S1) and by an HMM approach (HMM; see Text S1).
(TIF)
Table S1 List of real time PCR primers.
(TIF)
Table S2 Peptides used in dot blots in Figure S1.
(TIF)
Text S1 Supplementary methods.
(DOC)
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Supplementary Methods 
Segmentation of H3K9me2 profiles by Hidden Markov Models (HMMs). To 
define H3K9me2 enriched regions, we segmented ChIP-chip data using 
HMMs, as described (Birney et al., 2007). The basic premise of HMMs is that 
observed data are generated stochastically from a pre-determined number of 
hidden background probability distributions, or states. We used two states to 
distinguish enriched from not enriched regions (an analysis using three states 
led to similar results, see Figure S3). The parameters of the HMMs (emission 
probabilities, here modeled as normal distributions, and the transition 
probabilities between states) are estimated via unsupervised learning (Baum-
Welch algorithm) from the H3K9me2 enrichment profile. For that purpose, 
log2 of bound/input ratios were calculated for 500 bp windows on the whole 
chromosome 19. For single windows not covered by an oligonucleotide on the 
array the average of the neighboring two windows was taken. Regions 
consisting of more than one 500 bp window not covered by array were omitted 
from the analysis. Enriched and not enriched states were assigned to genomic 
positions according to the most probable path through the trained model 
states given the observed data (Viterbi algorithm). The analysis was 
performed independently on each biological replicate and 500 bp windows 
being in a high state in both replicates were considered to be enriched for 
H3K9me2. Consecutive genomic positions with identical H3K9me2 
enrichment states were merged. For the 3 state HMMs, we performed the 
analysis in the same way, except for using averaged H3K9me2 enrichment 
values from the two biological replicates. Analysis was done using the 
  2 
“RHmm” R package (http://CRAN.R-project.org/package=RHmm (Taramasco, 
2009)). 
Analysis of H3K9me2 changes in gene bodies. We calculated the average 
H3K9me2 signal per transcript (RefSeq start to end, downloaded 06/24/2010) 
as the weighted sum of the log2(ChIP/input) enrichment of oligos within the 
transcript divided by the weighted number of oligos within the transcript, with 
oligo weights defined as the fraction of overlap with the particular transcript. 
Significant changes between ES cells and neurons were then determined 
using the “LIMMA” R package (Smyth, 2004; Smyth and Speed, 2003). 
Definition of H3K9me2 enriched regions by a simple threshold method 
(t-peaks). To cross validate H3K9me2 enriched regions obtained from HMMs 
by an independent approach we made use of a simple threshold method. For 
that purpose, average log2 bound/input ratios from two replicates were 
calculated for 500 bp windows on the whole chromosome 19. For both 
samples (ES cells and neurons), we defined the respective median of log2 
bound/input ratios as a threshold. We then merged adjacent regions with a 
log2 bound/input ratio above the threshold into domains. Domains separated 
by 1 kb or less were fused. These H3K9me2 enriched domains show high 
overlap with domains defined by the HMM approach (Figure S10). 
Deep sequencing analysis. ChIPseq and RNAseq samples were sequenced 
on an Illumina GA II analyzer. Low quality reads (not passing Illumina chastity 
filter or containing more than two N’s) and low complexity reads (based on 
entropy, typically less than 1%) were removed. We mapped reads to the Mus 
musculus genome (mm9) and transcriptome (RefSeq, downloaded on 
  3 
07/17/2009) using bowtie (Langmead et al., 2009) allowing for up to two 
mismatches and retaining all best hits for reads with up to 100 alignments 
ignoring sequence qualities.  
Identification of H3K27me3 and H3K4me2 peaks.  H3K4me2 ChIP samples 
(from one differentiation) and H3K27me3 ChIP samples (from two 
independent biological replicates) and Input DNA from ES cells (as a 
background sample) were sequenced on an Illumina Genome Analyzer. 
Reads were filtered, mapped and counted as described above. We obtained 
the following number of reads mapping to genome (in Mio. reads); 
ES_H3K27me3_a1 4.96, ES_H3K27me3_a2 4.60, ES_H3K27me3_b 12.58, 
ES_H3K27me3_a1 4.59, ES_H3K27me3_a2 4.74, ES_H3K27me3_b 7.5, 
ES_H3K4me2 13.25, TN_H3K4me2 10.33 and Input 11.9 (with a and b being 
independent biological replicates and 1 and 2 being technical replicates).  In 
order to identify peaks in the H3K27me3 and H3K4me2 datasets we used 
MACS peak finder (Zhang et al., 2008). MACS was used with standard 
settings (lambad-set: 2kb, 10kb, 20kb) and the Input sequencing sample as a 
background. Peaks were filtered in the following way. We counted the number 
of reads from the histone modification ChIP library and from the Input library in 
the peak regions identified by MACS. For each sample we then normalized 
the number of mapped reads per peak to the total number of reads which 
could be mapped to the genome. Next, we determined for each peak the 
enrichment ratio of normalized read numbers from ChIPseq to the normalized 
reads from Input-seq (after addition of eight pseudo-counts per peak to reduce 
sampling noise). For further analysis we only used peaks with a two-fold 
enrichment ratio and more than four mapped reads per 100 bp. We 
  4 
crossvalidated peaks by comparison to peaks identified by two independent 
methods; BayesPeak (Spyrou et al., 2009)  and a variation of the t-peaks 
method described above. The peaks identified by using these three different 
methods showed a high overlap (data not shown). 
RNAseq data analysis. RNA from ES cells, neurons and MEFs from two 
independent biological replicates was used separately for cDNA preparation 
followed by sequencing on an Illumina GA II analyzer. Reads were filtered, 
mapped and counted as described above. We obtained the following number 
of reads mapping to the transcriptome (in Mio. reads); ES_RNA_a 13.3, 
ES_RNA_b 35.7, TN_RNA_a 10.8, TN_RNA_b 21.5, MEF_RNA_a 27.2 and 
MEF_RNA_b 27.5, (with a and b being independent biological replicates). 
Next, we calculated expression levels of the transcripts as the weighted sum 
of reads aligning to the transcript, with read weights defined as the observed 
count divided by the number of genomic hits of each read or the number of 
hits in a single transcript if greater than the number of genomic hits. This sum 
was length normalized by dividing through the transcript length and multiplying 
by the average length of all transcripts. In order to allow comparison among 
different cell types and biological replicates, transcript levels were normalized 
to the total number of reads mapping to transcripts for each sequence run. For 
Repeat analysis, genomic read alignments were compared to the Mus 
musculus Repeatmasker annotation (Smit, AFA & Green, P, 
www.repeatmasker.org) as described for transcriptome analysis. Read counts 
mapping to 3’927’115 repeat instances were collected in pools according to 
their corresponding repeat elements and were length-normalized to the 
summed length of all instances per element. For further analysis we 
  5 
normalized read counts of repeat instances to the total number of reads 
mapping uniquely to the genome for each sequence run and merged read 
counts into their corresponding repeat classes. 
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Figure S1. Specificity of H3K9me2 antibodies used in this study.
Indicated amounts of either modified or unmodified H3 and H4 peptides (H3 residues 1-20, 19-38 and 25-45, H4 
residues 12-31) were spotted onto polyvinylidene difluoride membranes (GE) and probed with (A) anti-
dimethyl-H3K9 (LP Bio, no. AR-0108) or (B) anti-dimethyl-H3K9 (Abcam no. 1220) at 1:1000 dilution each. Both 
antibodies are highly specific towards H3K9me2.
0.98 Mb 
29.89 Mb 
ES Wen et al. 
ES Lienert et al.
7.11 Mb 
Figure S2 Lienert et al
A
B
Figure S2. High similarity of ES cell H3K9me2 datasets.
(A) Comparison of our H3K9me2 enrichment profiles in ES cells to a previously generated ES cell profile 
(Wen et al.). (B) Venn diagram illustrating the overlap of H3K9me2-occupied regions between the two ES 
cell datasets from (A) (defined by an HMM approach). The overlap agrees with the high correlation we 
observe for this previously generated ES cell dataset with our two ES cell replicates (Pearson correlation of 
0.73 and 0.74, on 500 bp windows).
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Figure S3. H3K9me2 enrichments on chromosome 19 are representative of the entire genome.
(A) H3K9me2 enrichments in ES cells from a previously generated dataset (Wen et al.). The boxplots 
show enrichments on the probe level per chromosome with chromosome 19 highlighted in blue.
(B) H3K9me2 enrichments per 900 bp promoter windows (defined in Mohn et al.) in ES cells. The 
boxplots represent average enrichments at promoters per chromosome with chromosome 19 high-
lighted in blue.
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Figure S4. (A) H3K9me2 enriched regions are robustly identified independent of HMM
parameters. Shown is the comparison of H3K9me2 enrichments in ES cells and neurons using a 3 state 
HMM to define non-occupied (low), intermediately and highly occupied domains (top). Importantly, the 
state specific HMM distribution parameters (mean and variance of H3K9me2 enrichment) are very similar 
between ES cells and neurons (bottom). Note that with a 3 state HMM the percentage of domains in the 
high state does not change between ES cells and neurons (TN). However, we detect an overall increase 
of the intermediate state of around 10%.
mean variance
0.02
0.06
0.10
-0.32
0.030.48
HMM state
low
intermediate
high
mean variance
0.02
0.08
0.10
-0.34
0.030.43
A
0 20 40 60 80 100
0.00
0.01
0.02
0.03
0.04
0.05
H3K9me2 domain size distribution
Domain size [kb]
D
en
si
ty
ES
TN
median domain size
ES: 9.5kb
TN: 9.5kb
B
Figure S4. (B) H3K9me2 domain size is highly similar in ES cells and neurons.
H3K9me2 domains were defined by HMM (see methods). While numbers of domains on chromosome 19 
increase from 1618 to 1914 from ES cells to neurons, their domain size distribution is very similar. This 
was also seen using alternative domain definition methdos (data not shown).
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Figure S5. Regions that lose are smaller than regions that gain H3K9me2 during differentia-
tion and gaining regions often overlap with gene bodies.
Histograms displaying the size distributions of regions that lose (A) and gain (B) H3K9me2 
during neuronal differentiation, respectively. Adjacent 500 bp windows being in a low HMM 
state in both ES cell replicates and in a high HMM state in the neuron replicates were grouped 
into H3K9me2 losing regions and vice versa. (C) Pie chart illustrating the percentage of large 
(>10kb) H3K9me2 gaining regions within (grey) and outside (white) of genes (left). This 
overlap is significantly higher than for all regions which have no H3K9me2 in ES cells, defined 
as being in a HMM low state in both replicates (right). (D) Boxplot showing expression levels 
of all genes (n = 138, adjusted P-value  < 0.05) that gain H3K9me2 in neurons. Note that the 
median expression does not change significantly between ES cells and neurons (TN), indicat-
ing that there is no global trend towards either up- or down-regulation upon accumulation of 
H3K9me2 in the gene bodies of these genes.
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Figure S6. Regions losing H3K9me2 during differentiation are close to background.
(A-C) Shown are representative genomic regions that significantly lose H3K9me2 as
defined by HMM analysis. (D) ChIP-real time PCR validation of those regions shown in (A-C).
Note that H3K9me2 enrichments are already low in ES and only slightly above background as
exemplified by the active housekeeping gene Hprt, which does not carry H3K9me2. The loss
of enrichment in neurons is small, though reproducible.
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Figure S7. H3K9me2 in neurons rarely overlaps with promoter regions of active genes.
Pie chart illustrating the percentage of promoters (1kb up- and downstream of TSS) (A) and gene 
bodies (B) of transcribed genes that overlap H3K9me2-occupied regions in neurons. Note that 
promoters are rarely H3K9 dimethylated when the gene is actively transcribed.  
95.8 %
4.2 %
57.8 %
42.2 %
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Figure S8.
(A) Venn diagram illustrating the overlap of transcripts expressed at a low level (log2 RNAseq reads 
between 2 and 5) in at least one of the examined cell types. Note that areas are not drawn to scale.
(B) Boxplots showing expression levels of transcripts per chromosomes.
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Figure S9. Absence of difference in transcriptome complexity is not a function of sample size in next genera-
tion sequencing.
Shown is the number of detected Refseq transcripts (at least 32 reads) relative to the the number of sampled 
reads. Number of detected transcripts is shown as the mean of a 100 different subsamples with the same read 
numbers. Irrespective of the sample size, a random sampling of RNAseq reads from ES cells (green line), 
neurons (dark green line) and MEFs (red line) revealed a smaller number of dected transcripts than an artificial 
sample with pooled reads from all three cell types (blue line).
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Figure S10. H3K9me2 domain definition by different statistical methods leads to similar results.
(A) HMM-independent quantification of genomic coverage of H3K9me2 in ES cells and neurons. Shown is 
the percentage of chromosome 19 that lies within H3K9me2 peaks defined by a simple threshold method 
(see Methods). (B) Diagram illustrating the actual overlap between regions defined to be occupied by 
H3K9me2 by two different methods; a simple threshold method (t-peaks; see Methods) and by an HMM 
approach (HMM; see Methods).
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Table S1. Real time PCR primers.
Genes sense/antisense Sequence
Gda s ACG ACG GCA CCA AAG AAT AC
as TTG CCA GAC AAG CAA TCA AC
Pcsk5 s CAA TGA AGT GAT GCC CTC CT
as CAT GCT TGG CTA GTA GTG GAA
Hprt s CCA AGA CGA CCG CAT GAG AG
as CAA CGG AGT GAT TGC GCA TT
Oct_4 s ACC TCC GTC TGG AAG ACA CA
as TCA CCT AGG GAC GGT TTC AC
Kif20b s GCC TCA AGG GGT TAA AGA GG
as TCT GCC CTA TAT GCA TGC TG
Hells s GAG AAT TGG GAC TGG AAG CA
as CCA GAG GAC CCA AGT TCA AA
Incenp s GCC TTG GTC TTG GAG AAA CA
as CTC ACA GGT CTG CCC ATT CT
Vsp13a s AGG CTT GTG TCT GAG CCA GT
as GCC TTT TTG ACG TCT TCA GC
Cbwd1 s TTG GGA GCT GGT AAG ACA CA
as TCA CCA GCT CTT GCA AAA CA
Saps3 s CTG GCC AAA TGT TAG CAC CT
as TCT AGG GAC CCT TGT GAT GG
Sgms1 s CAG GGT TAC TGG ACC CCT TT
as AAC AAG CCC CTC ATC AAA TG
K9downAs AGC CCA GGG TGA GTC AGT T
as GCC ACC ATC ATA TCT CAC CA
K9downBs GGG GTA GAG GGA GAT GGA AA
as ATG CGC ATA CAG ATC ACG TC
K9downCs AAA GCA TCC TGG ACA TAA AAG AA
as GAA TCC TTT CGG CTT TAG GG
Table S2. Peptides used in dot blots in Figure S1.
protein modification sequence
H3 (1-20) unmod ARTKQTARKSTGGKAPRKQL-cys 
H3 (1-20) K4(Me) ARTK(Me)QTARKSTGGKAPRKQL-cys 
H3 (1-20) K4(Me)2 ARTK(Me2)QTARKSTGGKAPRKQL-cys
H3 (1-20) K4(Me)3 ARTK(Me3)QTARKSTGGKAPRKQL-cys 
H3 (1-20) K9(Me) ARTKQTARK(Me)STGGKAPRKQL-cys 
H3 (1-20) K9(Me)2 ARTKQTARK(Me2)STGGKAPRKQL-cys 
H3 (1-20) K9(Me)3 ARTKQTARK(Me3)STGGKAPRKQL-cys 
H3 (19-38) unmod QLATKAARKSAPATGGVKKP-cys 
H3 (19-38) K27(Me) QLATKAARK(Me)SAPATGGVKKP-cys 
H3 (19-38) K27(Me)2 QLATKAARK(Me2)SAPATGGVKKP-cys 
H3 (19-38) K27(Me)3 QLATKAARK(Me3)SAPATGGVKKP-cys 
H3 (25-45) unmod ARKSAPATGGVKKPHRYRPGT-cys 
H3 (25-45) K36(Me) ARKSAPATGGVK(Me)KPHRYRPGT-cys 
H3 (25-45) K36(Me)2 ARKSAPATGGVK(Me2)KPHRYRPGT-cys 
H3 (25-45) K36(Me)3 ARKSAPATGGVK(Me3)KPHRYRPGT-cys
H4 (12-31) unmod KGGAKRHRKVLRDNIQGITK-cys 
H4 (12-31) K20(Me) KGGAKRHRK(Me)VLRDNIQGITK-cys 
H4 (12-31) K20(Me)2 KGGAKRHRK(Me2)VLRDNIQGITK-cys 
H4 (12-31) K20(Me)3 KGGAKRHRK(Me3)VLRDNIQGITK-cys 
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3.2. Identification of genetic elements that autonomously 
determine DNA methylation states 
 
Lienert F., Wirbelauer C., Som I., Dean A., Mohn F. and Schübeler D. 
 
3.2.1. Summary 
DNA methylation is an epigenetically inherited, repressive chromatin modification that 
has an important role in silencing of repeats, in genomic imprinting and during X-
chromosome inactivation (Walsh and Bestor 1999). In mammals, genome-wide DNA 
methylation gets reprogrammed during germ cell development and early embryogenesis 
(Guibert et al. 2009). While most CpG-rich promoters remain unmethylated in all cell types, a 
subset of these regulatory regions gets de novo methylated during early development 
(Weber et al. 2007; Farthing et al. 2008; Illingworth et al. 2008; Meissner et al. 2008; Mohn 
et al. 2008; Borgel et al. 2010). 
We here used a well-defined ES cell differentiation system (Bibel et al. 2004) to 
investigate how patterns of DNA methylation are established during loss of pluripotency and 
subsequent commitment to a neuronal lineage. In order to test whether promoter methylation 
is guided by the underlying DNA sequence, we chose a set of promoter regions with different 
DNA methylation levels and inserted them at an ectopic site in the genome. To do so, we 
made use of an insertion method that allows sequential insertions at the same genomic site 
without the need of a transcribed marker gene (Seibler et al. 1998). By following DNA 
methylation levels at ectopically inserted promoter elements during cellular differentiation we 
aimed to address the targeting principles of this repressive chromatin modification.  
Our results show that 1 kb promoter elements are sufficient to recapitulate 
endogenous DNA methylation patterns in ES cells. This finding is in agreement with earlier 
reports on sequence mediated protection from DNA methylation at two different CpG island 
promoters in ES cells (Szyf et al. 1990; Brandeis et al. 1994; Macleod et al. 1994). Our study 
generalizes this finding and reveals that also differentiation-induced de novo methylation is 
determined by the underlying promoter sequence. We further define that DNA methylation 
patterns and their differentiation-induced changes are established independently of 
transcription. Moreover, insertion of numerous truncated promoter elements led to the 
identification of methylation determining regions (MDRs); sequence elements of varying size 
that are required for an unmethylated promoter state in ES cells. Mutations of predicted 
transcription factor binding sites in the MDR of Alf (GTF2A1L) suggest that protection from 
Results 
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DNA methylation at these sequence elements critically depends on TF binding. Specifically, 
we provide evidence that RFX2 represents a potential transcription factor involved in 
mediating an unmethylated state at the Alf MDR. In agreement with a general role of TFs in 
protecting from DNA methylation, it was recently reported that the zinc finger protein VEZF1 
defines the unmethylated state of the chicken β-globin enhancer and the murine APRT CpG 
island (Dickson et al. 2010). Such TF mediated protection from DNA methylation might be 
facilitated by CXXC domain proteins that bind unmethylated CpGs and possess or recruit 
H3K4 methyltransferase activity (Thomson et al. 2010). However, CpG-richness alone does 
not seem to be sufficient for protection from DNA methylation, as the majority of ectopically 
inserted CpG-rich sequences from E. coli get methylated in ES cells. Remarkably, at 
promoters that get de novo methylated upon differentiation, MDRs encode both, protection 
from DNA methylation in ES cells as well as de novo methylation. We further show that 
MDRs can protect neighboring sequence from DNA methylation in ES cells and from de 
novo methylation during differentiation. 
Based on these results we propose that TF factors are critically involved in locally 
protecting genomic regions from DNA methylation. We further speculate that differentiation-
induced de novo methylation could be triggered by reduced binding of TFs that protect from 
DNA methylation. 
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DNA methylation is an efficient repressor of transcriptional activ-
ity and represents a true epigenetic modification, as its mechanism 
of inheritance during the cell cycle is well established1. In mam-
mals, DNA methylation is essential2 and occurs almost exclusively 
at cytosines in the context of CpG dinucleotides. As a result of an 
increased mutation rate of methylated cytosines, most of the genome 
is depleted of CpGs except for small regions, which represent two-
thirds of all mammalian promoters and are termed CpG islands3. 
Recent genome-wide analyses have corroborated that the majority of 
CpG islands are kept unmethylated at any given time during devel-
opment, whereas most CpGs outside of CpG islands are methylated 
by default4,5.
Several mechanisms have been proposed for how this global pat-
tern of DNA methylation is established. Single-transgene studies 
have suggested that DNA-binding factors are involved in creating 
an unmethylated state6–8. In contrast, DNA methylation and certain 
active chromatin marks occur in a mutually exclusive manner5,9,10. 
Of note, in plants and fungi, a functional role for an interplay between 
DNA methylation and chromatin has been well established11,12, mak-
ing it possible that chromatin could be a determining factor in estab-
lishing global methylation patterns in mammals, as well13.
Notably, DNA methylation patterns are not static. In mammals, a 
subset of promoters that are enriched for CpG islands of intermediate 
CpG density becomes de novo methylated in a cell lineage–dependent 
manner9,14,15. In this context, it has also been suggested that sequence-
specific factors16–19 and epigenetic modifications20,21 may account for 
the observed selectivity of this de novo methylation process. However, 
these observations have not yet resulted in predictive models of 
dynamic DNA methylation, underscoring our limited understanding 
of the basic principles that govern this DNA modification. Such 
advanced knowledge of regulatory logic would further assist in the 
identification of potential mechanisms that underlie erroneous DNA 
methylation in disease-22 or environment-induced changes, such as 
those observed in the brain upon stimulation23.
To gain systematic insight into the constraints that define endogenous 
DNA methylation patterns, we integrated a multitude of different DNA 
elements into the same genomic locus in mouse embryonic stem (ES) 
cells. This experimental setup made it possible to control for chromo-
somal environment and also to dissect out potentially indirect effects, 
such as those mediated by ongoing transcription. This enabled us to 
measure the contribution of DNA sequence to the establishment of 
DNA methylation. Moreover, we were able to quantify the contribution 
of DNA sequence to methylation changes during cellular differentiation. 
In sum, we here demonstrate that proximal promoters show unexpected 
autonomy in defining their own DNA methylation states in pluripo-
tent cells and in reprogramming these states during cellular differentia-
tion. Furthermore, we show that this regulatory potential is genetically 
encoded by small sequence modules within these promoters.
RESULTS
Recapitulation of Nanog promoter methylation
To define sequence contribution to DNA methylation states, we used 
mouse embryonic stem cells as a cellular model. The methylation 
landscape of ES cells is comparable to epiblast cells, with established 
genome-wide methylation outside of CpG islands24. Furthermore, dif-
ferentiating ES cells can recapitulate in vivo development and lineage- 
specific epigenetic reprogramming, as we have shown in an optimized 
system that generates highly purified neuronal progenitors15,25. 
Identification of genetic elements that autonomously 
determine DNA methylation states
Florian Lienert1,2, Christiane Wirbelauer1, Indrani Som3, Ann Dean3, Fabio Mohn1,4 & Dirk Schübeler1,2
Cytosine methylation is a repressive, epigenetically propagated DNA modification. Although patterns of DNA methylation seem 
tightly regulated in mammals, it is unclear how these are specified and to what extent this process entails genetic or epigenetic 
regulation. To dissect the role of the underlying DNA sequence, we sequentially inserted over 50 different DNA elements into the 
same genomic locus in mouse stem cells. Promoter sequences of approximately ,000 bp autonomously recapitulated correct 
DNA methylation in pluripotent cells. Moreover, they supported proper de novo methylation during differentiation. Truncation 
analysis revealed that this regulatory potential is contained within small methylation-determining regions (MDRs). MDRs can 
mediate both hypomethylation and de novo methylation in cis, and their activity depends on developmental state, motifs for 
DNA-binding factors and a critical CpG density. These results demonstrate that proximal sequence elements are both necessary 
and sufficient for regulating DNA methylation and reveal basic constraints of this regulation.
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Here we have chosen the β-globin gene locus as a genomic site to 
test whether DNA methylation is DNA sequence dependent, and we 
uncouple this event from chromatin context and transcription. This 
well-studied locus is active only during erythropoiesis26 and accord-
ingly shows no transcriptional activity or presence of the active histone 
H3 lysine 4 dimethylation (H3K4me2) modification in either stem 
cells or derived neuronal progenitor cells27 (Fig. 1a). In addition, 
this genomic region shows no occurrence of the repressive histone 
H3 lysine 27 trimethylation (H3K27me3) modification and harbors 
no CpG islands, suggesting that it represents an inert epigenetic envi-
ronment in non-erythroid cells (Fig. 1a). We engineered a targeting 
site in this locus by replacing a 3.6-kb region around the Hbb-y gene 
with a selection cassette flanked by two inverted loxP sites via homol-
ogous recombination. This site enables efficient genomic insertions 
by recombinase-mediated cassette exchange (RMCE)28–30. Notably, 
any correct insertion will replace the selection marker during the 
recombination process and therefore circumvent the need of active 
transcription after targeting, which might otherwise override insert-
driven epigenetic modifications (Fig. 1b).
We first inserted sequences from the well-characterized promoter 
region of Nanog; a gene encoding a transcription factor essential for 
maintaining the pluripotency of ES cells31,32. During differentiation, 
the Nanog promoter switches from a highly active, unmethylated state 
to a silent, methylated state15,33. A 5,712-bp Nanog sequence including 
the transcriptional start site (TSS), the proximal promoter and a strong 
enhancer element34 recapitulated the methylation state of the endo-
genous locus after insertion in the β-globin locus. That is, both the 
promoter and the enhancer region of the transgene remained unmeth-
ylated in stem cells (Fig. 1c and Supplementary Fig. 1). Upon in vitro 
differentiation, the enhancer region remained unmethylated, whereas 
the proximal promoter became de novo methylated to once again 
mirror the endogenous locus (Fig. 1c and Supplementary Fig. 1). 
We conclude that a 5,712-bp sequence around the Nanog promoter is 
sufficient to recapitulate not only the unmethylated state in stem cells 
but also de novo methylation during differentiation.
To narrow down the functional DNA element within this 5,712-bp 
region, we next inserted a 1,013-bp fragment of the proximal pro-
moter to test its behavior in the absence of the enhancer. Like the 
longer element, the 1,013-bp fragment was sufficient to recapitulate 
an unmethylated state in stem cells and a methylated state in neuronal 
progenitors (Fig. 1d). However, in contrast to the endogenous Nanog 
gene, the inserted sequence had no transcriptional activity and did not 
recruit RNA polymerase II in stem cells (Fig. 1e). This suggests that 
the generation of correct endogenous methylation patterns occurs 
independently of transcriptional activity. Also of note, we observed 
that the inserted fragment lost H3K4 dimethylation upon de novo  
DNA methylation in a similar fashion as the endogenous locus 
(Fig. 1e), in agreement with previous data5,9. This finding further 
suggests that sequences introduced ectopically into the β-globin locus 
can behave as their endogenous counterparts.
Autonomy of -kb promoter elements
To further investigate our observation of the epigenetic autonomy of 
the Nanog promoter, we similarly inserted nine additional promoter 
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Figure 1 Ectopic Nanog promoter recapitulates 
the methylation state of the endogenous 
promoter. (a) RNAseq and chromatin 
immunoprecipitation sequencing (ChIPseq) 
tracks for H3K4me2 and H3K27me327. Read 
counts (per 100 bp) are shown for the β-globin 
locus (left) and a randomly chosen region 
(kctd15; right) in ES cells and derived neuronal 
progenitors (NPs). The UCSC CpG island and 
gene tracks are shown below. (b) Sequence 
fragments (gray box) are integrated in the  
β-globin locus by Cre recombinase. The target 
site consists of two inverted loxP elements 
(triangles) flanking a fusion of a hygromycin-
resistance (Hy) and a ganciclovir-sensitivity 
gene (Tk), which is replaced by the sequence of 
interest. (c) DNA methylation levels for single 
CpGs at the inserted 5.7-kb promoter fragment 
of Nanog are depicted as black (methylated) 
or white (unmethylated) circles. Every line 
corresponds to a sequenced bisulfite PCR 
amplicon. Colored vertical bars summarize 
these results, as defined by the color legend. 
(d) CpG methylation levels at the inserted  
1-kb Nanog promoter fragment. (e) RNA Pol II  
occupancy and RNA levels (in ES cells) and 
H3K4me2 occupancy (in ES and NP cells) at 
the inserted 1-kb Nanog promoter fragment. 
ChIP enrichment for RNA Pol II and H3K4me2 
was normalized to Hprt. RNA levels were 
determined using reverse transcription followed 
by real-time PCR and normalized to Lmnb1. 
Values at a methylated promoter and at an 
intergenic region are shown as a comparison. 
Error bars indicate s.d. from two independent 
biological replicates. The location of primers 
for the endogenous and inserted promoter is 
depicted above.
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fragments ranging in size from ~700 to ~1,000 bp that had different 
CpG density to test the generality of this finding. The endogenous loci 
of these ten promoter sequences represent the different DNA methyla-
tion patterns that we have previously identified in our genome-wide 
survey15, including maintaining high or low methylation levels in 
undifferentiated or differentiated cells or gaining methylation during 
cellular differentiation. Notably, nine out of ten inserted promoter 
fragments correctly recapitulated the endogenous methylation pat-
tern in stem cells (Fig. 2a and Supplementary Fig. 2). The inserts 
recapitulated hypomethylated states, and promoters that are typically 
fully methylated at their endogenous loci were also correctly methyl-
ated when inserted. This rules out the possibility that the detected 
hypomethylation in stem cells is simply due to insertion at this 
particular ectopic site.
Of note, the sole fragment that did not recapitulate its endogenous 
epigenetic state was a 1,025-bp fragment encompassing the TSS of 
Hes3. In this case, the insert acquired methylation in stem cells, 
even though the endogenous locus is unmethylated. We therefore 
hypothesized that the fully functional promoter of this gene might 
be longer than 1,025 bp and tested this idea by inserting a 1,579-bp 
fragment that included a CpG-rich region downstream of the TSS 
(Fig. 2b and Supplementary Fig. 2). This longer fragment remained 
unmethylated (Fig. 2b), suggesting that the shorter fragment lacked a 
critical component.
Taken together, these data indicate that all ten promoter frag-
ments tested, when of the correct length, direct their methylation 
levels in stem cells. Of note, the inserted fragments recapitulate the 
endogenous methylation with very high accuracy (r = 0.93, P value < 
10−13, Fig. 2c,d and Supplementary Fig. 2), underscoring their 
regulatory autonomy.
Genetic determination of dynamic DNA methylation
To ask whether the same regulatory logic determines DNA methyla-
tion states during cellular differentiation, we derived neuronal progen-
itors for each cell line containing one of the studied promoter inserts. 
Similar to the situation in stem cells, methylation levels of ectopically 
placed promoter fragments were in perfect accordance with their 
endogenous counterparts, showing either no 
change in DNA methylation or de novo meth-
ylation (Fig. 2a and Supplementary Fig. 2). 
As for Nanog, all the inserted promoters that were tested recapitulated 
the endogenous H3K4 methylation pattern and its changes during 
differentiation (Supplementary Fig. 3).
These findings indicate that promoter DNA methylation is primar-
ily regulated by cis-acting sequences and is thus genetically encoded. 
Our data also argue that methylation patterns and their changes can be 
established independently of transcription, as most studied promot-
ers were inactive at their endogenous sites and when placed into the 
ectopic site (Fig. 2a and Supplementary Fig. 4). Further supporting 
the idea that maintenance of the unmethylated state is independent 
from transcriptional activity, the endogenously expressed Nanog 
and Tcl1 recapitulated their dynamic DNA methylation patterns at 
the ectopic site without being transcriptionally active (Fig. 1e and 
Supplementary Fig. 4).
Methylation autonomy depends on critical regions
Given the ability of 1-kb elements to accurately recapitulate endo-
genous DNA methylation, we next asked if smaller fragments had 
similar capabilities. For this purpose, we inserted a total of 23 trun-
cated variants derived from the initial set of unmethylated promoters. 
Unexpectedly, the truncated fragments behaved differently in many 
cases (Fig. 3a and Supplementary Fig. 5). Below a promoter size 
of approximately 700 bp, the otherwise unmethylated state became 
unstable, leading to increased DNA methylation in stem cells (Fig. 3b). 
This finding raises the possibility that the length of the insert is a 
critical determinant of its epigenetic state. Notably, our empiri-
cally identified size threshold is comparable to the average length 
of unmethylated regions around start sites reported in a recent 
genome-wide methylation survey4. We suggest that these regions 
in most cases harbor the cis-regulatory information sufficient for 
directing hypomethylation.
Our truncation experiments further revealed several smaller ele-
ments that contain all information necessary to recreate the correct 
endogenous methylation pattern. In the Gtf2a1l (also known as Alf) 
and Hes3 promoters, these elements consist of 176 and 301 bp, respec-
tively (Fig. 3c and Supplementary Figs. 5 and 6). For Syt1, Nanog and 
Trf, the critical region ranges in size from 515 to 720 bp (Fig. 3c and 
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Figure 2 One-kb elements autonomously set 
DNA methylation state. (a) Summary table of 
inserted fragments. Length of fragments is 
given in bp. The heat map summarizes DNA 
methylation levels of endogenous and inserted 
promoters in ES cells and in NPs, as defined 
in the color legend. Transcriptional activity of 
endogenous and inserted promoters is indicated 
for ES cells. (Endog., endogenous promoter; 
Insert, inserted promoter element; ND, not 
determined). (b) CpG methylation levels in ES 
cells at the endogenous Hes3 promoter and 
the inserted 1-kb and 1.6-kb Hes3 fragments. 
Methylation levels of the regions indicated by a 
horizontal bar are shown below each fragment. 
(c) CpG methylation levels in ES cells at the 
endogenous and the ectopically inserted Trf 
promoter. (d) Comparison of methylation levels 
between inserted fragment and endogenous 
promoter, as determined by bisulfite PCR, 
illustrating the quantitative similarity in DNA 
methylation levels (see also supplementary  
Figs. 1 and 2).
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Supplementary Fig. 5). Of note, in the cases of Hes3 and Syt1, the 
respective sequences do not include the transcriptional start site, further 
supporting the notion that actual transcription is not needed for pro-
tection from DNA methylation. We conclude that the regulation of 
promoter hypomethylation depends on smaller embedded regions, 
which we refer to as methylation-determining regions (MDRs).
CpG density alone does not account for MDR function
To gain further insight into the regulatory logic of MDRs, we com-
pared the sequence features of all promoter fragments and their 
DNA methylation in stem cells. From this analysis, we noticed a 
significant anti-correlation (r = −0.49, P < 0.05) between hypermeth-
ylation and the number of CpGs (Fig. 4a). 
We hypothesized that CpG density, as a dis-
tinguishing feature of CpG islands, might be 
critical to establish a hypomethylated state. 
Regardless of their CpG content, promoters 
contain many transcription factor–binding 
sites whose occupancy might be involved in 
regulating DNA methylation. Thus, we rea-
soned that a proper test for CpG dependency 
would require DNA sequence that contains no such binding sites. To 
maximize evolutionary distance and thus to minimize the likelihood 
of functional binding sites for mammalian transcription factors, 
we inserted ten random genomic regions from the prokaryote 
Escherichia coli. The tested E. coli sequences had an average length 
of 780 bp and varied in CpG density from 4.4 to 6.8 CpGs per 
100 bp (Supplementary Fig. 7). This corresponds to a CpG den-
sity where almost all (>98%) endogenous mouse promoters are 
unmethylated15 (M. Stadler, R. Murr, L. Burger and D.S., unpub-
lished data). Unexpectedly, upon insertion seven out of ten E. coli 
fragments became fully methylated in stem cells, whereas the 
remaining three showed a level of methylation below 50% (Fig. 4b 
and Supplementary Fig. 7). These three fragments also showed 
enrichment for the H3K4me2 modification (Supplementary Fig. 8). 
Consistent with earlier findings that CpG density is highly corre-
lated with hypomethylation5,35, the inserted bacterial DNA shows 
a trend toward hypomethylation with increasing CpG content. 
However, despite the fact that all ten E. coli fragments have a CpG 
content equal to or greater than most unmethylated mouse promo-
ters, the majority were still methylated. Together, these findings 
suggest that for most mouse promoters, CpG content alone cannot 
account for their unmethylated state in vivo.
Mutation of DNA-binding motifs impairs MDR function
We next tested whether motifs for DNA-binding factors, potentially 
in conjunction with CpG density, contribute to the unmethyl-
ated state in stem cells. To this end, we generated several 4-bp 
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Figure 4 MDR function depends on CpG density 
and DNA-binding motifs. (a) Methylation level 
in ES cells plotted against number of CpGs 
at inserted promoter elements and deletion 
fragments. (b) Methylation level in ES cells 
plotted against CpG density at inserted promoter 
elements and E. coli sequence fragments.  
(c) Part of the inserted Gtf2a1l promoter 
sequence (104 of 176 bp) with predicted DNA-
binding motifs36,49 and mutation deletions 
(in green) indicated. CpG methylation levels 
in ES cells are shown for each mutated 
MDR fragment. (d) Rfx2 occupancy of the 
inserted Gtf2a1l MDR. ChIP enrichments were 
normalized to Pdcl2, which also contains a Rfx-
binding site38. Error bars indicate s.d. from two 
independent biological replicates. WT, wild type.
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deletions in predicted DNA-binding motifs in the short MDR of 
the well-characterized Gtf2a1l promoter36. Notably, the deletions 
did not affect CpGs, allowing us to study the dependency of DNA 
methylation on DNA-binding motifs uncoupled from CpG density 
(Fig. 4c). We inserted these mutated fragments into the target site 
and determined their DNA methylation in ES cells (Fig. 4c and 
Supplementary Fig. 9). Three of four tested mutations in predicted 
DNA-binding motifs resulted in increased methylation at the pro-
moter element compared to the original sequence. These mutations 
affected DNA sequences that were predicted to bind Sp1, CTCF 
or members of the Rfx winged-helix transcription factor family36. 
A combination of mutations affecting the SP1, CTCF and Rfx binding 
sites led to an even higher methylation level, suggesting an addi-
tive effect of factor binding in MDRs. As Sp1 and CTCF have been 
previously implicated in the regulation of DNA methylation6,7,37, we 
tested whether Rfx factors might have a similar role. We measured 
binding by Rfx2, which has previously been reported to occupy the 
Gtf2a1l promoter in spermatocytes38. These experiments revealed 
that Rfx2 binds the Gtf2a1l MDR in ES cells and that this binding is 
strongly diminished when its binding site is mutated (Fig. 4d). We 
conclude that the unmethylated state of the Gtf2a1l MDR requires 
the combinatorial presence of DNA-binding motifs and presumably 
their corresponding factors. Of note, this effect is independent of 
transcription per se, because the inserted Gtf2a1l MDR is inactive 
in stem cells (Supplementary Fig. 6). Thus, DNA binding motifs in 
MDRs contribute to hypomethylation even in the absence of pro-
ductive transcription.
MDRs regulate de novo methylation
Having identified MDRs and sequence features that mediate 
hypomethylation in stem cells, we next wanted to identify promoter 
regions that are crucial for inducing de novo methylation during 
cellular differentiation. We first tested the MDRs of the Gtf2a1l, Trf 
and Nanog promoters during differentiation from stem cells into 
neuronal progenitors (Fig. 5a and Supplementary Fig. 10). All three 
fragments were de novo methylated in progenitors similarly to their 
endogenous counterparts. We therefore conclude that MDRs require 
no additional sequence information for differentiation-induced 
de novo methylation.
MDRs act in cis on heterologous regions
Because MDRs are critical for the correct methylation of adjacent 
promoter sequences, we next asked whether they are able to confer 
DNA methylation states in cis on heterologous fragments. For these 
studies, we turned to the Hes3 promoter, whose hypomethylation 
depends on an MDR downstream of the transcriptional start site 
(Fig. 2b). We fused the MDR of Hes3 to the promoters of Mrap and 
Orm1, which when inserted individually are fully methylated in 
stem cells (Fig. 2a). When fused to the Hes3 MDR, both the Mrap 
and Orm1 promoter had much less DNA methylation (Fig. 5b and 
Supplementary Fig. 11), showing that an MDR associated with 
hypomethylation can independently confer this epigenetic state on 
adjacent heterologous sequences. In all cases examined, the induced 
hypomethylation occurred primarily at sequences directly adja-
cent to the fused MDR. This was not limited to the Hes3 MDR, 
as the MDRs of Syt1 and Gtf2a1l were equally capable of induc-
ing hypomethylation when fused to Mrap and Orm1 (Fig. 5b and 
Supplementary Fig. 11). We therefore conclude that the ability 
to confer hypomethylation on adjacent sequences seems to be a 
general feature of MDRs that induce an unmethylated state in stem 
cells. To test whether this ability to induce the hypomethylation 
of heterologous sequences in cis similarly relies on DNA-binding 
motifs, we fused the mutated Gtf2a1l MDR to Mrap and Orm1. In 
both cases, we saw a detectably weaker spread of the unmethylated 
state, suggesting that transcription factor–binding sites determine 
both the methylation state of an MDR and its ability to function 
in cis (Fig. 5b and Supplementary Fig. 11). Whereas the Gtf2a1l 
and Syt1 MDRs are both capable of conferring hypomethylation 
on heterologous sequences in stem cells, they act in opposing ways 
during differentiation. Gtf2a1l induces de novo methylation and 
Syt1 maintains hypomethylation (Fig. 2a). Thus, we wondered how 
these seemingly opposing activities would influence each other. We 
fused the two MDRs and inserted them into the β-globin locus. In 
stem cells, the hybrid of the two MDRs caused a hypomethylated 
state, as one would expect from the single insertion of each MDR 
(Figs. 3a,c and 5c and Supplementary Fig. 12). The hybrid stayed 
unmethylated, even after differentiation into neuronal progenitors 
(Fig. 5c and Supplementary Fig. 12). This finding suggests that the 
Syt1 MDR overrides the de novo methylation signal in the Gtf2a1l 
a
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Figure 5 MDRs control de novo methylation 
and function in cis on heterologous DNA. 
(a) CpG methylation levels in ES cells and 
NPs at MDRs of promoters that get de novo 
methylated, showing that MDRs are properly 
reprogrammed. (b) CpG methylation levels 
in ES cells at a hybrid of the Mrap promoter 
fragment with MDRs of the Syt1, Hes3 and 
Gtf2a1l promoters. In each case the MDR 
confers partial hypomethylation in cis. 
This effect is diminished in a hybrid with a 
mutated Gtf2a1l MDR. (c) CpG methylation 
levels at a hybrid of the Gtf2a1l and Syt1 
MDRs revealing inhibition of de novo 
methylation. (d) Model of MDR function 
in mediating hypomethylation. Sequence 
dependence of DNA methylation relies on 
MDR regions (dark green) that reside within 
hypomethylated promoters (gray box). MDR 
activity is dependent on DNA-binding motifs 
(light green bars) and mediates proximal 
hypomethylation in cis, probably by protecting 
against DNA methylation.
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MDR, further supporting the notion that MDRs are regulatory 
modules that enact hypomethylated states in cis.
DISCUSSION
The epigenetic nature of inheritance of symmetric DNA methylation is 
well understood in mammals, where Dnmt1 and Uhrf1 were shown to 
function in a bona fide copying mechanism39. However, the rules that 
govern the establishment of DNA methylation patterns remain unde-
fined, despite emerging genome-wide data sets of DNA methylation 
patterns, their developmentally and environmentally driven variability 
and their correlations with histone modifications4,5,9,14,15,35,40. Using 
a highly controlled system in which we repeatedly target the same 
chromosomal locus, we show that promoter sequences of ~1,000 bp 
are generally sufficient to precisely recapitulate DNA methylation 
patterns in stem cells and to replicate the changes that occur during 
differentiation. These results argue that DNA methylation levels are 
genetically defined in cis. This is compatible with several previous 
single-transgene studies, which mostly did not separate effects arising 
from the genomic integration site from those caused by transcrip-
tion6–8. Indeed, transcription has been suggested as a likely mediator 
of a hypomethylated state, as it provokes high local levels of activating 
histone modifications, such as H3K4 methylation41. Unexpectedly, 
we observed correct methylation of cis-regulatory regions that are 
transcriptionally inactive, suggesting that transcription does not play 
an essential part in the establishment of DNA methylation states.
We further show that DNA sequence–driven patterns rely on even 
smaller methylation determining regions (MDRs) that reside within 
promoter elements. These elements are necessary and sufficient for 
correct DNA methylation. On the basis of truncation and mutagenesis 
analyses, we show that DNA-binding motifs are critical for generating 
a hypomethylated state. This finding suggests that DNA-binding fac-
tors mediate hypomethylation without necessarily leading to active 
transcription. These results further argue against a locus-specific, 
distal regulation of DNA methylation by transcription, regulatory 
regions or chromatin states.
Given the overall absence of DNA methylation at CpG islands and 
the existence of proteins capable of recognizing unmethylated CpGs42, 
it would be conceivable that CpG density alone is sufficient to medi-
ate a hypomethylated state. Our observation that nonmammalian 
CpG-rich sequences are frequently methylated after insertion argues 
against such a scenario. We favor a model in which CpG density, in 
combination with DNA-binding motifs, generates functional MDRs 
capable of establishing a hypomethylated state (Fig. 5d). This idea is 
consistent with a recent evolutionary analysis of primate CpG islands 
that suggests that there is no particular selective constraint on CpGs 
in these regions43.
We show that MDRs confer hypomethylation on larger promoter 
fragments, which is compatible with a model that they function 
via a protective mechanism that extends to neighboring sequences 
(Fig. 5d). In line with this model, we have shown that MDRs are 
capable of conferring a hypomethylated state on heterologous DNA 
in ES cells and that they can further protect against de novo meth-
ylation during differentiation. As this protective activity of MDRs 
seems to depend on DNA-binding motifs, it is conceivable that DNA 
methylation states are influenced by tissue-specific expression of 
trans-acting factors. In line with this notion, differentiation-induced 
de novo methylation of the Gtf2a1l MDR coincides with transcrip-
tional downregulation of Rfx2 (data not shown), which binds this 
MDR in ES cells (Fig. 4d). The expressed repertoire of trans-acting 
factors might therefore explain the observed tissue specificity of 
promoter DNA methylation4,5,9,14,15,44, as well as the variability of 
DNA methylation in regions adjacent to CpG islands, referred to as 
CpG island shores45–47. Similarly, loss of MDR protective activity, 
for example, through loss of DNA-binding factors in disease, might 
define aberrant targets of de novo methylation, as has been suggested 
in cancer48.
These findings do not exclude the possibility that chromatin 
structure is crucial in mediating local DNA methylation; however, 
our results show that the local DNA sequence is the primary deter-
minant of target specification for DNA methylation in mammals. 
This genetic determination further predicts that sequence variation 
between individuals can contribute to differential DNA methylation 
patterns, which needs to be taken into account by any study linking 
DNA methylation differences to phenotypes.
METhODS
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
ACknoWLeDgMentS
We are grateful to M. Pietrzak for sequencing. We thank M. Lorincz of the 
University of British Columbia–Vancouver for providing plasmids for RMCE 
and S. Fiering for advice. We would also like to thank members of the Schübeler 
group and S. Gasser for critical comments on the manuscript. F.L. is supported 
by a PhD fellowship of the Boehringer Ingelheim Fonds. Research in the 
laboratory of A.D. is supported by the Intramural Program of National Institute 
of Diabetes and Digestive and Kidney Diseases, US National Institutes of 
Health. Research in the laboratory of D.S. is supported by the Novartis Research 
Foundation, by the European Union (NoE “EpiGeneSys” FP7-HEALTH- 
2010-257082, LSHG-CT-2006-037415), the European Research Council  
(ERC-204264) and by the RTD “Cellplasticity” of the Swiss initiative in  
Systems Biology (SystemsX.ch).
AUtHoR ContRIBUtIonS
F.L. and C.W. performed experiments. I.S. and A.D. generated the target  
ES cell line. F.L., F.M. and D.S. designed the study, analyzed data and wrote  
the manuscript.
CoMPetIng FInAnCIAL InteReStS
The authors declare no competing financial interests. 
Published online at http://www.nature.com/naturegenetics/.  
Reprints and permissions information is available online at http://www.nature.com/
reprints/index.html.
1. Law, J.A. & Jacobsen, S.E. Establishing, maintaining and modifying DNA methylation 
patterns in plants and animals. Nat. Rev. Genet. 11, 204–220 (2010).
2. Li, E., Bestor, T.H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase 
gene results in embryonic lethality. Cell 69, 915–926 (1992).
3. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 
(2002).
4. Lister, R. et al. Human DNA methylomes at base resolution show widespread 
epigenomic differences. Nature 462, 315–322 (2009).
5. Weber, M. et al. Distribution, silencing potential and evolutionary impact of promoter 
DNA methylation in the human genome. Nat. Genet. 39, 457–466 (2007).
6. Brandeis, M. et al. Sp1 elements protect a CpG island from de novo methylation. 
Nature 371, 435–438 (1994).
7. Macleod, D., Charlton, J., Mullins, J. & Bird, A.P. Sp1 sites in the mouse aprt gene 
promoter are required to prevent methylation of the CpG island. Genes Dev. 8, 
2282–2292 (1994).
8. Dickson, J. et al. VEZF1 elements mediate protection from DNA methylation. PLoS 
Genet. 6, e1000804 (2010).
9. Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and 
differentiated cells. Nature 454, 766–770 (2008).
10. Hawkins, R.D. et al. Distinct epigenomic landscapes of pluripotent and lineage-
committed human cells. Cell Stem Cell 6, 479–491 (2010).
11. Tamaru, H. & Selker, E.U. A histone H3 methyltransferase controls DNA methylation 
in Neurospora crassa. Nature 414, 277–283 (2001).
12. Jackson, J.P., Lindroth, A.M., Cao, X. & Jacobsen, S.E. Control of CpNpG DNA 
methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416, 
556–560 (2002).
©
20
11
 N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
Nature GeNetics  ADVANCE ONLINE PUBLICATION 
A rt i c l e s
13. Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns 
and paradigms. Nat. Rev. Genet. 10, 295–304 (2009).
14. Farthing, C.R. et al. Global mapping of DNA methylation in mouse promoters reveals 
epigenetic reprogramming of pluripotency genes. PLoS Genet. 4, e1000116 
(2008).
15. Mohn, F. et al. Lineage-specific polycomb targets and de novo DNA methylation 
define restriction and potential of neuronal progenitors. Mol. Cell 30, 755–766 
(2008).
16. Brenner, C. et al. Myc represses transcription through recruitment of DNA 
methyltransferase corepressor. EMBO J. 24, 336–346 (2005).
17. Suzuki, M. et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. 
Oncogene 25, 2477–2488 (2006).
18. Sato, N., Kondo, M. & Arai, K. The orphan nuclear receptor GCNF recruits DNA 
methyltransferase for Oct-3/4 silencing. Biochem. Biophys. Res. Commun. 344, 
845–851 (2006).
19. Velasco, G. et al. Dnmt3b recruitment through E2F6 transcriptional repressor 
mediates germ-line gene silencing in murine somatic tissues. Proc. Natl. Acad. Sci. 
USA 107, 9281–9286 (2010).
20. Zhao, Q. et al. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, 
coupling histone and DNA methylation in gene silencing. Nat. Struct. Mol. Biol. 16, 
304–311 (2009).
21. Viré, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. 
Nature 439, 871–874 (2006).
22. Robertson, K.D. DNA methylation and human disease. Nat. Rev. Genet. 6, 597–610 
(2005).
23. Dulac, C. Brain function and chromatin plasticity. Nature 465, 728–735 (2010).
24. Borgel, J. et al. Targets and dynamics of promoter DNA methylation during early 
mouse development. Nat. Genet. 42, 1-93–1100 (2010).
25. Bibel, M. et al. Differentiation of mouse embryonic stem cells into a defined neuronal 
lineage. Nat. Neurosci. 7, 1003–1009 (2004).
26. Fromm, G. & Bulger, M. A spectrum of gene regulatory phenomena at mammalian 
beta-globin gene loci. Biochem. Cell Biol. 87, 781–790 (2009).
27. Lienert, F. et al. Genomic prevalence of heterochromatic H3K9me2 and transcription 
do not discriminate pluripotent from terminally differentiated cells. PLoS Genet. 7, 
e1002090 (2011).
28. Feng, Y.Q. et al. Site-specific chromosomal integration in mammalian cells: highly 
efficient CRE recombinase-mediated cassette exchange. J. Mol. Biol. 292, 779–785 
(1999).
29. Schübeler, D. et al. Genomic targeting of methylated DNA: influence of methylation 
on transcription, replication, chromatin structure, and histone acetylation. Mol. Cell. 
Biol. 20, 9103–9112 (2000).
30. Lorincz, M.C., Schubeler, D., Hutchinson, S.R., Dickerson, D.R. & Groudine, M. 
DNA methylation density influences the stability of an epigenetic imprint and 
Dnmt3a/b-independent de novo methylation. Mol. Cell. Biol. 22, 7572–7580 
(2002).
31. Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining 
factor in embryonic stem cells. Cell 113, 643–655 (2003).
32. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency 
in mouse epiblast and ES cells. Cell 113, 631–642 (2003).
33. Deb-Rinker, P., Ly, D., Jezierski, A., Sikorska, M. & Walker, P.R. Sequential DNA 
methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during 
neuronal differentiation. J. Biol. Chem. 280, 6257–6260 (2005).
34. Levasseur, D.N., Wang, J., Dorschner, M.O., Stamatoyannopoulos, J.A. & Orkin, S.H.  
Oct4 dependence of chromatin structure within the extended Nanog locus in ES 
cells. Genes Dev. 22, 575–580 (2008).
35. Illingworth, R. et al. A novel CpG island set identifies tissue-specific methylation 
at developmental gene loci. PLoS Biol. 6, e22 (2008).
36. Kim, M. et al. Regulatory factor interactions and somatic silencing of the germ 
cell–specific ALF gene. J. Biol. Chem. 281, 34288–34298 (2006).
37. Pant, V. et al. The nucleotides responsible for the direct physical contact between 
the chromatin insulator protein CTCF and the H19 imprinting control region manifest 
parent of origin-specific long-distance insulation and methylation-free domains. 
Genes Dev. 17, 586–590 (2003).
38. Horvath, G.C., Kistler, M.K. & Kistler, W.S. RFX2 is a candidate downstream 
amplifier of A-MYB regulation in mouse spermatogenesis. BMC Dev. Biol. 9, 63 
(2009).
39. Sharif, J. et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting 
Dnmt1 to methylated DNA. Nature 450, 908–912 (2007).
40. Rauch, T.A., Wu, X., Zhong, X., Riggs, A.D. & Pfeifer, G.P. A human B cell 
methylome at 100–base pair resolution. Proc. Natl. Acad. Sci. USA 106, 671–678 
(2009).
41. Deaton, A.M. & Bird, A. CpG islands and the regulation of transcription. Genes 
Dev. 25, 1010–1022 (2011).
42. Thomson, J.P. et al. CpG islands influence chromatin structure via the CpG-binding 
protein Cfp1. Nature 464, 1082–1086 (2010).
43. Cohen, N.M., Kenigsberg, E. & Tanay, A. Primate CpG islands are maintained by 
heterogeneous evolutionary regimes involving minimal selection. Cell 145, 773–786 
(2011).
44. Schilling, E. & Rehli, M. Global, comparative analysis of tissue-specific promoter 
CpG methylation. Genomics 90, 314–323 (2007).
45. Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island 
shores distinguishes human induced pluripotent stem cells, embryonic stem cells 
and fibroblasts. Nat. Genet. 41, 1350–1353 (2009).
46. Irizarry, R.A. et al. The human colon cancer methylome shows similar hypo- and 
hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 
178–186 (2009).
47. Ji, H. et al. Comprehensive methylome map of lineage commitment from 
haematopoietic progenitors. Nature 467, 338–342 (2010).
48. Gebhard, C. et al. General transcription factor binding at CpG islands in normal 
cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer 
Res. 70, 1398–1407 (2010).
49. Pachkov, M., Erb, I., Molina, N. & van Nimwegen, E. SwissRegulon: a database of 
genome-wide annotations of regulatory sites. Nucleic Acids Res. 35, D127–D131 
(2007).
©
20
11
 N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
Nature GeNetics doi:10.1038/ng.946
ONLINE METhODS
Cell culture. TC-1 ES cells (background 129S6/SvEvTac) were cultured and 
differentiated as previously described15,50.
Homologous recombination. The pZRMCE plasmid used for targeting mouse 
TC-1 ES cells (background 129S6/SvEvTac) in the β-globin locus was con-
structed in the pZERO multiple cloning site (MCS) and included a 2.4-kb 
NotI–XhoI fragment designated upstream arm (from positions –3,700 to 
–1,300 relative to the Hbb-y ATG start) and a 3.0-kb KpnI–NotI downstream 
arm (positions +2,332 to +5,432) cloned 5′ and 3′, respectively, to the selection 
cassette that was flanked by inverted loxP sites (L1-HygR-TK-1L28). Further 
5′ to the upstream arm at the FspI site of the vector, a SalI–ClaI fragment 
containing the gene encoding diptheria toxin A (DTA) was inserted.
TC-1 ES cells were electroporated with 100 µg of pZRMCE plasmid using 
a Bio-Rad Gene Pulser (at 500 µF and 250 V/cm). Cells were selected with 
150 µg/ml hygromycin for 7–10 d after transfection. Clones were tested for 
successful recombination events by Southern blot analysis.
Recombinase-mediated cassette exchange. For targeted insertion, DNA frag-
ments were cloned into a plasmid containing a multiple cloning site flanked 
by two inverted L1 Lox sites (a kind gift from M. Lorincz). Promoter regions 
were amplified from TC-1 ES cell genomic DNA. Start and end sites relative 
to the TSS of promoter fragments are depicted in Supplementary Figures 1, 
2, 5, 9, 10, 11 and 12, with the TSS corresponding to the following genomic 
coordinates (mm9): Nanog (chr6:122′657′610), Tcl1 (chr12:106′460′914), Trf 
(chr9:103′132′448), Gtf2a1l (chr17:89′068′017), Fes (chr7:87′532′781), Syt1 
(chr10:108′448′031), Zic3 (chrX:55′283′805), Orm1 (chr4:63′005′600), Mrap 
(chr16:90′738′569) and Hes3 (chr4:151′665′771).
RMCE was performed as described28 with slight modifications. TC-1 ES 
cells were selected under hygromycin (250 µg/ml, Roche) for 10 d. Next, 4 × 
106 cells were electroporated (Amaxa nucleofection, Amaxa) with 25 µg of 
L1-promoter-1L plasmid and 15 µg of pIC-Cre (a kind gift from R. Terranova). 
Selection with 3 µM Ganciclovir (Roche) was started 2 d after transfection and 
continued for 7–10 d. Clones were tested for successful insertion events by 
PCR and Southern blot analysis.
Chromatin immunoprecipitation. ChIP experiments were performed as 
described15, starting with 70 µg of chromatin and 5 µg of antibodies to the 
following: RNA Pol II (Santa Cruz Biotechnology, no. SC899), dimethyl-H3K4 
(Upstate, no. 07-030) and Rfx2 (Santa Cruz Biotechnology, no. SC10557). Real-
time PCR was performed using SYBR Green chemistry (Applied Biosystems) 
and 1/80 of the ChIP reaction or 20 ng of input chromatin per PCR reaction. 
Primer sequences are listed in Supplementary Table 1.
RT-PCR. RNA was isolated using TRIzol (Invitrogen) and subsequently DNase 
digested (RQ1 RNase-free DNase, Promega). First-strand cDNA was generated 
using random hexamers (Superscript III, Invitrogen) and analyzed by real-time 
PCR using SYBR Green chemistry. Expression levels of primary transcripts 
were calculated as 1 / Ct, followed by subtraction of the control lacking reverse 
transcriptase and normalization for amplification efficiency. Primer sequences 
are listed in Supplementary Table 1.
Bisulfite sequencing. Genomic DNA (2 µg) was bisulfite converted with the 
EpiTec Bisulfite Kit (QIAGEN). Regions of interest were amplified by PCR and 
cloned by TOPOTA cloning (Invitrogen). Sequences were analyzed using BiQ 
Analyzer51. Primer sequences for PCR are listed in Supplementary Table 1.
50. Bibel, M., Richter, J., Lacroix, E. & Barde, Y.A. Generation of a defined and uniform 
population of CNS progenitors and neurons from mouse embryonic stem cells. Nat. 
Protoc. 2, 1034–1043 (2007).
51. Bock, C. et al. BiQ Analyzer: visualization and quality control for DNA methylation 
data from bisulfite sequencing. Bioinformatics 21, 4067–4068 (2005).
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Supplementary Figure 1 Recapitulation of DNA methylation at ectopic Nanog promoter. (a-c) DNA methylation 
levels are shown for the endogenous Nanog locus (a) and the inserted 5.7 kb (b) and 1 kb (c) promoter fragments 
in stem cells (ES) and neuronal progenitors (NP). CpGs are depicted as vertical bars and the two loxP sites by 
triangles. The gray box indicates sequence regions corresponding to the endogenous promoter with start and end 
of the region relative to the transcriptional start site indicated above. DNA methylation levels for single CpGs are 
depicted as black (methylated) or white (unmethylated) circles. Every line corresponds to a sequenced bisulfite 
PCR amplicon. The numbers indicate percentage of methylated CpGs in the promoter regions highlighted by a 
gray bar. Red bars indicate regions whose methylation levels are compared in Supplementary Fig. 2t.
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methylation [%]
promoter region state endog. insert
Nanog 1 ES 7.4 2.8
Nanog 1 NP 41.1 43.3
Nanog 2 ES 2.5 20.2
Nanog 2 NP 47.2 93.8
Tcl1 1 ES 23.3 8.1
Tcl1 1 NP 97.6 88.9
Tcl1 2 ES 46.4 45.2
Trf 1 ES 13.8 10.8
Trf 2 ES 75.0 70.5
Trf 1 NP 74.3 76.3
Trf 2 NP 94.4 93.1
Alf 1 ES 11.3 9.5
Alf 1 NP 83.2 50.4
Fes 1 ES 28.6 23.2
Fes 1 NP 34.2 27.5
Syt1 1 ES 1.1 0.6
Syt1 1 NP 3.2 7.1
Syt1 2 ES 1.4 15.8
Syt1 2 NP 6.6 23.4
Zic3 1 ES 2.9 1.4
Zic3 1 NP 3.3 1.7
Orm1 1 ES 98.6 84.5
Orm1 1 NP 100.0 92.9
Mrap 1 ES 88.5 90.7
Mrap 1 NP 98.3 92.6
Mrap 2 ES 77.6 84.5
Mrap 2 NP 97.1 96.8
Hes3 (1.6kb) 1 ES 14.0 23.6
Hes3 (1.6kb) 1 NP 60.0 65.5
Supplementary Figure 2 Recapitulation of DNA methylation at ectopic promoter fragments. (a-s) DNA methyla-
tion levels are shown as in Supplementary Fig. 1. For most inserts methylation is also shown for the endog-
enous promoter as a comparison. Some of these has been published before (Mohn et al.,Mol Cell, 2008). (t) 
Comparison of methylation levels between inserted fragment and endogenous promoter as determined by 
bisulfite PCR illustrating the quantitative similarity in DNA methylation levels. Analyzed regions are indicated by 
a red bar and number in Supplementary Figs. 1 and 2 a-s.
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Supplementary Figure 3 H3K4me2 occupancy (in ES and NP cells) at inserted 1 kb promoter fragments. ChIP 
enrichments were normalized against Hprt.
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Supplementary Figure 4 RNA levels and RNA PolII occupancy in ES cells at inserted 1 kb promoter 
fragments. RNA levels were determined using reverse transcription followed by real-time PCR and 
normalized to LaminB. Values at a methylated promoter and at an intergenic region are shown as a 
comparison. Error bars indicate standard deviation from two independent biological replicates. ChIP 
enrichments for RNA PolII were normalized against Hprt. 
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Supplementary Figure 5 DNA methylation at inserted truncated promoter fragments. 
(a-e) DNA methylation levels are shown as in Supplementary Fig. 1. 
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Supplementary Figure 6 H3K4 dimethylation and RNA levels at inserted truncated promoter fragments. 
(a) H3K4me2 occupancy (in ES and NP cells) at three inserted truncated promoter fragments. ChIP enrich-
ments for H3K4me2 were normalized against Hprt. (b) RNA levels in ES cells at inserted Alf MDR. RNA levels 
were determined using reverse transcription followed by real-time PCR and normalized to LaminB. Values at a 
methylated promoter and at an intergenic region are shown as a comparison. Error bars indicate standard 
deviation from two independent biological replicates.  
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ab
c
AGA GGG AAA CAA CCC AGA CCGCC AGC TGG TAT CTT CGA CT6.8796Fr11
TTC TGG TGT GAT CCC GTT CTTAC CGG TGA ACT GGT GGG TA6.7761Fr10
CTG CCA GAC CTT CAG GGA TAGGT AAA CCA GTG AGC CGA AA6.6761Fr12
GCA GGG TTA ACG CTT TCT GAGAT GGG CGA GGT TGT CTA AC6.5832Fr1
GAT GTC CGA CCA GGA TTA GCCTA CGG TGC TGA AGC AAC AA6.5781Fr4
AAT GTA TCA GTT CGC TTG CTC AAAC TGG GGA TTG TTC AGG TG4.5762Fr6
TAT TGA AAC AGC GAC GAT GCAAA AGG TCG GGG AAC TGA TT5.3782Fr5
CCT TTG CGA CCA ACT CAT CAAC GTG CCT ACC GTA AGC TG5.4780Fr2
GGC CTA CAG TCC TGG TAC AAAAAG CCC TTC ATC AGC AAA GA4.5798Fr3
TCG TTT ACT CGT ATG GCG TTTCCT TTG ATG ACA GCC CAG TT4.4780Fr9
Primer sLength [bp] Primer asCpG frequency [%]
171/190 93.6% 48/64
131/156 84.0%
Fr3
Fr9
Supplementary Figure 7
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Supplementary Figure 7 DNA methylation at inserted sequences from E.coli. (a) Table showing length 
and CpG density of each fragment. The last two columns indicate primer sequences that were used for 
amplification of fragments from  E.coli genomic DNA (TOP10, Invitrogen). (b-k) DNA methylation levels of 
inserted E.coli sequences in stem cells are shown as in Supplementary Fig. 1.
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Supplementary Figure 8  H3K4me2 occupancy in ES cells at inserted E.coli sequences. ChIP enrichments 
for H3K4me2 were normalized against Hprt. The three fragments that possess low DNA methylation show 
enrichment for H3K4me2. Interestingly, Fr10 is also occupied by H3K4me2 although being methylated to 
83.3%. At this fragment, H3K4me2 might be specifically enriched at unmethylated alleles in analogy to what 
has been shown for a CpG-rich transgene (Thomson J.P., Nature,2010). 
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Supplementary Figure 9 DNA methylation levels at inserted Alf MDR containing different mutations.
DNA methylation levels in stem cells are shown as in Supplementary Fig. 1. Sequence mutations are shown in 
Fig. 4.
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Supplementary Figure 10 DNA methylation levels at inserted MDRs in neuronal progenitors.
DNA methylation levels in neuronal progenitors are shown as in Supplementary Fig. 1.
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Supplementary Figure 11
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Supplementary Figure 11 DNA methylation levels at inserted hybrid fragments.
(a-j) DNA methylation levels in stem cells are shown as in Supplementary Fig. 1. (k) DNA methylation levels of 
Orm1 hybrids are shown as in Fig. 5b. (n.d. = not determined)
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Supplementary Figure 12
Supplementary Figure 12 Syt1 MDR overrides de novo methylation of Alf MDR. (a) DNA methylation levels at 
inserted hybrid of the Alf and Syt1 MDR in embryonic stem cells (ES) and neuronal progenitors (NP) are shown 
as in Supplementary Fig. 1. (b) DNA methylation at the endogenous Alf promoter in the same clone is shown as 
a control.
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217/262 = 82.8%
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Supplementary Table 1
Primer sequences 
The first three subtables indicate the combinations of primers used for reverse transcription RT-PCR,
 ChIP RT-PCR and bisulfite PCR.
The last subtable indicates the primer sequences.
Reverse Transcription RT-PCR
promoter location fragment s-primer # as-primer #
Nanog endog. Nanog outs.1 Nanog RT1
Nanog insert. 1kb 44 Nanog RT1
Zic3 endog. 520 521
Zic3 insert. 1kb 44 6
Tcl1 endog. 101 85
Tcl1 insert. 1kb 30 85
Trf endog. 51 65
Trf insert. 1kb 44 51
Syt1 endog. 73 45
Syt1 insert. 1kb 30 45
Alf endog. 10 56
Alf insert. 1kb 44 10
Alf insert. MDR 44 386
Fes endog. 49 67
Fes insert. 1kb 30 49
LaminB endog. 518 519
Gapdh endog. 516 517
Mrap endog. 522 523
intergenic endog. interg3 s interg3 as
Nature Genetics: doi:10.1038/ng.946
ChIP RT-PCR
promoter location fragment s-primer # as-primer #
Nanog endog. Nanog outs.1 Nanog RT1
Nanog insert. 1kb 30 Nanog RT1
Nanog insert. MDR 30 fm60
Tcl1 endog. 101 85
Tcl1 insert. 1kb 30 85
Trf endog. 51 65
Trf insert. 1kb 44 51
Syt1 endog. 73 45
Syt1 insert. 1kb 44 46
Alf endog. 56 10
Alf endog. mGTFA1L as2 mGTFA1L s2
Alf insert. 1kb 44 10
Alf insert. MDR 44 386
Alf insert. Alf (A) 44 171
Fes endog. 49 67
Fes insert. 1kb 44 50
Hes3 endog. 53 27
Hes3 insert. 1kb 30 27
Pdcl2 endog. 502 503
Oct4 endog. Oct s Oct as
E.coli Fr9 insert. 30 354
E.coli Fr3 insert. 44 389
E.coli Fr6 insert. 30 351
E.coli Fr5 insert. 44 391
E.coli Fr2 insert. 30 347
E.coli Fr1 insert. 44 387
E.coli Fr4 insert. 30 349
E.coli Fr12 insert. 30 415
E.coli Fr10 insert. 30 411
E.coli Fr11 insert. 30 413
Bisulfite PCR
promoter location fragment s-primer # as-primer #
Nanog endog. 327 317
Nanog endog. 255 Nanog bis. 1
Nanog endog. 437 302
Nanog insert. 5.7 kb Mb 1 317
Nanog insert. 5.7 kb 277 303
Nanog insert. 1 kb Mb 1 Nanog bis. 1
Nanog insert. 1 kb 277 302
Nanog insert. 1 kb 277 303
Tcl1 insert. 1kb Mb 1 Tcl1 bis. A
Tcl1 insert. 1kb 277 137
Trf endog. 107 42
Trf endog. 108 43
Trf insert. 1kb Mb 1 42
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Trf insert. 1kb 277 43
Alf endog. 39 bGTF2A1LF as1
Alf insert. 1kb Mb 1 38
Alf insert. 1kb 277 123
Fes insert. 1kb Mb 1 326
Fes insert. 1kb Mb 1 36
Fes insert. 1kb 277 37
Syt1 endog. 321 105
Syt1 insert. 1kb Mb 1 105
Syt1 insert. 1kb Mb 1 35
Syt1 insert. 1kb 277 34
Zic3 insert. 1kb Mb 1 62
Orm1 insert. 1kb Mb 1 279
Orm1 insert. 1kb 277 299
Mrap insert. 1kb Mb 1 289
Mrap insert. 1kb 277 301
Hes3 endog. 59 32
Hes3 endog. 33 50
Hes3 insert. 1kb Mb 1 404
Hes3 insert. 1.6kb Mb 1 315
Hes3 insert. 1.6kb 277 159
Hes3 insert. Hes3 (D) Mb 1 315
Hes3 insert. Hes3 (D) 277 325
Hes3 insert. Hes3 (F) Mb 1 315
Hes3 insert. Hes3 (F) 277 325
Hes3 insert. Hes3 (G) Mb 1 315
Hes3 insert. Hes3 (H) 277 431
Trf insert. Trf (B) Mb 1 135
Trf insert. Trf (B) 277 133
Trf insert. Trf (D) Mb 1 135
Trf insert. Trf (D) 277 133
Trf insert. Trf (F) 277 133
Trf insert. Trf (E) 277 133
Trf insert. Trf (C) Mb 1 42
Trf insert. Trf (C) 277 43
Syt1 insert. Syt1 (A) Mb 1 35
Syt1 insert. Syt1 (A) 277 34
Syt1 insert. Syt1 (B) Mb 1 105
Syt1 insert. Syt1 (C) Mb 1 35
Syt1 insert. Syt1 (C) 277 134
Syt1 insert. Syt1 (D) Mb 1 35
Syt1 insert. Syt1 (E) Mb 1 292
Syt1 insert. Syt1 (E) 277 293
Alf insert. Alf (A) Mb 1 38
Alf insert. Alf (A) Mb 1 128
Alf insert. Alf (D) Mb 1 128
Alf insert. Alf (C) Mb 1 128
Alf insert. Alf (C) 277 129
Nanog insert. Nanog (A) Mb 1 122
Nanog insert. Nanog (B) Mb 1 Nanog bis. 1
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Nanog insert. Nanog (C) Mb 1 Nanog bis. 1
Nanog insert. Nanog (C) 277 144
Nanog insert. Nanog (D) Mb 1 143
Nanog insert. Nanog (F) Mb 1 143
Nanog insert. Nanog (J) Mb 1 143
Nanog insert. Nanog (J) 277 144
E.coli Fr9 insert. Mb 1 381
E.coli Fr9 insert. 277 382
E.coli Fr3 insert. Mb 1 370
E.coli Fr6 insert. Mb 1 375
E.coli Fr5 insert. 373 374
E.coli Fr2 insert. Mb 1 368
E.coli Fr2 insert. 277 357
E.coli Fr1 insert. Mb 1 356
E.coli Fr1 insert. 277 355
E.coli Fr4 insert. Mb 1 371
E.coli Fr4 insert. 277 372
E.coli Fr12 insert. Mb 1 424
E.coli Fr12 insert. 277 423
E.coli Fr10 insert. Mb 1 418
E.coli Fr10 insert. 277 417
E.coli Fr11 insert. 420 434
Hes3 - Mrap insert. Mb 1 315
Hes3 - Mrap insert. Mb 1 314
Hes3 - Mrap insert. Mb 1 141
Hes3 - Mrap insert. 278 289
Hes3 - Mrap insert. 277 301
Syt1 - Mrap insert. Mb 1 292
Syt1 - Mrap insert. 293 289
Syt1 - Mrap insert. 277 301
Alf - Mrap insert. Mb 1 289
Alf - Mrap insert. 277 301
Hes3 - Orm1 insert. Mb 1 314
Hes3 - Orm1 insert. Mb 1 141
Hes3 - Orm1 insert. 435 279
Hes3 - Orm1 insert. 277 299
Syt1 - Orm1 insert. Mb 1 292
Syt1 - Orm1 insert. 293 279
Syt1 - Orm1 insert. 277 299
Alf - Orm1 insert. Mb 1 279
Alf - Orm1 insert. 277 280
Alf - Syt1 insert. Mb 1 35
Alf - Syt1 insert. 277 34
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primer # sequence
6 AAG TTG CAG CTC CGG GTA G
10 TTT TCA CCA TGG GGT ACA GG
27 CGG CAG GCC TGT TAA ATA GA
30 TCT TGG AAG AGA AAC TCT TAG GG
32 CTT TCC AAA TAC CTT AAA AAC CCT A
33 GGA GGA GGG AAA TTT AGG TTT TT
34 GGG GTG AAT TAA GAG GAG ATT AGA T
35 AAA TCT AAT CTC CTC TTA ATT CAC C
36 AAC TAT ACT CTC TCT TCC CTA TAA TAA ACC
37 GGT TTA TTA TAG GGA AGA GAG AGT ATA GTT T
38 CAT ACC TCA CTA AAT ATC ACT CAC AAC TA
39 TTT TAT TTT TTA AAG ATG AGG TTG TTT TAT
42 AAA TTA CAT ACA TAA CCA ACC AAT CC
43 GAT TGG TTG GTT ATG TAT GTA ATT TTT
44 TGT ATA CAG ATC TAC CAA CAT TAC GA
45 AGG TAA GGC AGC CCC ACT
46 GCG AGA GAG GCA GAA GTT TG
49 CAG AAC CCC ACC CAT GTC
50 AGG CGC CAG CCA CTA TTT
50 AGG CGC CAG CCA CTA TTT
51 GCT GGT GGC TTA GAC TAG GG
53 CAC ACG TGG ATG GCT AAA TG
56 AAA CAC AGA GGA AAT CAT CCT GA
59 TTT GGT TGG AGG AAG TGA GG
62 CTC TTC ACC TCC AAA ATA ATA TCC
65 GGT GAG GAG TCA GCA GGA TG
67 CTT CCT GCA TCT GCT GCA CT
73 ATG CAC TTG TGG TCT TGC AT
85 ATC ATT CGG GGT GAA ACA AG
101 GGA AGG TGC CTC TAG AAG AGA T
105 CAA CCC CCA ATA TCT TTC CT
107 ATA GAG GGA GGG AGA GTT GTT TT
108 AAT TTA AAC CCC AAA ATT CTA ACT TC
122 TCT ATA CAA AAC ATC TCA ATA ACA AAC C
123 TTT AGT GAG GTA TGG TAA AAA TAG GAA
128 CTT CCT CCT TAC CAC CAA ATT A
129 TTA ATT TGG TGG TAA GGA GGA A
133 GGT GAT TAT TAG GGT AAG AAA GGA
134 TTT GGG TTT TAG AAG AAA AAT AAA T
135 CCC TAA TAA TCA CCT CAT TTC CT
137 GGA ATA GGG GTA AGG TTT AGG TT
141 CAA AAC AAA TTA CCC TAC TAC TAA CTT AAC
143 AAA CAT CCT CTA ATC TAA AAA CAT CC
144 GAT TAA TTG TGA ATT TAT AGG GTT GG
159 TTT AAA GTT TGT TTT TGT AGT TGA GG
171 GCA AAC GGT TAG GCA CAG AG
255 GTA TGG TGG TAG ATA AGT TTG GTT TAT
277 ATA TAA AAT AAT AAC AAT ATA TAC AAA TCT ACC AAC
Nature Genetics: doi:10.1038/ng.946
278 GTT TTT GGA TAG GGG TTT GTT
279 TAC TAT CCC TAA CTT CAA TCC CAT AC
280 TTT ATT AGT ATT TGG GAA ATG TTT TG
289 CCC CTA ACC TTC CAA CCA TA
292 TAT CAA ATA ACC AAA AAC AAA CTT CT
293 TAG AAG TTT GTT TTT GGT TAT TTG AT
299 ATT TAG AGT TAT TAG GTT TGG GAA AA
301 GTA GGG TTT TTG GTT TTT GTT TTT
302 TTG ATT TGG TTG GTG TTT TG
303 AGA TAT TGA GTT TTT TGG TTG TTG
314 CCA AAC ACA ATA CCC TTA ACA CT
315 ACT TCA ATC ACA TCA CCA ACC
317 AAC CCC CAT TCC TAT CCT AC
321 ATA GAG GAG AGA ATG GAA GAA GTA AG
325 GTT GGT GAT GTG ATT GAA GTT TA
326 AAC ACT ATT AAA AAC CCT AAA C
327 TTT TAA TTT TAG TTT TTT AGA GTT AGA GGT AG
347 CTT CGC CAT CTC CAT CAT CT
349 CTA CCT GAC CAC CTG TGT CG
351 TAT ACC AGA GGC GGT TCC TG
354 TGC GTA AGT CGT ACC TGC AC
355 GGG GTG TTG AAG GTT TTA TAG ATA G
356 TAT AAA ACC TTC AAC ACC CCA CTA C
357 GGT TAT TAT TAT GAA AGT ATT AGT TTT AGG TAT G
368 AAC TCT CAA CCT TAA ACA AAA TCA A
370 CTT CAT TTC CAA ACA ACA TTA AAA C
371 ACC TAT CCT ACA CAT CAA AAC TCA A
372 ATT GAG TTT TGA TGT GTA GGA TAG G
373 TGT GAT GTA TTT TGG AAA TTG AA
374 CAA AAT CTT ACT AAA AAT TCT TAC ACT TAC T
375 CAA TTA TCA TTA CAT CAT TCC CTT T
381 CCT AAA AAT ATA CCT TTC CCT TCA
382 TGA AGG GAA AGG TAT ATT TTT AGG
386 CAA CCT GGT GGT AAG GAG GA
387 AAC GCT TGC CAT TGC TTA CT
389 CAG TGT GAA ATT GAC ATA AAT GTG G
391 TGC AGG TAG CCC AGT TCA A
404 CAA AAT AAA CAA CTA TCT CTC CTT ACC
411 AGT CCC CAC ACG CAT ATC TC
413 GCA AAA TGG TGC CGT AAC TT
415 GAA GTT GGG GAT GAC ATT GC
417 TGG TAG GGT TTA TAT TGT TGT GTT
418 CCA TCA AAT CCC CAC ATA AA
420 TTT GAT GTT ATT TGA TGT TTA GAG G
423 TTG TGT TGG GTT ATG GAA TG
424 TCC ATT AAT AAA ATA AAC AAC ATA ATC C
431 GAT TTT GTG ATT GAA GTT TAG AGG
434 ACC CAA ACA ACC AAA ATA TTA ACT T
435 TTA AGT TAG TAG TAG GGT AAT TTG TTT TG
437 CCC TAC TAC TAA AAA CAC CAC TCA
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502 ATC AGG GCC TCA AAC TTC CT
503 AGA TGC CCC AGA ACT TGA TG
516 TAT GCC CGA GGA CAA TAA GG
517 ACC GCC GTT ATG AAA TCT TG
518 CGT GGC GAT CAT TTC TAG GT
519 AAC CCA CCA GAT GCT TTG TC
520 CTC CCC AAC TCA GTC AGC TC
521 CAA AAT AGG GGG AGG GAG AG
522 CAA GCG TAA GTC GGA ACA CA
523 GTT TGA GTC CCA TGC CTG AT
bGTF2A1LF as1 TAC CCT AAA ACC TAA ATA ACC TCA ATT AA
Oct as TCA CCT AGG GAC GGT TTC AC
fm60 GCG TTT CTT GCT TGC TCT TC
Oct s ACC TCC GTC TGG AAG ACA CA
interg3 as GGA CAG ACA TCT GCC AAG GT
interg3 s ATG CCC CTC AGC TAT CAC AC
Mb 1 ATT AAA TAA AAT GAA AGT TTT GGA AGA G
mGTFA1L as2 AGT AGG ACC GGG CAA GAA AG
mGTFA1L s2 TGA GGC ATG GTA AAA ACA GG
Nanog bis. 1 AAA ACA CCA ACC AAA TCA ACC
Nanog outs.1 TCC TGT GTC CCG GAT CTC TA
Nanog RT1 AAA CGG GCT GAA GGG TTA TT
Tcl1 bis. A CAA ACC CAC ACC TAA TAA TAA TAA ATA A
Nature Genetics: doi:10.1038/ng.946
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3.2.3. Additional results 
 
Demethylation of in vitro methylated promoters 
 
 Our site-specific insertion experiments revealed that the underlying sequence is 
sufficient to recapitulate an unmethylated promoter state in ES cells. While the promoter 
fragments used in these experiments were cloned in E.coli and therefore were unmethylated 
at the time point of insertion, previous work indicated that ES cells are able to demethylate 
DNA that is in vitro methylated before genomic integration (Frank et al. 1991). In order to test 
this possibility, we in vitro methylated sequence fragments of the Alf and Syt1 promoter and 
inserted them in the beta globin locus. Bisulfite PCR analysis revealed that both in vitro 
methylated promoters were unmethylated after genomic insertion in ES cells (Fig. 5). It 
cannot be excluded that a minor fraction of promoter plasmids resisted in vitro methylation 
and preferentially integrated in the genome. However, it is more likely that the in vitro 
methylated promoter fragments got demethylated after genomic insertion. As the cells went 
through several rounds of replication between the time of insertion and extraction of DNA for 
bisulfite PCR, the mechanism of demethylation could be active or passive. These results 
further implicate that the binding of transcription factors that are potentially protecting these 
promoters from DNA methylation is methylation-insensitive. 
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Figure 5. In vitro methylated promoters get demethylated upon insertion in ES cells. 
(A and B) Restriction digest analysis of plasmids that were in vitro methylated at CpGs using M.SssI 
as described previously (Schubeler et al. 2001). The restriction enzyme (RE) MspI cuts both plasmids 
irrespective of methylation. In vitro methylated plasmids are not cut by the methylation-sensitive RE 
HpaII, confirming the efficiency of the M.SssI reaction. M = marker (C and D) Representation of 
methylation levels at Alf and Syt1 promoter fragments after in vitro methylation and insertion in ES 
cells. Methylation levels at fragments that were inserted without in vitro methylation are shown as a 
comparison.
 123 
 
  
 124 
 
 
 
 
 
 
 
 
 
 
 
 
4. General conclusions 
General conclusions 
 
125 
 
While there are several chromatin marks that correlate with gene repression, the 
dynamics and establishment of their genomic distribution is still poorly understood. During 
my PhD studies I have investigated the genomic targeting of two repressive chromatin 
modifications: H3K9me2 and DNA methylation. Genome-wide mapping of H3K9me2 during 
neuronal differentiation revealed that this heterochromatic mark is almost as highly abundant 
in pluripotent ES cells as in post-mitotic neurons. Together with results from other groups our 
data suggest that cellular differentiation entails local, rather than global changes in 
repressive chromatin modifications. Our study on the establishment of local patterns of DNA 
methylation revealed that this process is mediated by the underlying sequence and likely 
involves binding of transcription factors that protect from DNA methylation. 
Below I will discuss the main findings of my PhD project and how they relate to what 
is currently known about the targeting and function of H3K9me2 and DNA methylation. 
 
4.1. Genome-wide distribution of H3K9me2 
 
By genome-wide mapping we show that the H3K9me2 mark is highly abundant and 
occurs in large domains that occupy more than half of the genome. In ES cells, H3K9me2 is 
only depleted from regions that are transcribed, enriched for H3K4me2 or targeted by 
polycomb mediated H3K27me3. Remarkably, together these chromatin features include 
around 90% of all sites that are devoid of H3K9me2. These findings therefore suggest that 
H3K9me2 marks per default all euchromatic regions that are inactive and not repressed by 
polycomb. Importantly, this is in accordance with current knowledge about the protein 
machinery that sets the H3K9me2 mark. While G9a and GLP, the two enzymes which 
catalyze dimethylation of H3K9, occur as a heteromeric complex, experiments using 
methyltransferase-defective mutants provided evidence that most of the in vivo KMT activity 
depends on G9a (Tachibana et al. 2005; Tachibana et al. 2008). Interestingly, in vitro 
purified G9a is not able to modify H3 peptides that are K9 or K4 acetylated, or are pre-
modified by K4 methylation (Chin et al. 2005). As K27me3 was not included in this study, it 
remains unclear whether this mark might have a similar influence on the activity of G9a. 
Nevertheless, this in vitro specificity might explain why H3K9me2 is excluded from regions 
with H3K4 methylation or active transcription. Additionally, structural analysis revealed that 
the ankyrin repeats of G9a and GLP can themselves bind to H3K9me1 and H3K9me2 
(Collins et al. 2008) and it has therefore been speculated that establishment of H3K9me2 
involves a spreading mechanism (Collins and Cheng 2010). Such spreading could 
potentially help to set up and maintain the large domains of H3K9me2 that we and others 
have observed (Wen et al. 2009). 
General conclusions 
126 
 
Given its occurrence at most euchromatic sites that are inactive, it is tempting to 
speculate that H3K9me2 helps to keep these regions in an inaccessible chromatin state. In 
line with that, G9a seems to be involved in promoter silencing at several genes, such as 
MAGE-2, IF-β and P21 (Tachibana et al. 2002; Gyory et al. 2004; Nishio and Walsh 2004). 
However, the interaction of G9a with co-repressor machineries, such as the CtBP complex, 
suggests that G9a can induce silencing independently of its catalytic activity (Ueda et al. 
2006). It is therefore unclear whether H3K9me2 is directly involved in transcriptional 
repression and how such a process could be mediated.  
HP1 represents one candidate protein with the potential to directly bind to H3K9me2 
and impact chromatin accessibility. While best studied for its interplay with H3K9me3 at 
pericentric heterochromatin, HP1 also shows in vitro binding activity towards H3K9me2 
(Hughes et al. 2007). Furthermore, G9a and GLP seem to be required for binding of HP1 to 
euchromatin, as knockout of either enzyme diminishes euchromatic HP1 staining (Tachibana 
et al. 2005). It is therefore possible that HP1 keeps the large domains of H3K9me2 in a 
repressed chromatin state, in analogy to the situation at pericentric heterochromatin (Shinkai 
and Tachibana 2011).  
Interestingly, H3K9me2 is enriched within domains of nuclear lamina association and 
within regions of late replication timing, which both are generally associated with repressed 
genes (Hiratani et al. 2008; Wen et al. 2009; Peric-Hupkes et al. 2010). Late-replication 
timing is however not functionally linked to H3K9me2, as an induced knock-out of G9a in ES 
cells does not alter replication timing (Yokochi et al. 2009). This study further revealed that 
deletion of G9a leads to upregulation of around 170 genes, which mostly locate to the 
nuclear periphery (6 out of 6 tested genes). However, loss of H3K9me2 and accompanying 
transcriptional upregulation does not affect location to the nuclear periphery (Yokochi et al. 
2009). It therefore remains unclear how the interaction with nuclear lamina or replication 
timing might affect H3K9me2 occupied regions. 
Alternatively, domains of H3K9me2 could be functionally linked to DNA methylation, 
since G9a knock-out ES cells show reduced DNA methylation at repeat elements and at 
promoters that get de novo methylated upon differentiation. However, these defects are 
rescued upon over-expression of a catalytic mutant of G9a, making it unlikely that the 
H3K9me2 mark is directly involved in targeting of DNA methylation (Dong et al. 2008; 
Epsztejn-Litman et al. 2008). On the other hand, H3K9me2 was suggested to facilitate 
recruitment of DNMT1, since UHRF1, a major mediator of this process, binds to H3K9me2 
peptides in vitro (Hashimoto et al. 2009). However, a recent structural study questioned this 
result by showing that UHRF1 exclusively binds H3K9me3 and it therefore remains unclear 
whether H3K9me2 plays a role in ensuring proper inheritance of DNA methylation during the 
cell cycle (Rottach et al. 2010). 
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In conclusion, the large domains of H3K9me2 might be established by binding of G9a 
to nucleosomes that are unmodified at the most N-terminal part of H3. This does not exclude 
transcription factor mediated targeting of G9a to specific loci, such as to promoters during 
the process of transcriptional silencing. Establishment and maintenance of H3K9me2 
domains might be further facilitated by a self-enforcing loop through binding of G9a to the 
modification it mediates. The role of H3K9me2 in these large domains remains elusive, but 
mostly likely involves an interaction with HP1 that could establish a repressive chromatin 
state. 
 
4.2. Chromatin modifications during cellular differentiation 
 
Cell lineage specification involves a gradual decrease in the developmental potential 
of differentiating cells. This process is most famously represented in Conrad Waddington’s 
concept of the epigenetic landscape (Waddington 1957). During recent years it has become  
clear that chromatin modifications are involved in shaping the trajectories of this lineage 
specification landscape (Hemberger et al. 2009). Accordingly, it has been suggested that 
loss of pluripotency, the earliest step of differentiation, is accompanied by a major increase 
in repressive histone modifications (Gaspar-Maia et al. 2011). 
In contrast to a previous study (Wen et al. 2009), our results show that the genomic 
occupancy of H3K9me2 is similar between pluripotent ES cells and differentiated neurons. 
This finding is in accordance with several additional studies on repressive chromatin 
modifications. It has, for example, been shown that only a small subset of promoters is 
subject to de novo DNA methylation during ES cell differentiation (Farthing et al. 2008; 
Meissner et al. 2008; Mohn et al. 2008). Further, while H3K27me3 and H3K9me3 occupancy 
was reported to be slightly higher in differentiated cells than in ES cells, the observed gain 
reflected a localized expansion of preexisting domains, rather than a global increase 
(Hawkins et al. 2010). Additionally, it was shown that the number of polycomb regulated 
promoters stays constant during ES differentiation (Mohn et al. 2008). Taken together, these 
genome-wide mapping studies suggest that repressive chromatin modifications are not 
generally depleted in pluripotent cells.  
Even without a global depletion of repressive chromatin modifications, certain 
properties of the chromatin structure seem to differ between ES cells and differentiated cells 
(Meister et al. 2011). For instance, the histones H2A, H3 and H1, as well as HP1, show a 
higher turnover rate in ES cells than in committed neuronal precursor cells (Meshorer et al. 
2006). Secondly, electron spectroscopic imaging revealed that ES cells possess highly 
dispersed chromatin, in contrast to differentiated cells that contain compact chromatin 
General conclusions 
128 
 
domains (Ahmed et al. 2010). Remarkably, this apparent more open chromatin arrangement 
in ES cells does not affect the general mobility of genomic loci, which rather seems to be 
lower in ES cells when compared to differentiated cells (Masui et al. 2011). Furthermore, 
while imaging studies suggested a differentiation-induced increase of compact chromatin at 
the nuclear periphery, genome-wide mapping revealed few changes in nuclear lamina 
association during ES cell differentiation (Peric-Hupkes et al. 2010).  
Importantly, our transcriptome analysis establishes that potential ES specific 
chromatin properties are not reflected by a net transcriptional output that is unique to a 
pluripotent cell type. This result is supported by experiments using genome-wide nuclear 
run-on (GRO-seq), which did not reveal any evidence for increased intergenic transcription 
in ES cells (Min et al. 2011). 
In conclusion, our results with data from other studies show that rearrangements in 
the global distribution of repressive chromatin modifications are not involved in shaping 
Waddington’s landscape of lineage specification, and suggest that this process rather entails 
changes of repressive histone modifications and DNA methylation that are localized to 
regulatory regions. 
 
4.3. Mechanisms of setting up DNA methylation patterns 
 
Our study on the establishment of DNA methylation patterns revealed small 
sequence elements (MDRs) that protect their immediate sequence environment from DNA 
methylation in ES cells and during differentiation. Mutations in the Alf (GTF2A1L) MDR 
showed that these elements depend on a combination of DNA binding motifs and led to the 
identification of RFX2 as a potential transcription factor involved in this process. RFX2 might 
act in similarity to the zinc finger protein VEZF1, which was recently reported to mediate the 
unmethylated state at the chicken β-globin enhancer and the APRT CpG island in ES cells 
(Dickson et al. 2010). In line with a role of TFs in mediating an unmethylated DNA state, it 
was reported that a combination of different TFs is needed to protect CpG islands from 
aberrant DNA methylation in tumor cells (Gebhard et al. 2010). 
There are different scenarios how TF binding might induce an unmethylated state. 
Firstly, it has been shown that DNA binding of a bacterial protein in mammalian cells can 
protect from DNA methylation, opening the possibility that TFs could exclude the DNA 
methylation machinery by steric hindrance (Han et al. 2001). Alternatively, a combinatorial 
binding of different TFs could induce a nucleosome free region, which might represent an 
unfavorable substrate for de novo methyltransferases. However, since in vitro experiments 
suggest that DNMT3s favor naked DNA over chromatinized sequences, it is unclear whether 
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such a mechanism could occur in vivo  (Zhang et al. 2010). Finally, transcription factors 
could directly recruit KMTs that catalyze H3K4 methylation, a histone modification that 
inhibits binding of DNMT3 proteins (Ooi et al. 2007; Otani et al. 2009; Zhang et al. 2010). At 
CpG islands the establishment of H3K4 methylation could be further facilitated through 
action of CXXC domain containing proteins, such as CFP1, which bind unmethylated CpGs 
and possess or recruit H3K4 KMT activity (Thomson et al. 2010). Of note, recruitment and 
local spreading of H3K4 methylation could explain our observation that MDRs can confer 
protection from DNA methylation to neighboring sequence regions. In fact, it is also plausible 
that TF binding at DMRs protects from DNA methylation by both, steric hindrance and 
recruitment of H3K4 methylation. 
Our study further revealed that besides MDRs no additional promoter sequences are 
needed for recapitulation of differentiation-induced de novo methylation. Moreover, a MDR 
that remains unmethylated during differentiation can protect a neighboring MDR from de 
novo methylation. Together these findings suggest that de novo methylation could reflect a 
loss of protection, rather than active recruitment of DNMT3s. In such a model, regions that 
are constantly unmethylated would be protected from DNA methylation by a combination of 
TFs that bind throughout development. Conversely, at promoters that get de novo 
methylated, binding of such TFs would get lost during early embryogenesis. At CpG-rich 
promoters, protection from DNA methylation could be further facilitated through recognition 
of unmethylated CpGs by CXXC domain proteins that induce H3K4 methylation, which in 
turn inhibits binding of DNMT3s. This self-reinforcing loop might be weaker or missing at 
promoters that get de novo methylated during early development. In line with this notion, it 
was shown that de novo methylation occurs at a higher frequency at promoters that are 
enriched for an intermediate CpG density (Mohn et al. 2008; Borgel et al. 2010). Importantly, 
the here proposed model (Fig. 6) does not exclude the involvement of TFs that recruit 
DNMT3s to de novo methylated promoters, as reported for E2F6 (Velasco et al. 2010). In 
addition, it is also possible that TFs can initiate de novo methylation by targeting of H3K4 
demethylases. 
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Figure 6. Model of establishment of DNA methylation patterns. 
Combinatorial binding of transcription factors (A-F) protects from DNA methylation, possibly by steric 
hindrance or by recruitment of H3K4 KMTs. Regions that lose binding of these factors during cellular 
differentiation get de novo methylated (right panel). At CpG-rich sequences, protection from DNA 
methylation could be further facilitated through recognition of unmethylated CpGs by CXXC domain 
proteins that induce H3K4 methylation, which in turn inhibits binding of DNMT3s. 
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